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A brief review of the physiology of sleep and
of the physiological differences between the two types of
sleep, namely, rapid eye movements (REM) and orthodox (NREM)
is followed by a review of the evidence of a need for each.
The effects of commonly used hypnotics on sleep is reviewed
with particular reference to their effects on REM sleep.
SECTION Hi
General methodology, including preparation of
subjects for recording in 'projects No. 1 aftd 3 is described.
SECTION Hit
(A) All night recordings of EEG, EOG and EDG
activity of six young, healthy male adults were oarried out
after administration of 10 mg. nitrazepam or 200 mg. sodium
amylobarbitone each for two nights. Compared with four plaoebo
nights, drugs shortened the delay to onset of sleep, reduced
peroent MT (movement) time and the number of shifts to MT and
Stage 1. Sodium amylobarbitone reduced also the peroent Stage
1 time. Stage 2 time was increased on drug nights but combined
Stages 3+4 did not show any significant difference.
The drugs caused a significant reduotion in the
REM sleep time and prolonged the delay to onset of the first
REM period. EDG activity during REM sleep and Stage 4 of
NREM sleep was significantly reduoed but there was no significant
difference between the two drugs.
A more striking effect was the drug-induoed
redistribution/
of EEG stages, with Stages 3 + 4 of NREM sleep almost confined
to the first half of the night. Stage REM on the other hand,
was inhibited in the first two hours but was increased in the
last third of the night.
(B) Both drugs given to three subjeets in doubls
doses (nitrazepam 20 mg. and sodium araylobarbitone 400 mg.) for
two nights produced changes similar to those caused by small doses
but more marked. With the big dose of drugs the time to onset
of sleep, percent stage 1, MT time, number of shifts to stage 1
or MT, all showed a marked reduotion. Stage 2 was increased. REM
■leep time showed greater reduotion with the big doses §nd delay to
first REM period was also much prolonged as compared with small
doses of drugs and placebo nights. EDG activity in Stage 4 and
REM sleep was markedly inhibited.
The big doses also markedly affected the distribution
of various sleep stages in the three thirds of the night. Most
of StageB 3 + 4 of NREM occurred in the first four hours of the
night and was virtually eliminated during the last third. On
the other hand REM sleep was totally absent in the first third
and partially suppressed in the second third of the night.
All the drug-induced abnormalities of sleep were
more marked with the big dose than the small dose, thus showing
a dose-effect of these drugs on the sleep of normal human subjects.
SECTION IV:
Continuous EEG monitoring was employed in a study
of 127 cases of acute drug poisoning. The drugs involved were
especially barbiturates (50 cases); "Mandrax" (methanualone and
diphenhydramine) in 23 cases, nitrazepam (19 oases), tricyclic
antidepressants/
(10 oases) end raisosllaneous drugs (25 oasss), Ths EEG
findings as seen in ths initial reoord wars classified as
followst-
GRADE I - Alpha rhythm or predominant alpha with beta
or some rare theta (20 oases).
GRADE II - Predominantly theta with some alpha, beta or low
voltage delta (17 oases).
GRADE III - Predominantly low/high voltage delta mixed with
some theta (24 oases).
GRADE IV
GRADE V
Delta with or without brief isoeleotrio intervals
(?5 cases).
Suppression burst activity, namely where 5-10
ops activity of several seconds duration would
alternate with electrical silence (19 cases).
GRADE VI Near silence but with isolated and low voltage
5-7 ops waves occurring singly or bursts of
half a second duration (12 oases).
GRADE VII An isoelectric record totally unresponsive to
any stimuli (10 cases).
EEG grades I and II were associated with consciousness
or drowsiness? EEG grades III and IV patients were unconscious
but responded to painful stimulation. Grades V to VII were
associated vith deep coma and these three grades oould not be
distinguished clinioally.
Grade VII lasting up to 28 hours was seen in 15 cases.
Ten of these showed this pattern in the initial reoord and five
developed it sometime after admission. Eleven of these 15 cases
made a full olinioal reoovery. One of the four patients who




Sever® EEG abnormalities were seen particularly
with barbiturate? and miscellaneous groups. Nitrazepam and
fenfluramine produced least ohange of oonsoiouaneee and least
EEG change even with large overdose.
Using non-parametrio tests a significant
correlation was found between the EEG grades and the age,
clinical assessment of depth of coma, body temperature, duration
of coma and blood drug levels.
SECTION V:
After reoovery of consciousness following drug
overdose, twelve patients transferred to psychiatrio care have
been studied for periods of weeks by electrophysiological
recordings of all-night sleep. "Mandrax", methyprylon,
nitrazepam, phenobarbitone, amylobarbitone sodium, butobarbitone,
pentobarbitone, aspirin and fenfluramine cases were studied.
In the course of this study restlessness, insoafcia,
delirium and also EEG epileptio-type abnormalities were observed
in patients in whom a high degree of toleranoe and dependance had
been acouired in the presence of massive concentrations of drug.
The phenomena described oannot be deemed non-speoifio
responses to hospital admission. Restlessness at night, for
example was not maximal in these patients at their entry to the
study but maximal about the time the drug ceased to act. A
patient who had taken a phenobarbitone overdose got more and
more restless, slept less and less, and got more and more
REM sleep as the three weeks to full excretion of phenobarbitone
proceeded. Two cases of nirazepam poisoning also well illustrate




After severe poisoning with hypnotio drugs
insomnia may be severe for several nights. '7ith eventual
disappearanoe of the drug from the blood or urine (or loss
of induced EEG fast activity) intra-sleep restlessness, as
indioated by frequenoy of shifts to Stage 1 sleep or wakefulness,
and REM sleep rise to a peak. Following phenobarbltone coma
of 96 hours this latter peak occurred after 3 weeks. Return
to normal of intra-sleep restlessness, and REM sleep percent,
took about two months. Sleep with high voltage EEG slow
waves (Stages 3 and 4) was absent or low in the first two
weeks after recovery of consciousness, rising to normal
thereafter.
SECTION VI\ (APPENDIX)
The detailed results of sleep studies on patients
included in Projeot No. 3 are tabulated.
CO-OPERATIVE STUDIES.
The following studies, inoluded in this thesis, were
carried out jointly with -
1. The effects of hypnotics on the sleep of volunteers
(Section III) - Dr. Ian Oswald.
2. Late brain recovery processes after drug overdose
(Seotion V) - Dr. Ian Oswald,
3. Significance of flat records in acute drug intoxication
(Seotion IV.P.) Drs. Ian Oswald and H.J.S. Matthew.
4. Fenfluramine poisoning (Seotion IV.P. and V).
Drs. I. Riley, J. Corson and Ian Oswald.
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In 1929» Berger, a German psychiatrist,
demonstrated a primitive form of vhat we know as the electro¬
encephalogram (EEG) which ie the written reoord of electrical
potentials from the brain. This method for the investigation
of brain function in health and disease, named electroencephal¬
ography, has been used by clinicians, pharmacologists and
neurophyBiologists,
Berger (1931) himself looked for electroence¬
phalograph^ signs of the central nervous actions of some drugs,
such as chloroform, morphine, cocaine, amyl nitrite and scopolamine.
Since then there have been many studies to determine the effects
of pharmacological agents on ihe htmian brain .Such observations were
usually carried out while the subject was awake or asleep during
the day. Attention was first focussed on the overnight sleep
when, in 1937, Loomis and his co-workers pointed to the changing
characteristics of brain waves with the onset and duration of
sleep. Since then innumerable studies have been devoted to
studying sleep, but the field of electroencephalography
contains relatively few systematic studies of the^ffects of
drugs on the electrical activity of the brain.
This thesis is devoted to the study of
electroenoephalographic (EEG) effects of some hypnotics,
antidepressants/
3.
and other drugs of elinioal interest on tha human brain, in
both clinical dosage and self-administered overdosage* The
three research projects included in this thesis ares-
(1) A study of effeots of snail and larger clinical doses
of two common hypnotic agents on the sleep of nomal
healthy volunteers*
(2) Investigation of EEC changes in patients suffering
froa acute drug poisoning*
(3) Folios up study of late brain recovery of sone of
these patients after they have nade a clinical
reoovery froa acute drug poisoning*
Hypnotics commonly used in clinical practice are
divided into barbiturates* such as sodium amylobarbitone, and
non-barbiturates of which one example is nitrazepam. Both
groups are in frequent clinical use but knowledge of their
effects on sleep is incomplete and much of the existing work
requires confirmation.
In a previous study (Haider* I960), 200 mg.
sodium aaylobarbitone and 10 mg. nitrazepam were reported to have
comparable effects and to be significantly better than placebo
with respect to induction* maintenance and quality of sleep*
As a result of a continuing interest in the effects of hypnotics
on sleep and the facilities available at the Sleep Laboratory in
the Department of Psyohiatry at Edinburgh University, to study
electroencephalograph^/
4.
electroenoephalographic effects of drugs on sleep, I
undertook among my studies an examination of barbiturates
and nitrazepam for their effects upon normal human subjects*
Discussion of action of drugs upon sleep
requires some knowledge of the gross nature of the electrioal
discharges recorded from the brain during sleep. It is
therefore necessary to describe the electrical characteristics
of human sleep.
5.
I.B. (i) THE TWO KINDS OF SLEEPt-
The realization that there are two different
kinds of sleep arose from the pioneering observations of
Aserinsky, Kleitman and Dement (Aserinsky and Kleitman, 1953*
1955» Dement and Kleitman, 1937) Dement, 1953). There are
available many reviews of the physiology end psychology of the
- ' V.,
states of sleep (Oswald, 1962j Jouvet, 19^5I Murray, 19651
Poulkes, 1966| Hartmann, 19671 Koella, 1967| Oswald, 1968),
The two states of sleep are commonly known ae
NREM (non-rapid-eye-movement) orthodox, forebrain or slow wave
sleep (SWS) on the one hand, and as REM (rapid-eye-movement)
paradoxical, hind-brain, activated, desynchronised, or "fast"
sleep on the other*
In normal young people, the first REM period does
not occur till after at least 43 minutes of sleep, more generally
60 minutes or so, and occupies about 10 minutes* Usually under
30 minutes of the first two hours of sleep is taken up with
REM sleep (Oswald, 1968)* The rapid eye movements tend to occur
in clusters and, in almost two-thirds of adults, some characteristic
EEC waves herald most of these clusters. These waves of 2-3 cps
have an immediately recognizable appearance and are called "saw¬
tooth" waves (Berger et_al.,1962). The EEC in REM sleep is of
low voltage, and in the cat it resembles the waking EEG (Dement,
1958)/
1958), but in man it contains much slower frequencies than
in wakefulness, made up chiefly of 4-10 ops waves. A period
of REM sleep in man lasts for on average aibout twenty minutes
and there are four or five periods of REM sleep in a normal
night's sleep.
Orthodox or NREM sleep, is characterized by
spindles and slow waves and in man is divided into Stages 1,
2, 3 and 4 (Fig. l) on the basis of the amount and amplitude
of the slow waves. Stage 4 having the largest and slowest
waves (Dement and Kleitman, 1957) Rechtschaffen and Kales,
1968). Normally Stage 3 and 4 occur in the first 3-4 hours
of the night.
I. B. (ii) PHYSIOLOGICAL CHANGES DURING THE TNO KINDS OF SLEEPi-
It has been shown that the two kinds of sleep
also differ in their physiologioal accompaniments, In NREU sleep
respiration and heart rate remain regular but in REM sleep they
are subject to sudden fluctuations (Snyder et al.. 1964). The
same authors also have shown that while in NREM sleep, blood
pressure remain steady, it fluotuates during REM sleep.
In NREM sleep the brain temperature tends to
fall below waking levels but at the onset of REM sleep brain
temperature shows a sharper rise than at the onset of awakening
(Kawamura and Sawyer, 1965)* Cerebral blood flow is also much
greater during REM sleep than in wakefulness (Reivich et al.,1968)
specially/
7.
specially when measurements are made in the brain stem
(Baust, 1967).
Oswald et al.. (1963), showed that in REM
sleep, brief major body movements are more frequent, yet
between movements there ie usually a loss .of muscle tone
(Berger, 196l| Jacobaon et al.. 1965)# This profound loss
of muscle tone has been attributed to inhibitory impulses
acting on the anterior horn cells of the spinal cord
(Pompeiano, 1967)* These inhibitory impulses desoend via
the anterior columns of the spinal cord (Shimizu et al.. 1966)
and bring about loss of electrically induced reflexes (Hodes
and Dement, 1963)*
The penis is flaccid in NREM sleep, but during
each REM period, it is erect except in a small percentage of
instances often linked with concurrent dream anxiety (Fisher
et al.. 1965l Karacan et al.. 1966).
Mental activity too differs in these two types
of sleep. If subjects are wakened from NREM-sleep, they
usually describe "thinking" of the day's events rather than "dreaming".
If people are wakened from REM or paradoxical sleep they usually
describe their immediately preceding mental life as "dreaming".
(Foulkes, 1966).
In waking life eleotrodermal responses (EDR)occur not on
in response to sudden stimuli but also spontaneously at a low rate.
Oswald et al.. (1959) desoribed the presence of almost continual,
spontaneous/
8.
spontaneous EDR, in Stage 4 of NREM sleep. Broughton et al.,
(1965) confirmed this and reported their sporadic appearance
in REM sleep.
I.B. (iii) THE NEED FOR EACH KISD OF SLF -;P»-
The demonstration of two kinds of sleep might
lead to the supposition that each type served a different, even
though unknown funotion. Experimental evidence does indeed
indicate a specific need for each. Dement (i960) carried out
an experiment in which volunteers were wakened for a few
minutes each time they began a REM period. He did this
repeatedly during the night. Since REM sleep is always
preceded by Ml KM, his volunteers got plenty of the latter
kind of sleep but were deprived of REM sleep. As a result
REM sleep began to appear at shorter and shorter intervals,
as if they were "trying" to get the REM sleep more and more
often, so that instead of having to be wakened 5 or 6 times
to prevent entry into REM sleep some 20 awakenings each
night became necessary. After five nights of this, they were
allowed to sleep undisturbed and spent an abnormally large
amount of the night in the REM sleep as if in compensation.
Repeated awakening from NREM sleep had no such effeot on
REM sleep. Dement's finding has been amply confirmed in animal
and human studies, though it may be noted here that the compensatory
increase/
9.
increase has never been found to be more them a moderate fraction
of that lost, whereas in the "rebound" after withdrawal of various
drugs such as hypnotics and alcohol (Oswald and.Priest,1965)^ Yules
et al.. 1966} Evans et al.. 1968), the increase of REM sleep has
more than exceeded both in amount and intensity the REM sleep lost
during drug administration. This rebound increase has been well
demonstrated in sleep studies of amphetamine withdrawal (Oswald
and Thacore, 1963) when about two months were needed for sleep
to return to normal.
While REM sleep rebound appears to be evidenoei of
a "demand" for REM sleep, animal studies show the effects of
repeated or prolonged REM sleep deprivation. Sexual and feeding
behaviour are increased in intensity in cats continuously deprived
of REM sleep up to as long as 70 days (Dement et al.. 1967). In man
there is evidenoe that selective REM sleep deprivation (Agnew et al..
1964} Clemes and Dement, 1967) causes some subtle emotional disorders,
mainly irritibility and lability of mood.
There is also some evidenoe of specific need for HREM
sleep. NREM sleep is commonly divided into stages as mentioned
previously. The four stages are not evenly distributed throu^iout
the nijght. Stage 4 being almost confined to the firs? half of the
night's sleep. This alone would suggest that there is some urgent
priority of whatever function this stage of sleep may serve. Total
sleep deprivation is followed on the first night of undisturbed
sleep by an excess of Stage 4 (Berger and Oswald, 1962) Williams
et al.. 1964)* which is suggestive of restorative priority (Oswald,1969)/
If normal subjects are deliberately disturbed whenever they
enter Stage 4t so that they become deprived of that stage, they
subsequently take more of It, as If In compensation (Agnew et al..
1964) a situation analogous to REM sleep deprivation.
On the basis of the amount and amplitude of slow wave
activity and changes In the arousal threshold, It oan be argued that
NREM sleep stages lie on a continuum of depth or possible "worth-
whileness" of NREM sleep. If this were so then it would follow that
loss of Stages 2 and 3 would lead to an increase in Stage 4 by way
of rapid and non-specific compensation. To test this hypothesis.
Dement and Greenberg (I966) restricted the sleep of subjects over
a pesriod of several nights to about 5-kours nightly (after 5 hrs.
of sleep, NREM sleep is normally aimestentirely made up of stages
1, 2 and Stage 3)* The procedure had the predicted effect of
increasing the absolute duration of Stage 4 in the night and they
suggested that Stage 4 "is worth more" than Stage 2. Similar
observations have been made by others (Webb and Agnew, 1965).
Physical exercise has also been observed to increase Stage 4
NREM sleep (Baekeland and Lasky, 1966). On the other hand
with increasing age the amount of Stage 4 NREM sleep diminishes
(Peinberg et al.. 1967l Kahn and Fisher, 1969)*
There is evidence that both kinds of sleep are
necessary. That each may subserve a different function is evident
in the suggestion by Williams and Williams (1966)1 "a chronic
deficit in Stage REM leads to personality disorders whereas
chronic loss of slow-wave sleep (i.e. Stages 3 and 4) leads to
impaired performance". Studies of such effeots are only in their/
II.
their infancy, but it is obvious that if a drug were to distort
the normal proportion of the two kinds of sleep, or the stages
of NREM sleep alone, the effect could be regarded as mn undesirable
or adverse effeot. $
I.B. iv.
MEASURES OF THE TWO KINDS OF SLEEP*-
It is appropriate at this point togive a general
outline of the technique and measures used in the sleep studies.
It has beoorae generally accepted that the results of the first
night's recording should be discarded owing to a "first night
effeot". Agnew et al.. (1966), and Mendels and Hawkins (1967).
have shown that the first night of laboratory sleep contains
more awake periods and less REM sleep. Both groups found an
inoreased delay to the onset of the first REM period and to the
onset of Stage 4* They also showed that there was a greater
rate of change of stage of sleep.
The value of baseline nights cannot be over-emphasised,
as the distribution of REM and NREM sleep is influenced by many
factors apart from drugs* for example,deliberate attempts, for
reward, to try to affect the distribution of the two kinds of
sleep cause a positive but very small effect (Rechtschaffen
and Verdone, 1964). The mere fact that a subject is asked to
take tablets, even if they are only placebo, can effect the sleep
stages (Hartmann, 1968,b.). It is therefore, good practice




While maximum information will be obtained from
recording of the whole-night the most essential information
may in some instances be obtainable by recording only the first
2 or 3 hours of sleep. While a subject is taking barbiturates
for example, the REM time for the early part of the night is
low while in withdrawal the proportion of REM sleep is very
high (Oswald and PrieBt, 1965). In project No. 1 only the
first six hours of night's sleep has been analysed as this
facilitated the division of the night into three constant and
equal periods of 2 hours in order to study the effects of
the hypnotics on the distribution of the sleep stages
throughout the night.
Where subjects are used as their own control, as
in Project No. 1, there are few problems in interpreting the
changes in, say, percent REM, during drug administration. In
studies using patients, such as project No. 3» norms, derived
from large groups of subjects have to be used in assessing
change•
In the past, the only dependent variables generally
measured in non-EEG studies of the effects of drugs on sleep
were* the amount of sleep, time to sleep onset and sometimes
a subjective measure of night's sleep. More recent work using
the EEG has involved a consideration of drug effects on both
kinds of sleep. However, attention has been fooussed more on REM
sleep/
13.
sleep and a general pattern Is emerging. It appears that
the majority of drugs In clinloal use will reduce REM sleep
time, at least Initially* If the administration of the drug
is oontinued over a period of days, some form of "tolerance"
(Oswald and Priest, 1965» Evans at al., 1968) may develop
and the REM sleep time gradually approach or return to pro¬
drug levels*
A mean of 23 or 24 percent in a night's sleep is
usually taken as a normal value for REM sleep and the
published results from many laboratories have shown remarkable
.... 4«* ~>*K.
uniformity* Oswald (1968) reviewed the studies from various
laboratories (including this laboratory) and suggested that
figures for REM sleep exoeeding 33 percent or under 12 peroent
for a total night's sleep of 7 hrs. or more should be regarded as
abnormal* Normal limits have also been suggested for other
variables (Dement and Kleitman, 19571 Agnew et al*. 1964l
Williams et al*. 1966).
At ivthe beginning of the night the normal subject
enters first into orthodox (NREM) sleep* After about an hour
the first REM period of paradoxioal (REM) sleep with rapid-eye-
movement begins. In 19&3, Oswald and Thaoore suggested 45
minutes as a lower limit for the delay to the first eye movement
of the night from the first spindle of the night* Although this
latenoy is negatively correlated with REM peroent it is not a
one-to-one relationship. The delay is increased with the
administration of hypnotios when REM time is low and conversely
is/
14.
lowered when hypnotics are withdrawn and REM time high. Oswald
(1968) suggested that this delay or latenoy is probably the
most sensitive single index of altered "pressure" for REM sleep.
A shortened delay has also been reported in occasional cases of
severe depression (Mendels and Hawkins, 1968) or chronic insomnia,
occasional cases of schizophrenia and organic dementia (Feinberg,
1967) or drug withdrawal delirium (Greenberg and Pearlman, 1967 i
Ivans and Lewis, 1968). It is possible that the limit set is
relevant only to young adults as it is this group who have been
most often studied. Feinberg et al.. (1967), who .have studied
the elderly, report some short latencies, though Kales et al..
(1967)* do not. However, in any study using elderly subjects,
...... v .
there is greater risk in there being contamination from drugs
as the proportion of the population taking sleeping pills for
sleep increases markedly after the age of 45 (McGhie and Russell,
1962).
Many drugs, including alcohol, affect sleep and
various studies have been reviewed by Hartmann (1965, 1966 a.)
and more recently by Oswald (1968). Therefore, only drugs
commonly used as hypnotios will be considered here,
i.e.
BARBITURATES1-
Oswald et al.. (1963) using heptobarbitone in a
dose of 400 mg., reported that the drug signifioantly reduced
not only the REM sleep but also the number of eye movements per
unit/
15.
unit time. It decreased the frequency of shifts from stage to
stage and the frequency of body movements. Baekeland (1967)
in a more comprehensive study showed that pentobarbitone given
as a single dose caused reduotion in time to onset of sleep,
less frequent body movements, fewer spontaneous awakenings,
abbreviated HEM epochs during the first half of the night and
a general decrease in the amount of Stage HEM.
Sleep studies published so far are qtainly concerned
with the effects of barbiturates on HEM sleep and only a few
deal with other sleep stages. The effects of drugs on autonomic
patterns associated with different stages of sleep has received
little attention. There is however, a study by Lester et al..
(1968) who found that sodium quinalbarbitone (200 mg.) decreased
REM percentage and increased Stage 2 percentage. There was a
decrease in the number of body movements and a trend toward
less waking. The drug caused inhibition of spontaneous
eleotrodermal responses (EDO) is slow-wave sleep.
Oswald and Priest (1965) studied the effeots of
sodium amylobarbitone on the sleep of two adults over a period
of four months. They gave 400 mg. nightly of sodium amylo¬
barbitone for nine nights and found lessening of the initial
effect of the drug. HEM sleep percentages returned to pre-drug
values. On increasing the dose to 600 mg. for a further nine
consecutive nights, again after an initial effect the proportion
of REM sleep returned to pre-drug values* On withdrawal* there
were abnormally short delays/
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to the first REM period associated with exoess amount of REM
sleep, especially in the early part of the night* It took,
five weeks for the return of normal (pre-drug) amounts of
REM sleep. Pentobarbitone 100 mg. given for three nights also
results in a similar REM "rebound" on withdrawal (Kales et al..
1968). Similar observations were made by Evans et al.* (1968)
with 200 mg. sodium amylobarbitone•
The withdrawal of barbiturates leads to an increase
above base-line in the number of eye movements per unit time
(Kales, 19&9l Oswald, 1969). There is therefore, a physiological
increase in REM intsneity. In the immediate drug withdrawal
period there is an increase in intensity of the psyohio
phenomenon of whioh REM sleep is a concomitant i.e. dreaming.
At this time Creams are more vivid and frequently described
as nightmares (Oswald and Priest, 1965) Kales and Jaoobson,
1967| Carroll et al.. 1969). Thus, in drug withdrawal there
is a physiological and psychological increase in intensity of
REM sleep manifest as increased amount of REM sleep, increased
number of eye movements and increased Intensity of dreams,
I.D.
NON-BARBITURATE HYPNOTICSi-
Like barbiturates, glutethimide 900 mg., methyprylon
900 mg., and methaqualone reduoe REM sleep and withdrawal of the
drug results in an exoess of REM sleep (Kales et al.. 1968).
Meprobara&te too has been reported to oause suppression of REM
sleep (Freeman et al.. 1969). However ohloral hydrate is said
to have little effect on REM sleep (Kales et al.. 1968).
Oswald/
17.
Oswald and Priest (19&5) have shown that nitrazepam
in a 15 mg. dose not only reduces REM sleep but also increases
the delay to the first REM period. It took several weeks
following withdrawal for REM sleep to return to normal. An
increased delay to the first REM period has also been noted
for nitrazepam by Lob et al.. (1966) in 12 psychoneurotic
patients. However, they did not find an overall reduction in
REM sleep. Lehmann and Ban (1968) in a study of the effects
of hypnotics on the sleep of ten normal volunteers found that
nitrazepam prolonged the delay to onset of first REM period and
reduced the total REM time in the night and Lewis (1968)
has demonstrated an increase in the number of eye movements
per unit time during nitrazepam withdrawal.
18.
GENERAL METHODOLOGY FOR RESEARCH




The invest!gatione were carried out in the sleep
laboratories of the Department of Psychiatry, University of
Edinburgh. They are sound-attenuated and ventilated. The
EEG machines used were 14-channel Alvar Reega XIV and a
portable 8-channel Alvar. An inter-communication system
connected the bedrooms and the recording room. One of the
laboratories adjoins a female ward in the Horth Wing of
the Royal Edinburgh Hospital and is ideally suited for the
recording of the sleep of the female patients without
having to take them out of the ward and was used in this
way for projeot (3),
II. B.
PREPARATIPS FOR RECORDING USED I« PROJECTS (l) AND (3).
Silver cup electrodes were filled with electrode
jelly and each one was placed on the faoe using adhesive plaster.
Two head electrodes were affixed to the scalp with collodion.
For Project (l) two more electrodes, one on the dorsum of the
forearm, and the other on the palm were affixed using
adhesive plaster, the selected points having been abraided
beforehand, with a battery driven drill, to remove stratum
corneum, thus reducing the resistance to a minimum. Electrodes
were fixed in the following positions!-




(ii) One lateral to the outer canthus of the left eye*
(ill) One above the right supraoiliary margin.
(iv) One above the left supraoiliary margin.
(v) One electrode in the middle of the forehead
above the naeion.
(vi) One on the palm of the hand on the distal end
of the fifth metacarpal bone*
(vii) One en the dorsal surface of the forearm at
its distal end.
(viii) and
(ix) Two over the submental muscles.
(x) and
(xi) Two head electrodes, one to a position corresponding
to Fg and the second at a point between Cg and Pg.
The wires from the palm of the hand and dorsum of
the forearm (project (l) ) were run along the entire length
of the arm and the side of the neck and gathered together
and fastened on the top of the head*
The pairs of the electrodes were connected to
various channels as follows!-
Channel It i and iv. Electro oculogram (EQG)
2s ii and iil. Electro oculogram (EOG)
3i x and xi. Electroencephalogram (EEG)
4! viii and ix. Electromyogram (EMG) - Project (3) only.




Electrode v was used as an earth electrode. -]ach
✓
subject was allocated 4 channels.
The EEG machine was run for a couple of pages to
ensure an artefact-free record. Each epoch ran through the
machine In 20 seconds, and therefore a whole night's record
was £ mile long. The recording lasted from approximately
25.3O hrs. which was rco incident' with putting out the
lights till the subjects wakened in the morning at 08.00 hrs.
II.C.
ANALYSIS OF THE KECORDs
A page by page analysis of each night's record
was made by the author. Reliability of reading was increased
by having some records checked by Dr. Ian Oswald. In cases
where doubt rose as to the appropriate sleep stage, the
particular portion of the record was discussed with Dr. Oswald
and other members of the sleep laboratory. The international
criteria was used for scoring each reoord (Reohtschaffen
and Kales. 1968). Examples of various stages of sleep (Fig.l)
and priteria for the sleep stages are as followss-
Stage Oi(Wakefulness) - The EEG contains alpha activity 9-11
cycles per second (cps) and or low
voltage mixed frequency activity.
Blinks may be present.
STAGE Is -A relatively low voltage, mixed frequency
EEG without rapid eye movements (REMS).
However slow rolling movements of the eyes
may be present.
STAGE 2s - This is characterised by the presenoe of
12-14 ops sleep spindles and K complexes
on a background of relativdly low voltage,
mixed frequency EEG activity./














Awake but drowsy with alpha rhythm in channel 5 and
slow, rolling eye movements revealed in channels 4
and 5,
Stage 1 NREM sleep. Alpha rhythm is lost and 4-6 cps
waves predominate.
Stage 2 NREM sleep. Bursts of fast waves at about
14 cps (sleep spindles) and brief, high voltage slow
wave complexes.
Stage 3 NREM sleep. The sleep spindles are slightly
slowed in frequency and there is general slowing and
increase of the background EEG.
Stage 4 NREM sleep. The EEG is dominated by high
voltage waves at about 1 cps. The EEG potentials are
visible in channels 4 and 5» Channel 6 continues as
a thick trace owing to innumerable little muscle
spikes. The heart rate is regular.
00.52 a.m. REM sleep. The EEG is of low voltage. Channels 4 and 5
reveal the large potentials of rapid eye movements
(also visible in channel l). In channel 1, just before
the burst of eye movements, a little run of "saw-toothed
waves at 2-3 cps. Channel 6 now indicates much









This is defined by the presenoe in 20-30
peroent of the epooh of waves of 2 ops or
slower which have an amplitude greater than
73 J*? from peak to peak. Sleep spindles
may or may not be present.
When more than 30 peroent of the epoch
consists of waves of 2 ops' or slower
waves with an amplitude of more than
73 Jiv peak to peak. Sleep spindles may
or may not be present.
Epoch during which the polygraph record
is obscured by movements of the subject.
This is characterized by a relatively low
voltage mixed frequency EEG in conjunction
with epiaodio REMS and low amplitude
electromyogram (EMG).
The onset of sleep at the beginning of the night
was defined aa the presenoe of a clearly visible rhythmic
sleep spindle of at least 0.3 seo. duration (Stage 2) and not
when the subject was merely drowsy (Stage l).
After scoring the record, the data were analysed
for the following indioesi-
i. Time taken to fall asleep, in minutes sinoe the lights
were put out.
ii. Time in minutes of sleep before the onset of first REM
since subject was defined asleep (first spindle aotivity).
iii. Duration in minutes of REMS during the first two hrs. of sleep.
(Project 3),
iv. Total sleep time (TST) in minutes.
v. Duration of wakefulness in the whole night in minutes between
sleep Onset«and final awakening (Project 3),
vi. Number of shifts to Stage 1 (usually MT) or wakefulness
from sleep during the first two hours of sleep.
vii. Percentage Stage 1 ($Sl), percentage Stage 2($S2),
percentage stages 3 plus 4 (5&S3 and 7&S4).







THE EFFECTS OF SODIUM AMYLOBARBITONE AM?
NITRAZEPAM ON THE SLEEP AND AUTONOMIC





Most hypnotios depress the central nervous system
and affect the reticular formation. In small doses they cause
sedationi in moderate doses sleepi and in large doses a state
resembling general anaesthesia. A typioal example of this
type of drug is the barbiturate group. Their extensive use is
apparent in Ministry of Health (1964) statistics which show
that barbiturates made up 8.1^ of all prescriptions. At the
same time overdosage by hypnotics has increased steadily as a
means of attempting suicide (Kessel, 1965).
Most of the patients who attempt suioide use drugs
readily available to them and these are quite often the hypnotics
prescribed previously for their own treatment (Harwitz. 1969).
Barbiturates promote sleep,though suppressing REX
sleep^with a concomitant increase in NREM sleep particularly
Stage 2. However, even while the drug administration continues




sleep time falls. To achieve the same effect, an increase
in dose is often required* This is the familiar problem of
tolerance. Stopping the drug often results in increase in
delay to sleep, increased awakenings, and frightening dreams
which lead to complaints of total insomnia (Evans et alM 1968).
Many clinical trials (Haider, 1968| Matthew et al..
1969) have reported comparable efficacy of nitrazepam and
barbiturates. Therefore one of the aims of this investigation
was to compare the effects of a standard barbiturate (sodium
amylobarbitone 200 mg.,) and a commonly employed non-barbiturate
hypnotic (nitrazepam 10 mg) on normal healthy volunteers and
EEC measures of sleep.
It is reasonable to assume that a large dose of
hypnotic, suoh as sodium amylobarbitone or nitrazepam would
have greater effect fiana smaller dose .To test this possible
dose - response effect of hypnotics, a large dose of both
sodium amylobarbitons (400 mg.) and nitrazepam (20 mg.) was
included during the second phase of the experiment.
III.C.
METHODS AND MATERIAL1-
Six paid male volunteermy all of whom were
medically and psychiatrically sound, and all over 21, were
included in the study. They were requested to maintain
their/
2B.
their sleep at the amount they reported as typical
for themselves for three nights prior to every experimental
night, to abstain from aloohol, and any other drugs, for
at least one week before the start of the investigation
and during the whole period of experiment, and to avoid
daytime naps. They all remained in good health throughout
the period of the investigation. They were told that on
each experimental night before going to bed, they would
be given tablets and that these would contain either a
commonly used hypnotio or plaoebo. This reduced
expectations and attendant apprehensions about the
experiment. They were shown around the sleep laboratory
and the procedure for each night explained. This briefing
was oarried out two weeks before the investigation began.
The first night of recording was some two weeks later.
This prooedure enabled the subjects to have any seoond
thoughts about participating.
Subjects were divided into two groups of
three. Each subject was recorded according to the schedule
shown in Tables 1 and 2. He attended the Laboratory on a
single night at weekly intervals and took tablets on
laboratory nights only.
On an experimental night, the three subjects of
a group came to the laboratory, one hour before their usual
bedtime. After changing into night attire, their eleotrodes
were fixed including those for eleotrodermogram. The leads
were taped together and run as a single cord to the head-box/
2f.
head-box at the head of the bed. This arrangement
allowed a free range of movement without entanglement
and minimised any annoyanoe to the subjects.
III.D.
ADMINISTRATION OF DRUGSi-
During the first phase of the experiment (Table l)
Group A received 10 mg. nitrazepam for two nights and Group
B wore given 200 mg. sodium amylobarbitone for two nights.
The drugs were administered just before the lights were
put out.
In the second phase, the order of drugs were
reversed (Table 2) so that Group A now reoeived 200 mg,
sodium amylobarbitone for two nights and Group B had
10 mg, nitrazepam for two nights. To examine the effects
of a large dose of the drugs on the same subjects, 400 mg.
sodium amylobarbitone for two nights (Group A), and 20 mg.
nitrazepam for two nights (Group B), were also included.
In eaoh phase the initial placebo nightie was treated as an
adaptation night and the results discarded (the ■*"first night"
effect)•
III.E. 1.
ANALYSIS OF THE RECORDSi-
All the records obtained from the twenty
experimental nights of this investigation (almost seven
miles of paper) were read page by page. The criteria/





































criteria adopted for analysis were as described
previously*
III.E* il*
MEASPRBMEKT OF ELECTRODERMOORAM (EDO).
For both Stage 4 and Stage REM, the first 15
minutes, after an initial 5 minutes of first appearance
of the relevant stage of sleep was used as a sample* These
samples were divided into 20 seo* epochs (twelve inches
long)* The first REM period of the night tends to be
less than the required 20 mine* The deficiency in the
sample was made up from the next REM period;. All samples
were divided into 20 sec* epochs (twelve inches long)*
A map measurer with a small wheel was run along the
EDG traoe of the epoch.
The ERG excess in inches for each epoch was
obtained by subtracting the twelve inches value for a
20 sec. epoch from the value for a 20 seo. epoch during
administration. Finally average EDG excess was calculated.
III.E. ill.
RIGHT'S SLEEPi-
Oswald and Friest (1965), have suggested that
although maximum information is obtainable from a whole
night's sleep recording, the essential information may
be/
29.
be obtained from recording of first two hours of a night's
sleep. In this investigation, only the first six hours*
sleep was analysed and is sometimes referred to as the
whole night's sleep.
The proportional amount of time each subject
spent in each sleep stage during the course of a night's
sleep is expressed as a percentage. These percentages were
derived for an individual by summing across the nights for
the minutes spent in a given sleep stage and total sleep
time for those nights and converted to a percentage.
Stages 3 and 4 have been oombined for disoussion of
results.
III.E. iv.
THREE PERIODS OF NIGHTt-
To examine the effects of drugs on the various
stages of sleep in relation to different parts of the night,
each night's record was divided into three two-hour periods.
Percentages expressed in relation to these three thirds
refer to the percent of the total time spent in each sleep
stage in each third of the night. For example, the mean
percentage of six hour sleep time for REM taken across four
nights on placebo is 20.25 (Table 6) of which 13»9$ occurred
during/
39
during the first third, 33*5during the second third
and 52.85k during the last third period of the night.
Ill.E. v.
STATISTICAL METHODS1-
In Project No. 1 two statistical tests were
used. The two tailed t-test (Guilford, 1956) to test for
differences between the mean amount of the various stages
of sleep on placebo, the small doses of nitrazepam and
sodium amylobarbitone. Analysis of variance was used to
examine the difference between the EDG activity in




III.F.l. SODIUM AMYLOBARBITORE 200 mg. AND NITRAZEPAM 10 mg.
The immediate effect of the drugs was to decrease the
delay to onset of sleep, reduce MT and the number of shifts to
Stage 1 and wakefulness. Stage 2 was increased but Stages 3
and 4 were little affected. REM sleep time was decreased and the
delay to onset of first REM period was increased. Spontaneous
electroderaal activity occurring during Stage 4 and REM sleep
was reduced. Drug induced fast activity was observed during
Stage 1 and REM sleep on the drug nights.
SIX HOURS SLEEPi-
Mean percentages for six hour sleep time for the
various sleep stages taken across four placebo nights and two
nights each on nitrazepam 10 mg. and sodium amylobarbitone
200 mg. are presented in Tables 3» 4 and 3 respectively. The
proportion of time for each sleep stage in six hour sleep and
the percentage of this time spent in each third of the night,
taken across placebo, nitrazepam and sodium amylobarbitone
nights for all six subjects is shown in Tables 6, 7 and 8.
ONSET OF SLEEPi-
The drugs shortened the delay to sleep onset as/













































































































































































20.25 9.36 40.97 23.78 5.62
13.9 44.2 28.2 47.7 35.8
33.3 34.2 34.7 30.7 33.7
52.8 21.6 37.1 21.6 29.4
TABLE6,
MEAKPERCENTAGESOFSIXHOURL EPTIMF RA LSTAG SFL P ANDPERCENTOFEA HSLEEPTAGEOCCU RINGINTHREI DSF NIGHTTAKENACROSSFOURNIGHTONPL CEBO( )NDTWNIGHT ON10mg.NITRAZEPAM( )FORALLTHSIXUBJECTS?
Sleep Stages
SIXHOURLEEPT IRDOFNIGHT PNFirstSeoondLast NP
REM20.2514.13 973 319 95 .878 3 19.367 744.238.35.62 .7 240.975 .0528 23O.94 7357.13 .3 3&423.784.297.73306.821.615.8 MT5.623 946.840.33 738.029.41. TABLE1,


































































compared to placebo (Fig.2; Table 9) the reduotlon was
more marked with sodium amylobarbitone 200 mg. (t - 8.19*
p <0.01) than with nitrazepam 10 mg. (t ■ 5.65, p <0.05) but
there was no significant difference between the two drugs.
EFFECTS OF DRUGS OH NREM SLEKFi-
1
Mean percentages for six hour sleep time for all
stages of sleep on placebo, sodium amylobarbitone 200 rag. and
nitrazepam 10 mg. for all six subjects taken together are
presented in Table 10.
Stage 1 sleep (Fig. 3» Table 10) was significantly
reduced only by sodiun amylobarbitone (t - 5.21, pCO.Ol), and
again the difference between the two drugs was not significant.
Although Stage 2 (Fig. 4) Table 10) was significantly increased
both by nitrazepam (t - 6.78} p 40.01) and sodium amylobarbitone
(t - 8.74, P <0.01) the two drugs did not show any significant
difference. Combined Stages 3 and 4 (Fig. 51 Table 10), were
little affected by either drug.
MT (Fig. 6| Table 10) was reduced by both drugs when
compared with placebo (sodium amylobarbitonet t - 5*28, p <0.01|
nitrazepam: t « 3*61, p<0.05). The difference between the two
drugs was also significant (t * 4.19, P<0.01), the greater
reduction being with sodium amylobarbitone. The number of
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significantly reduced by both drugs as compared with placebo
(sodium amylobarbitonei t » 7.26, p <0,01j nitrazepam» t - 5.46,
p <0.01). The difference between the two drugs was also
significant (t - 5.^9, P 40.05), the greater reduction being
with sodium amylobarbitone*
EFFECTS OF DRUGS ON REM SLEEPt-
REM sleep was affected in two ways. The proportion of
time spent in REM sleep (Fig.Sj Table 12) was signifioantly
reduced both by nitrazepam (t = 6.50, p <0.0l) and sodium
amylobarbitone (t « 4.91» P <0.0l) but there was no significant
difference between the two drugs. Secondly the delay to the
onset of the first REM period (Fig. 9; Table 15) was increased
from an average of 94 minutes on placebo to 150 minutes on
nitrazepam 10 mg. (t » 7*08} p <0.0l) and 144 minutes on
sodium amylobarbitone 200 mg. (t « 5«52| p<0.0l), but there
was no significant difference between the two drugs.
THREE PERIODS OF THE NIGHT»-
Mean percentage of each sleep stage occurring in
the three two-hour periods of night sleep time for all stages
of sleep on placebo, sodium amylobarbitone 200 mg. and nitrazepam
10 mg. for six subjects is presented in Table 14*
In the first third of the night both drugs caused a
reduction in time spent in Stages 1 and MT. Stages 2 and 5+4/
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P v SN - t - 7.08| p ^0.01
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were little affected. During the second third, Stages 3 * 4
were increased (Fig. 10| Table 14).
Both the drugs not only reduced the total REM sleep
but also affected the distribution of REM sleep in relation to
three thirds of the night. It was markedly suppressed in the
first third (Fig. 11| Table 14)» partially suppressed in the
second third and most of the night's REM sleep occurred during
the last third.
'EFFECT OF DRUGS ON EDO ACTIVITY*-
Spontaneous electrodermal (EDO) aotivity occurring
during Stage 4 was measured as described previously. Mean
excess EDG activity (in inches) of the first 15 minutes of the
first period of Stage 4 sleep taken across four nights on
placebo, two nights each on nitrazepam 10 mg. and sodium
amylobarbitone 200 mg. is presented in Table 15* It was
reduced by both the drugs (Fig. 12, Table 16). Analysis of
variance showed a significant difference between treatments
(F = 15.05} df - 2, IOj p <,0.001). During REM sleep too, EDG
activity was reduced by both the drugs (Fig.lJj Tables 17 and 18).
Analysis of variance again showed a significant treatment effect
(F . 37.33} df - 2, 10} p <.0.001),
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wwp0.01assessedbyNewm n-Keulsmethod(Win r,1962). TABLE16.
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Significanceefdiff rencesbetw enpairsomeanass ss d byNewman-Keulsethod(Wi r,1962). TABLE18.
35.
III.F.li.
SODIUM AMYLOBARBITOHE 400 mg. AND NITRAZEPAM 20 mgt
During the second phase of the investigation, an
exploratory study of large doses of both sodium amylobarbitone
(400 mg.) and nitrazepam (20 mg.) was carried out. Group A
subjects (SI, S2 and S3) were given 400 mg. sodium amylobarbitone
(BA) on 2nd and 7th night (Table 2). Similarly Group B subjects
(34, S5 and S6) were given 20 mg. nitrazepam (BN) on the 2nd
and 7th nights (Table 2). On nights 4 and 3 the subjects
received the smaller doses of the drugs.
Both drugs in the higher doses shortened the delay
to sleep onset (Fig. 2), decreased the time spent in Stages 1
(Fig. 3) and MT and reduoed the number of shifts to Stages 1
(KT) and wakefulness. Stages 2 (Fig. 4) and 3 * 4 vers increased
(Fig. 5)# REM sleep time was reduoed (Fig. 8) and the delay to
onset of first REM period increased (Fig. 9). EDG activity both
in Stage 4 (Rig* 12) and REM sleep (Fig. 13) was suppressed.
Both drugs induced EEG fast activity (18-20 cps) activity during
Stages 1 and REM.
SIX HOUR SLEEPi-
Mean percentage of six hour sleep time for all stages
of sleep taken across two nights each on sodium amylobarbitone
400 mg. (BA) and nitrazepam 20 mg. (BN) for three subjects is
presented in Table 19.
A/













































A comparison of mean percentages of six hour sleep
time for all stages of sleep and percent of each sleep stage
time occurring in three two-hourly thirds taken across four
nights on placebo and two nights on sodium amylobarbitone 400 mg.
(BA) for group A subjects is shown in Table 20 and nitrazepam
20 mg. (BN) for three subjects of group B is shown in Table 21.
EFFECTS OF DRUGS ON NREM SLEEPi-
Both drugs shortened the delay to sleep onset
(Fig. 2| Table 9) from an average of 28.4 minutes on placebo
to an average of 9*4 minutes on drug nights. The amount of
Stage 1 of sleep was reduced (Fig. 3j Tables 20 and 21) from
an average of 9• 49^ on placebo nights to an average of 2.1$ on
drug nights. MT time was reduoed (Fig. 6) from an average of
*
9*6$ on placebo nights to 1.8$ on drug nights, while Stage 2
was increased (Fig. 4) from an average of 41*0$ on plaoebo
nights to 99*2$ on drug nights. Also increased was Stages
5+4 (Fig. 9| Tables 20 and 21) from an average of 23.8$ on
placebo to 29*6$ on drugs. The total number of shifts to
Stage 1 (MT) and wakefulness was also reduced (Fig. 7) Table 11)
from an average of 34 on placebo to 16 on drug nights.
EFFECTS OR REM SLEEPi-
a The percent REM sleep (Fig. 8| Table if) was markedly
reduced from an average of 20.3$ on placebo nights to 7»2$
on drug nights. A second REM sleep change was the concomitant/
COMPARISONFME NPERCENTAGESPSIXHOURL EPTIMEF RALLTAGES OFSLEEPANDPERC NTFEA HTAGETIMCCURRINGIHR.70 HOURLYPERIODS.TAKENAC SF URNIGHTSNLAC BO( )NWO ON400tag.SODIUMAMYLOBARBITONE(B )FTHREEUBJECTS.























































































































increase in tha delay to onset of first REM period (Fig.91
Table 13) from an average of 94 minutes on placebo to an
average of 203 minutes on drug nights.
THREE PERIODS OF THE NIGHT1-
Both drugs affected the distribution of sleep stages
in relation to three thirds of night. In the first third both
drugs (Tables 20 and 21) caused a reduction in time spent in
Stages 1 and MT. Stages 3 ♦ 4 (Fig.l 0) occurred in the first
and second thirds and were almost absent from the last third.
REM sleep was completely suppressed in the first
third of the night (Tables 20 and 21). partially suppressed in
the second third) most REM was seen in the last third of the
night (Fig. 11).
EFFECTS OF DRUGS ON THE EDG ACTIVITYi-
Spontaneous EDG activity occurring during Stage 4
(Fig. 12) was reduced both by sodium amylobarbitone (400 mg.) from
an average of 4*74 inches on placebo nights to 1.31 inches on
drug night and by nitrazepam (20 mg.) to an average of 1.72 inches.
A similar reduction was observed in EDG activity during
REM sleep (Fig. 13» Table 17).
IIl.F.iil.
SMALL AND LARGE DOSE OF SODIUM AMYLOBARBITONE AND NITRAZEPAM.
In the preceding account of the effects of large doses
of the drugs, statistical tests were not possible owing to the
smallness of the samples. However, the tables and figures
reveal that the effect of the large doses was in the same
direction as the significant effect of the small doses and
that without exception the mean effects of the large doses
exceeded the mean effect of the small doses. Thus Tables 9,
11,12,13,15 and 17 show that for every individual the mean
effect of the large dose exceeded the mean effect of the
small dose with respect to delay to sleep onset, shifts to
Stage 1 and wakefulness, total REM sleep time, delay to the
first REM period, EDG activity in Stage 4 and Stage REM.
Fig. 8 indicates the greater effects of the large doses on
REM sleep duration. In view of the consistency of the trends
with larger doses we may conclude that in both drugs the effect
of the larger dose on the sleep variables exceeded the
significant effect of the small dose. No obvious differences





Comparison of 200 mg. sodium amylobarbitone and 10 mg.
nitrazepam on EEG sleep, shows that both drugs caused a significant
reduction in time to onset of sleep, which is consistent with
the similar reduction by heptabarbitone (Oswald et al..l963)
and nitrazepam (Lehmann and Ban, 1968), Stage 1 of NREM sleep
was reduced by both drugs as compared with placebo, though the
difference was significant only on sodium amylobarbitone nights.
Stage 2 was significantly Increased by both drugs, a finding
similar to that reported by other workers (Baekeland, 1967|
Lester et al.. 1968).
Combined Stages 5 + 4 were not signifioantly affected
by either drug. This does not agree with the findings by
Leohner (1965) who reported a decrease in Stages 5+4 with
nitrazepam.
The reduction of MT time and number of shifts to
Stage 1 and wakefulness during the night caused by both the drugs
is consistent with the similar reduction by heptabarbitone
(Oswald et al.. 1963) and by quinalbarbitone (Lester et al.,1968).
Both/
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Both drugs not only reduced the REM sleep proportion
per night hut also significantly prolonged the delay to onset
of first REM period. This supports the similar finding by
Lob et al«. (1966) and confirms the findings of Oswald and
Priest (1965)»
The EDO activity during Stage A and REM was significantly
decreased by both drugs. This is consistent with the findings
of Lester et al.. (1968) who reported a significant reduction
in EDO activity during REM sleep with a single dose of 200 mg,
sodium quinalbarbitone. In the present investigation, while
both sodium amylobarbitone and nitrazepam caused a significant
reduction in EDp activity, there was no difference between the
two drugs. This in fact, is a notable feature of this investigation,
A comparison of the three two-hourly periods of the
night showed that both drugs caused changes in the distribution
of sleep stages* Although there was a reduotion in absolute
values of REM sleep time on drug nights, the distribution of REM
sleep time was especially changed. These findings are similar
i
to those reported by Lester et al.« (1968) who found a shift
towards the first half of the night in the distribution of
Stages 3+4 and inhibition of REM sleep in the first half.
It is concluded that both 200 mg. sodium amylobarbitone
and 10 mg, nitrazepam affect the sleep of normal human subjects
and both produce similar abnormalities. The two drugs also
resemble each other in the extent to which they produce changes ,
the only exceptions being that 200 mg. sodium amylobarbitone/
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caused greater reductions In MT time and shifts to Stage 1 or
MT. Both drugs Induce similar abnormal fast activity at about
18 cps in the EEC during Stage 1 and REM sleep*
The second phase of this investigation was an
exploratory study of larger doses of both drugs. It is
accepted that the experimental design was not ideal as it
does not give enough numbers for comparison by normally
applicable statistical methods, but as the magnitude of
work and volume of data that must be collected from even
one subject-night, is considerable, and in view of consistency
of results with large does in this study it was not considered
worthwhile to do a more extensive study of the bigger dose of
the drugs such as used in this project*
The results show that both sodium amylobarbitone
400 mg, and nitrazepam 20 mg, shortened the delay to sleep,
reduced the Stage 1 time, MT time and the number of shifts
to Stage 1 or MT compared to plaoebo nights. Stages 2 and
Stages 3+4 were increased. From the tables and histograms
it is obvious that both drugs have caused these effects to a
greater degree than the smaller doses of these drugs.
REM sleep time on the drug nights was reduced and
the delay to the onset of the first REM period was also
prolonged. These changes were more marked with the big dose*
EDO/
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EDG activity occurring during Stage 4 and REM sleep
was also depressed, the depression being more marked with the
bigger doses of the drugs as compared with the placebo and the
small dose.
Therefore, nitrazepam and sodium amylobarbitone did
not allow normal sleep physiology in healthy subjects. The
changes produced were related to the dose. Both drugs in
small doses showed similar changes and these changes were





TITLE! ELECTROENCEPHALOGRAPHS CHANGES IN
ACUTE DRUG POISONING.
IV.B.
Introduction!- Recent progress In the field of experimental
and elinioal psychopharmacology has made available a large
number of psychotropic drugs and has made possible their
vide range application in the treatment of psychiatrio
disorders. At the same time the number of oases of self-
poisoning being admitted to the Poisoning Treatment Centre
is also rising and accounts for almost 10^ of all acute
medical admissions to certain general hospitals (Hatthev,
1966). Figures of yearly admissions of poisoned patients
to the Royal Infirmary, Edinburgh (Matthew and Lawson, 196?)
shoved a sharp rise in inoidenoe of poisoning from 120
admissions in 1940, to 340 in 1938 and 1067 in 1968. The
same authors reported that 8O9& of their patients indulged in
self-poisoning. A recent report from the same centre (Matthew
et al.. 1989) has shown an increase in the inoidenoe of self-
poisoning to 95$. The epidemic inature -■ of acute non-fatal
poisoning has been highlighted in a recent publication (Central
and Soottish Health Services Councils, 1968).
An important faotor in the increase of acute drug
poisoning is the ready availability of drugs. In recent years,
the tranquilUsing and antidepressant drugs have Joined the
hypnotics as common agents in suicidal attempts. Many of these
drugs/
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drugs, at high doses, oan produce CNS depression, loss of
consciousness and even death. The majority of the patients are
conscious on admission, about l/5th being unconscious (Matthew
et al.. 1969), Twenty one percent of poisoned patients
require resuscitation on arrival at the hospital (Jenkin
et al.. 1969)* Burston (1969) reported that 25.5$ of cases
of self-poisoning admitted to the hospital were "severely
poisoned and would possibly have died without admission to
hospital". Many reports (British Medical Journal, 1964)
Matthew and Lawson, 1966) Rasmussen, 1966) Matthew, 1968)
Matthew et al.. 1968) Matthew et al.. 1969) Burston, 1969)
Kennedy et al.. 1969. Freeman et al., 1969), have been
published describing the olinioal signs and symptoms and
management of oases of acute drug poisoning. Observations
on the psychiatric aspects of these patients have been reported
by Kessel (1969), Kessel and MoCullooh (1966), MoCullooh and
Philip (1967), MoCulloch et al.. (1967), Aitken and Carstairs
(1968), and Kreitman et al.. (1969). Little work, however,
has been done on the effects of overdose of drugs on brain
functioning during aoute drug poisoning and subsequent recovery.
IV. C.
REVIEW OF THE LITERATURE1
Isolated EEC studies of coma patients were recorded
in the early literature, e.g. by Berger (1932), Gibbs et al..
(1937)/
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(1937) were the first to comment that marked slowing
was oharaoteristio of a variety of comatose states. Davis
and Davis (1939) believed that the delta activity in coma
was analogous to the delta of deep sleep, on opinion with
which Strauss et al., (1932) later concurred. In study of
delirium Romano and Engel 3 (1944) observed a general
correlation between degree of disturbance of consciousness
and the degree and character of the ££6 slowing, regardless
of the aetiology of the comatose stats. However, exceptions
to the rule of delta slowing in coma were reported by
Fisohgold and Bournes (1946), Loeb and Poggio (1933),
Gastaut (1954), Whelan et al.. (1955), Lundervold et al..
(1936) and Kaada et al.. (1961). In line with the investigation
of Banoaud et al.. (1955) and of Dell (1957) on oerebf>sll
lesions with and without disturbances of consciousness, Mathls
et al.. (1957) proposed that reaotivity in comatose states was
an important prognostic sign. Lennox and Petersen (1958) found
a good correlation between clinical severity and EEG changes in
patient* with carbon monoxide poisoning. Pampiglione (1962)
reported on 20 children with cardiac arrest and considered
subsequent early ESGs to be of prognostic value. Loeb (1958)
failed to find the EEG a reliable index of ooma depth. He also
described a variety of EEG patterns in 25 selected ooma patients
with verified brain lesions and concluded that generalized
slowing was not to be found in this type of ooma and that
there was no definite relationship between the degree of ooma
and/
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and the types of EEG change*
The most exhaustive study of coma vas reported
by Fisohgold and Mathis (1959)* They studied 159 patients*
roughly one-third of whoa had ooma due to trauma and one
third due to spaoe-oooupying lesionsi only three oases were
of toxio or aetabolio origin. They described four stages
of ooaa froa both the olinloal and the eleotrioal viewpoints.
On their soheae the ESQ in Stage I shows a mixture of alpha,
theta and soae aonophasio frontal or fooal delta activity and
with alerting stiaull usually oaae soae initial blooking -
patients oan be aroused and when alerted have no loss of
oephalio reflexes. In Stage II, only motor or monosyllabio
verbal responses to stimuli oan be obtained! the EES shows
delta aotlvity which alternates with flattened and faster
rhythms during periods of oardiao and respiratory slowing!
alerting stimuli rarely oause blooking, but more often
aooentuate the delta activity (at times sons alpha and theta
may appear or a delta focus beoome apparent). In Stage III
all oontaot is lost, all cephalio reflexes disappear, vegetative
derangements ensue and at times a state of decerebrate rigidity
exists! the EEG tends to beoome flat and is rarely effected
by any arousal stimuli. In Stage I? life has to be supported
by artificial respiration. The EEG in this stage is isoelectric.
The prognosis, they reported, is progressively graver as one
prooeede down the scale of ooaa * from 25^4 mortality in Stage 1
to 100# in Stage IT. As far as differentiating ooma from other
states, they oonoluded that there were no eleotrioal properties
speoifio for ooaa and "still less for a determined aetiology".
Jouvet (1959) described Stage IV isoelectric comas
of/
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of traumatic origin in 4 patients who vara trephined! ha
found alaotrioal silence in the thalamus as vail as in the
*
soalp recording. Ha fait that efforts to maintain life vith
artificial respiration for mora than 24 hours vera hopeless if
the EEC remained iaoeleotrio, a sentiment vith vhioh Sohvab
at al., (1962)concurred. On the other hand, Bental and Leibowits
(1961) published a case of possible encephalitis in vhich the
EEC vas flat for veeks, yet the patient ultimately recovered.
Loeb (1959) emphasised that considerable care must be exercised
in assessing a flat reoord in a coma patient) vith stimulation
(e.g. mechanical opening and closing of eyelids) some
reaotivity and a normal appearing alpha rhythm may be
demonstrated, particularly vhen the lesion is in the upper
two-thirds of the pons. Chatrian et al.. (196?) observed
normal sleep state potentials in some cases of trauma in
whioh there may have been depression of the reticular
activating system with consequent ooma.
Silverman (1963) in a retrospective study revieved
the EEG of 184 patients in relation to ooma depth and the EEG.
He divided olinioal and eleotrioal findings into four stages
of ooma identical vith those of Flsohgold and Hathis (1959)*
Seven out of twelve oases of drug intoxioation vere Stage I,
if
one Stage II and four Stage III. He oonoluded that study of
the eleotrioal responses to external stimuli, as veil as the
appearance of sleep state potentials, gave a reasonable
eleotrioal indication of coma depth. In Stage I, ooma
reaotivity and sleep approaohed the normal) in Stage II
both/
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both reactivity and sleep became distorted| in Stages III
to X? both reactivity and,sleep disappeared and the reoord
tended to become monorhythmio and finally isoelectric* It
vas further concluded that a marked discrepancy between the
clinical and electrical signs of deep coma suggests a brain
stem lesion with a relatively intact cortex. He added that
the finding of a barbiturate fast type of EEG record or of
the mixed fast-theta records vas suggestive of barbiturate
or other sedative drug poisoning.
An isoelectric EEG in a patient with deep coma has
become a problem in recent years with the greater success of
resuscitation teams and with the greater efficiency in maintaining
circulation and respiration in intensive care units. As
surgeons and immunologists have made advances in organ trans¬
plantation, patients in irreversible coma become the main
source of donor organs. Obviously the patient must be oertifiably
dead before organs can be transplanted, yet the organs must
not have undergone degeneration. This has raised questions
i
regarding the truth and oertifiability of death artd the exact
time of death. With respect to the latter, there are two
alternatives, either to await the cessation of the heart after
the withdrawal of mechanical aids, or to declare the patient
dead before such withdrawal once the irreversibility of the
ooma is established. Exceptions to the rule of oerebeai.
death with isoelectric EEGs have been reported in the literature.
It has been shown (Rplts and.Schneider, 1950) that in animals
during experimentally produced anoxia the EEG becomes progressively
lower in amplitude until it reaohes sero potential, and if this
anoxic state is allowed to persist for more than approximately
four/
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four minutes* the brain and the EEC will not recover their
function (Sohneider, 1961 a,b.), and in doge Spoerel (1962)
found a time of from 3 to 5 minutes from onset of isohaemia to
irreversible SEG electrical silence* Under experimental
conditions normal cardiac and respiratory function is usually
maintained, so that perfusion of the brain vith normally
oxygenated blood follows immediately on oessation of anoxia)
these conditions do not usually occur in clinical situations.
The changes observed in the human BEG during anoxia
have been" described by many investigators. Grorfquist et al.,
(1952), Bellvilla and Howland (1937) and Breohner et al.. (1961)
have described fast (16-23 ops) low voltage activity ("file
pattern") in otherwise severely depressed or flat records.
Sellville et al.. (1935) noted slowing within 4 seconds of
cerebral1 ischaemia in a patient undergoing cardiac surgery.
Thiem-Puppel and Wieners (1961) studied 30 patients undergoing
cardiac surgery during hypothermia, and found that the
interval between onset of isohaeaia and disappearance of all
electrical activity of the brain varied from 12-60 seconds.
Return of EEG occurred between 3° seconds to 4 minutes
after restoration of blood flow when Isohaemia had been
less than 7 minutes and up to 23 minutes after over 8 minutes
of isch&emia. Breohner et al.. (1961) noted that the EEG
reappeared and beoame normal within minutes after oardiao
arrest of only 2 minutes.
Biokford and co-workers (1965) reported their
experience with twenty five post-anoxic patients initially
comatose. The irrecoverable state/
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state exhibited a flat EEG with no reaotivity. In partly
recoverable states EEG activity ranged from burst-suppression
patterns to diffuse delta, while in the reversible oases, patterns
ranged from diffuse delta to non-responding spindle formation
activity.
Hookaday et_al., (1965) reported EEG changes in
59 comatose patients who had suffered oardiao arrest (26) or
who had apnoea (13)*
The EEGs were olassified into 5 grades, eaoh with
two subdivisions (a, b).
GRADE I (Within normal limits)
a. Alpha rhythm.
3Sjtv ' Predominant alpha with rare theta,
GRADE II (Mildly abnormal)
a. Predominant theta, with rare alpha
b. Predominant theta, with some delta.
GRADE III (Moderately abnormal)
a. Delta, mixed with theta and rare alpha.
b. Predominant delta, with no other activity.
GRADE IV (Severely abnormal)
a. Diffuse delta, with brief isoelectric intervals.
b. Scattered delta in some leads only with absenoe of
activity in other leads.
GRADE V (Extremely abnormal)
a. A nearly flat reoord.
b. Mo EEG at all.
This system of olassifioation consisting of ten
types of EEG abnormality (5 grades eaoh with two subdivisions)
was, therefore, used in a selected group of patients of acute
cerebral/
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cerebral anoxia* The anoxia was in every oase sufficiently severe
so that early reoovery of consciousness failed to ooour and the
emergency EEG was obtained to establish whether the brain was alive
and* if so* whether olinioal reoovery would follow*
Only 6 of the 39 patients survived. Patients with
records of Grades IV and V (26) had a nearly hopeless prognosis as
only one (Grade IV) survived* Patients with EEGs of Grade I, who
invariably were conscious at the time of recording, carried an
excellent prognosis for full reoovery. Reoords of Grades II and
III were of less certain prognostic value as only one of three
of Grade II and three of nine survived. Their overall acouraoy
of prognosis was 83$. They concluded that the EEG can be of
considerable help in establishing death in the presence of a
restored heart beat, and suggested that further attention be
given to the definition of death*
It has also been known experimentally and clinically
that anaesthetics produce periods of isoelectric activity in the
EEG. Kiersey et al., (1951) studied the EEG patterns after
thiopentone sodium anaesthesia to patients undergoing surgical
treatment for varicose veins of the legs* They analysed the
frequencies with the Grey Walter frequency analyser* and
classified the 1EG changes into five patterns* The first pattern
(fast) was characterised by hieb-amplitude* fast* spiky activity
of mixed frequencies varying between 10 and 30 ops with the
predominant frequency near 20 ops* During this pattern* consciousness*
though dulled* was retained in the early phases. The second
pattern (complex) consisted of many frequencies of predominantly
slower/
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slower wave forms of very irregular oontour and random occurrence.
Superimposed on these slower waves and oocupying the intervals
between them was a faster aotivity at about 10 ops rather spiky
in oharaoter and irregular in amplitude* This seoond pattern
was accompanied by loss of consciousness and reduced reflex
activity. Withdrawal reaotion to painful stimuli was abolished.
The third pattern was characterized by a progressive suppression
of cortical activity taking the form of short periods of
relative quiesoence that separate groups or bursts of waves* In
this jattem the periods of inactivity did not exceed three seoonds
in length. As the third pattern appeared* reduction of respiratory
minute volume became more marked* The fourth pattern differed
from the third in respect of duration of the periods of cortioal
inactivity which were defined as lasting between three and ten seoonds.
The amplitude of the waves in the periods of activity was slightly
less than in the third pattern but the frequency characteristics
remained unaltered* In the fifth pattern periods of inactivity did
not appear more frequently than onoe every ten seconds and there was
further reduotion in the amplitude of the component's to below
- -•« • •<?
25 microvolts* The frequency of the waves was the same as that
found in the active phases of the fourth pattern. There was
marked respiratory depression* possibly requiring a respirator.
The pupils retained some reaotion to light*
Several reports have disoussed the EEG changes in
man during hypothermia. Pearcy and Virtue (1959) described EEG
changes in 74 patients subjected to hypothermia. Beginning
temperatures were 36.0 to 37.0°C and ohanges were determined at the
lowest temperature reaohed. Twenty nine patients showed no ohange
as/
54.
as oooling progressed, thirty nine patients shoved a tendenoy toward
slowing of frequency, even though this was usually slight. A typioal
change was a reduction from 16-17 cps at 36.0°C to 13-14 ops at
30.0°C. Of five records of patients whose temperature fell below
29.0°C, four showed decrease in frequenoy. In two voltage
increased, in two others no change in voltage appeared. The
one record showing increased frequenoy also shoved a decreased
voltage. None of their patients had oomplete cessation of
oerebral ^electrical activity. Hale and Moraoa (1938) reported
slowing of frequenoy and deorease in voltage in the EEC with
cooling by infusion of oold blood from a pump oxygenator. Scott
(1933) reported 23 patients oooled to 28.0°C for reseotion of
berry aneurysms. With deorease in temperature there was a reduction
in voltage from 60-80 miorovolts to 50 microvolts. Below 30.0°C the
voltage drop continued and the record became irregular but without
suppression.
More extensive work has been reported in animals.
'
Callaghan et al., (1954) reported progressive flattening of the
EEC of monkeys as the temperature was lowered. At 20.0°C there
was minimal activity present. During rewarming the rhythms
returned in reverse order. MoKurrey et al.. (1958) desoribed
changes seen in the EEG of monkeys subjected to hypothermia and
cerebral occlusion. They observed flattening of the EEG after
one minute of total ooolusion, and noted recovery time was
directly related to ooolusion time. Gaenshirt et_J&., (1954)
cooled isolated oat's heads by perfusing with cooled blood
from/
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from a donor oat, and found a slowing of frequenoy vith an
inoraaaa in voltage to 30.0°C, below 30.0°C dysrhythmia
appeared with slow fraquanoias dominating and the voltage
decreased. Their raoorda heoame iaoalaotrio between 15.0°C
and 20.0°C,
Techniques such as speotral analysis and auto¬
correlation have also been used in studying EEQs in coma.
Ferillo at al.. (1969) have made a speotral analysis of the
EEG activity of patients in comatose states arising from organic
*rs' ' " ' *
brain lesions and were able to record oscillatory periodic
potentials ("rhythmic" activity) in all degrees of cbma except
in the terminal stage of coma or ooma "depasse". The dominant
rhythmio activity belonged to the delta band. Theta and alpha
rhythms oould be recorded. They concluded that a certain
organisation of the cerebral eleotrioal activity is compatible
vith a severe disorganisation of cerebral functioning. However
they did not find any clear-out relation of ooma and type of rhythmic
activity. Bergamini at al.. (1965) studied the EEG rhythm of six
subjects in post-trsumatlo coma and suggested aperiodic coma
delta rhythm was probably a sua of eleotrioal potentials which
were only apparently rhythaioal but which in reality represented
a bioelectrioal activity without periodic events, of random type.
The investigations reported so for are based on either
retrospective studies or EEG recordings for a short time. The
reports on EEG changes, particularly regarding the significance
of flat reoords in cases of coma, are conflicting (Jouvet, 1959l
Loeb/
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Loeb, 1938| Bontal and Leibowitz, 1961) possibly because in
all these studies EEG recordings were done only for short periods*
The existing literature does not contain any report of continuous
EEG recording of oonatose patients from the time of adaission
to hospital till their recovery froa ooaa. It appeared likely
to me, that continuous EEG recording or EEG recording over fairly
long periods might be important for the understanding of the
significance of the various EEG changes seen in coma*
The published reports (Fisohgold and Mathls, 1959I
Chatrian et al.. 1963) reveal a lack of correlation between the
clinical and eleotrioal signs of depth of ooaa. Moreover most
studies have been done on patients with organic brain disease,
including head injury, and little is known about drug-induced
coma.
Many pharmacological agents influenoe the EEG but
because of the widespread use of barbiturates for sedation,
anaesthesia, and in the therapy of convulsive disorders, the EEG
effeots of this drug group have been studied more widely than
others. Earlier reports emphasised the similarity between reoords
obtained under barbiturate sedation and those of natural sleep
(Berger, 1931| Lennox et al.. 1936, Oibbs et al.. 1937)* There
has been increasing emphasis on the initial appearance of fast
activity preoeding the loss of consciousness (Cohn and Katzenelbogen,
1942) Brazier and Finesinger, 19451 Brazier, 1948). In very
heavy doses, as in deep anaesthesia near the oollapse stage
(Brazier, 1951) silent periods are interrupted by bursts of aotivity




ffulff (1950) studied 26 patients suffaring from
acuta barbiturate poisoning. EEG records vara taken daily
until the patient either reoovered oonaoiousness or died.
In one oase cortical activity was absent. In the most severely
poisoned patients, periods of absent oortioal activity (blackouts)
m - ■ * ■ '"v
of a few seconds to several minutes duration were observed. Most
of these oases died, but the blackouts disappeared before death.
Neither variations in blood pressure (from subnormal to normal)
nor oxygen therapy had any effect on the blaokouts. He suggested
that presence of blaokouts indicated an unfavourable prognosis.
Mants and his oo-workera (1965) reported six oases of
severe barbiturate coma with episodes of five to one hundred
and eighty seconds of EEG flattening interrupted by paroxysmal,
high voltage bursts. All the six oases reoovered, and they
authors emphasised that a well-conducted reanimation programme
"oan succeed in intoxications clasaioally considered mortal"•
Bird and Plum (1968) reported a oase of aoute barbiturate
poisoning who had an isoelectric EEG record for twenty-three
hours but reoovered after five days of coma.
Sament and Huott (1969) from the Massachusetts
General Hospital have reported EEQ changes in 26 oases of
aoute barbiturate poisoning. Seven of twenty six (27?<>) cases
died, including every one of their six cases which had completely
isoelectric records (Stage VI). The remaining death was in a
patient who had an isoelectric record with bursts of sharp
aotivity (stage V). Their stages I-III were aasooiated with
drowsiness or confusion and Stages IV-7I with coma. These
authors/
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could not distinguish clinically the three stages (IV-VI)
associated with ooma but found a correlation between these
EEG changes and complications. Cardiac arrest occurred only
during Stage VI, whereas respiratory failure oocurred during
Stages III-VI, and the authors emphasised "if these complications
can be prevented, all oases of barbiturate intoxioation are
potentially reversible"•
The majority of the reports published so far have
been oonoerned with EEG changes in aoute barbiturate intoxication*
There is only one single oase report, by vall ace and Allen (1968)
of EEG changes in "Mandrax" overdose* They found a "flat" EEG
with irregular bilateral spike complexes appearing at intervals
of 1-8 seconds'. The patient recovered and 1J days after the drug
her EEG was reported to be "nearing normal".
The care of a patient who has taken an overdose of
a psychotropic drug must be based on the olinioal assessment of
the patient, with the assistance of a toxioologist* However, if
we are to advanoe out understanding of coma we must be able to
follow the behaviour of the important physiologioal variables
continuously* A record of these changes may make it possible
to compare cases and establish significant points of change during
the coma. These could be correlated with the toxicological
findings*
The existing literature shows that EEG studies have
been entirely based on sampling, using short runs of EEOs usually
without consideration of any other variables. Some attempts have
been/
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been made to correlate the degree of abnormality of EEG and
tha clinioal level of oonaoiouanaaa. Aa far aa long ton
EEG monitoring ia concerned, thia haa boon almoat exclusively
used in aloep reaoaroh and then rarely oarried on for more than




The investigation vas carried out at the Edinburgh
Regional Poisoning Treatment Centre whioh serves a population of
about half a million in Edinburgh and the surrounding district.
All adult oases of aoute drug poisoning are admitted, regardless
of the severity of the poisoning. The number of admissions has
doubled in the past five years and in 1966 there were 1067
admissions (634 women and 433 men). The unit has seven-day
laboratory support for the qualitative and quantitative
estimation of commonly involved poisons. The funotioning
of the unit has been described in detail by Matthew et al..(l969).
the ward physicians to assess the olinioal level of consciousness
and vas graded into one of the following grades (Matthew and
Lawson, 1966).
On admission eaoh patient was examined by one of
x Grade 0 Fully conscious
Grade 2
Grade 1 Drowsy but responds to verbal commands
Response to mild painful stimulation.
Grade 3 Minimum response to maximum painful
stimulation.
Grade 4 No response to maximum painful stimulation.
x The olinioal grade of coma is not to be confused with
the EEG grading. To enable easy distinction, the
olinioal grade will be designated by Arabic numerals
and the EEG grade by Roman numerals.
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Rubbing the patient's sternum with the knuokles
was used ae the standard painful stimulus •
The level of oonsoiousnese and progress of the
patient while under oare was based on repeated olinical
evaluation and regular sampling of such physiological
variables as temperature, pulse rate, blood preasure
and respiration* This was supported by supplementary
investigations where possible, suoh as estimation of the
blood levels of the toxio drug, assessment of serum electrolyte
levels and blood gases. The clinical examination included
assessment of the presence of any co-existing disease which
would have made the patient more vulnerable to the toxio
effects of the drug*
Continuous BEG monitor!; g was started as soon as
possible after admission to the ward. A delay of two to
three hours between admission of the patient and starting the
EEG reoording was quite common owing to the fact that some
patients required such procedures as intubation, stomaoh washout
or special nursing procedures before preparation for EEG
reoording.
IY.E*
PREPARATION FOR RECORDING USED IK PROJECT 2i-
Silver oup electrodes were filled with electrode jelly
and were attaohed to the soalp with the collodion, in positions
Fz, Cg, Pz, F^, C^, P^, Fj, Cy and Py of the international
M10/2<>" system of eleotrode placement* Every attempt was made to
attach the electrodes in the desired position despite awkward/
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awkward positions of the head in some unconscious patients.
It was particularly difficult to fix the electrodes when
the foot of the bed was raised to support the blood pressure
or when the patient was attached to a ventilator.
A central montage with the following channels was
used in most of the patients studied.
1 mm PZ - cz
2 - CZ - pz
3 - pz -
4 mm pz - *5
5 - cz °4
6 - cz - °3
7 - pz - P4
8 - pz - P3
This oentral montage proved to be advantageous as
this allowed the patient*s head to be kept on the side, an
important principle in the management of unconscious patients*
In some cases two extra electrodes, one on the
left 3rd or 4th intercostal spaoe, 1" from the midstemal
line and the other on the left shoulder, were attached to
monitor the ECG. It was found possible though not easy to
continue ECG recording whilst the patient was receiving
aotive nursing attention.
Eaoh eleotrode had 4 inches of wire and was connected
to the headbox by means of a longer connecting lead.(Pig,13b).This
procedure made it possible to disconnect the patient from the
machine for nursing care, physiotherapy, or when the patient
became/
flfti 13 It
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restless at about tha time of regaining consciousness* The
resistances of the eleotrodes were checked to ensure that they
were below 10 K ohms.
The EEQ machine used in this project was a portable
16 ohannel Elema-Sohonander Mingograph. It is specially
modified for continuous recording and is capable of running
from batteries as well as from the mains supply. Therefore*
it was possible to more the maohine to the bed-side of the
patient. The maohine was run at a oonstant speed of 1.5 cm.
m
per second* producing 4000 sheets of reoorded paper over the
24 hour period.
As a routine procedure the machine was calibrated
at 1 om. per 100 microvolts ( jiy.,) time constant ■ 0.5 second
and high frequenoy filters - 0. Precautions were taken to
ensure an artefaot-free record*
In eaoh patient recordings were made continuously
throughout the period of unoonsoiousness till either the
patient recovered or died. After reoovezy twice daily
recordings were usually made and a pre-disoharge full-
montage EEG.
When patients were medically fit to be discharged
from the hospital* a battery of psychological tests were
administered to the first forty patients in the hope of
detecting any possible organic brain damage. The battery
was made up of the following testsi-
I. The Mill Hill Voo&bulary Scale (Synonym only)
Form 1 Senior. (Haven* 1958 a.)
II. The synonym Learning Test. (Kendriok* 1965)*
III. The Digit Copying Test. (Kendrick, 1965).
IV. Raven's/
64.
IV. Raven's Progressive Matrices.
V. Design Copying Test (Orme et al.. 1964)
At intervale of one. three and nine months, after
discharge from hospital the first forty patients attended for
follow-up examination, when both EEC and psyohometrio tests
were repeated1 while in a further thirty nine oases only
EEG examination was repeated. As no evidenoe of residual
brain damage was found in these patients the follow-up
procedure was discontinued.
IV.F.
ANALYSIS OF THE RECORDi-
All records from eaoh patients were read page by
page by the author. This involved the analysis of approximately
two thousand hours of EEG reoord, or rou^ily 83 miles of paper.
As no internationally agreed method of scoring coma records
oomparable to that for analysing sleep records is available, a
system of classifying these records had to be established. After
reoording the first few records the following system of
olassifioation was found useful and these criteria were
employed in sooring all the records.
An EEG was classified as follows*-
x
GRADE I - When it oontained alpha rhythm or predominant
alpha with beta or some rare thetai this type
of abnormality is illustrated in Fig. 14. taken
from a oase of nitrazepam overdose 16 hours after
ingestion of 40 tablets (200 mg.).of nitrazepam.
It shows drug-induoed 16-18 ops.
x Note that Roman numerals are
used for the EEG grade of coma.
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Figure 141
Grade 1 EEG abnormality. Drug-induced 16-18 ops activity,
after nitrazepam overdose.
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Figure 15:
Grade II EEGabnormality. Dominant activity at 5-8 ops with
bursts of slow wave activity at 1-4 ops, in a case of








Where there wee predominant theta with some alpha,
beta and low voltage delta as illustrated in Fig.
15 from a phenobarbitone overdose 56 hours alter
ingestion of the drug.
When it showed the presenoe of predominant low/high
voltage delta mixed with some theta. This is
illustrated in Fig. 16 from a oase of meprobamate
overdose 20 hours after drug ingestion.
When it oontained delta with or without brief
isoeleotrio intervals, as illustrated in Fig. 17
from a oase of phenobarbitone poisoning, 30
hours after drug ingestion.
When it contained suppression-burst activity
(Fig. 18) namely where 3-10 ops aotivity of
several seoonde duration would alternate with
electrical silenoe.
When it oontained near silenoe (Fig. 19) but
with isolated and low voltage 5-7 ops waves
ooourring singly or bursts of half a second.
An isoelectric reoord totally unresponsive to
any stimuli. (Fig. 20 a. and 20 b.)
IV.G.
STATISTICAL METHODS»-
In this project a rank correlation method was used. In
view of the nature of the data the most suitable technique was that
developed by Kendall (1939)* This is the correlation statistic
"tau". The teohnique used for calculating tau involved oontingenoy
tables and hence there were a great many tied ranks. The value
of tau obtained had therefore to be corrected for continuity
thereby giving a unit normal deviate (z). The significance of
this s was evaluated in the usual way giving exact probability
values. For example z values of I.64 and 2.33 give a significance
level of p - 0.05 and p - 0.01 respectively.
It/
EXAMPLES OF EEG ABNORMALITY IN ACUTE DRUG POISONING.
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Figure 16:
Grade III EEG abnormality in a case of meprobamate poisoning.
Dominant activity at 1-2 cps with some 3-5 ops activity on which
was superimposed fast activity of 14-18 cps.
Patient 118, Female, 20 years old.





Grade IV EEG abnormality. Almost continuous slow wave
activity at ^--1 cps, after phenobarbitone overdose.
Patient 11, Female, 28 years old.
EXAMPLES OF BEG ABNORMALITY IN ACUTE
DRUG POISONING.
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Figure 181
Grade V EEG abnormality (suppression burst activity), 5-10 cps
activity of several seoonds duration alternates with electrical
silence, in a case of barbitone overdose.
Patient 14, Female, 64 year old.
TIME MARKER*—-—1—1—1—r~' 1 1—»■■ v~'——1—1—1—1——*—
FZ-CZ . ' r X A




. : ; 7 • ~
CZ-C3
PZ-P4 . ~~
PZ-P3 7 r T ~~
control - cow nrn&| rcojs«
isec
Figure 19:
Grade VI EEG abnormality. Low voltage 5-7 cps waves occurring
singly (marked with arrows), after Ingestion of barbitone.
Patient 14, Female, 64 year old.
















Grade VII EEG abnormality} an isoelectric record at average
gain (100 /av/cm), in a case of orphenadrine and promazine
poisoning. Patient 104, Male, 41 years old.
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Figure 20 b.
Grade VII EEG abnormality. Same patient's record at maximum
amplification (20 yuv/cm) contained ?~ECG-artefacts at increased
sensitivity but remained isoelectric.
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It is appreciated that there are probably
correlations between all the parameters although only the
correlations with the EEC gradings have been quoted. These
additional correlations would imply that partial correlation
should be oaloulated. However rank correlation methods do
not lend themselves easily to this form of correlation.
IV.H. PATIENTSt-
One hundred and twenty seven patients formed the
population studied. All were in-patients of the Regional
Poisoning Treatment Centre. Edinburgh, between January 1968
and July, 1969* All patients were admitted beoause of aoute
drug poisoning. Patients with a history of oarbon monoxide
poisoning alone or in oonjunotion with other drugs were
excluded. The total number of male and female patients together
with the drug ingested are shown in Table 22. All patients
except 4 mad«» clinical recovery from acute drug poisoning. The
main drugs involved were barbiturates, Mandrax (a combination
of methaqualone 290 mg. and diphenhydramine hydrochloride
29 mg.) and nitrasepam. As barbiturates alone accounted for
approximately half the patients this drug group has been
discussed separately, the other drugs having been coabfned
for the presentation of the results.
All the 29 patients in the Mandrax group survived.
One patient, however, (see ease histories - Case No.4 ) though
recovering from the aoute drug poisoning, on the 7th day after
admission/
NUMBER OF MALE AND FEMALE PATIENTS AMD
DRUG INGESTED BY - 127 PATIENTS.
DRUG GROUP MALE FEMALE TOTAL
BARBITURATES 15 35 50
MANDRAX 9 14 23
NITRAZEPAM 2 17 19
TRICYCLIC COMPOUNDS 3 7 10
OTHERS 6 19 25
TOTAL 35 92 127
TABLE 22
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developed ventricular fibrillation and died. Aa can be
seen from hie history there was considerable prior pathology.
Another patient (Case Ho. 61) developed two transient oardiao
arreste from whieh she was resuscitated, while another patient
(Case Ho. 54) required assisted ventilation 15 hours after
admission and was kept on a Bird respirator for 14 hours. Five
oases showed some ECO abnormality. A small amount of alcohol
in addition to 18 tablets of Mandrax was ingested by one
patient (Case Ho. 62) though the blood concentration of
aloohol was not estimated.
Ten patients wers studied who had been admitted
for overdose of trioyolio compounds (Table 22). This
group was composed of 5 who had taken amitriptyline. 5
imipramine. one nortriptyline and one protriptyline. One
patient (Case Ho,101) had taken an uncertain amount of
alcohol in addition to imipramine. Four patients (Cases
Hos. 95* 94# 95 and 90) developed some oardiao irregularities
but in none was the irregularity serious and all disappeared
as they recovered. Three patients (Cases Hos. 95* 94 and 98)
developed fits. All patients survived.
Nineteen oases of nitrasepam poisoning were
inoluded (Table 22). All made a full clinical recovery,
from acute drug poisoning. Three patients (Cases Hos. 79*
85 and 91) had taken some alcohol in addition to nitrazepam
but the blood alcohol concentrations were not estimated.
It will be noticed that for the nitrazepam group
of/
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of patients correlations between EEQ grades and other parameters
are not presented. This is becapse all the 19 patients were
either EEO grade X or II. Any correlation found therefore
<■■<■***» ..«*'• -it,
m.
would- be meaningless owing to the clustering of the patients
in these two EEG grades.
The miscellaneous (other) group was made up of 6 men
and 19 women. The drugs involved are shown in Table 23* Three
patients died (Cases Hoe. 104. 106 and 126). The first (Case
Ho. 104) had taken orphenadrine hydrochloride (Disipal) in
combination with promazine (Sparine) and, on admission to the
ward, developed oardlao arrest for approximately 5-7 minutes
from which he was resusoitated but died 16 hours after admission.
The seoond patient (Case Ho.108) was admitted to the ward in an
unconioioue state* A blood examination revealed only a email
amount of barbiturate (1.2 mg.$). He developed oardiao arrythmias
and died 20 hours after admission. The third patient, a young
female (Case Ho.126) had taken paracetamol and ferrous sulphate
tablets and oollapsed. After admission to the ward she had
severe gastro-intestinal haemorrhage and died.
One patient (Case Ho. 110) who took Bioonal x and
Mandrax made a clinioal recovery from aoute drug poisoning
but suffered brain damage, manifesting itself as a persisting
dementia with disorientation and recent memory impairment. One
patient (Case No. 120) had taken a small amount of alcohol with
the tablets but blood alcohol concentration was not estimated.
x Diconal is a combination of dipipanone
hydrochloride 10 mg. and oyolizine hydrochloride
30 mg.
NUMBER OF PATIENTS AND DRUG INGESTED BY
25 CASES OF MISCELLANEOUS (OTHER) GROUP.
DRUG OR DRUGS NUMBER OF PATIENTS
MEPROBAMATE 5
GLUTETHIMIDE + BARBITURATES 1
GLUTETHIMIDE + DIAZEPAM 1
GLUTETHIMIDE + NITRAZEPAM 1
DICHLORALPHENAZONE 1
QUINALBARBITONE + TRIFLUOPERAZINE + NITRAZEPAM 1
BARBITURATES + ? 1




ORPHENADRINE + PROMAZINE 1
MANDRAX + DIPIPANONE HYDROCHLORIDE 1
BARBITURATES + ANTIDEPRESSANT + ALCOHOL 1
BARBITURATES + PHENOTHIAZINE 1
FENFLURAMINE 5
THYROXINE 1
SALICYLATE + ? 1
PERPHENAZINE + ? 1





EEC ABNORMALITY IK THE INITIAL RECORDi-
Each patient's record was classified in terms of
the EEG grade as described previously* The EEG abnormality, as
seen in the initial record of the patients in the various drug
groups, is shown in Table 24. Forty one of the 127 cases (32$)
were Grades V-VII, and of these 20 had taken barbiturate, 8
Mandrax, 3 trioyclic oompounds and 10 had taken miscellaneous
(other) drugs.
Forty percent of patients in both the barbiturate
and miscellaneous groups, and 35$ of the Kandrax group, were
Grade V-VII, In the nitrasepam group, on the other hand, only
minor EEG abnormalities were observed and, of the 19 cases in
this group, 16 were Grade I and the remaining 3 Grade II,
In the tricyclic antidepressant group none of the
10 patients was Grade VI or VII and eaoh revealed Grade II-V
EEG abnormalities. Fifteen of the 23 patients (60$) in the
miscellaneous group were Grades I-IV and all the three patients
who had taken fenfluramine were Grade I.
Fifteen patients had an isoelectric record at
some point during their aoute drug poisoning state. In ten
of these it was observed at the time of initial recording, while
in the remaining five patients it was not seen till some time
after admission, In two of the 4 cases of Mandrax poisoning
with complete electrical silenoe it was seen in the initial
record. In Case No, 62 it lasted for 13.50 hours and for 22 hours
in/
EEQ ABNORMALITY AND DRUG INGESTED BY 127 PATIENTS
NUMBER OP CASES
EEC GRADE OP COMA ,.DRUG GROUP —vv*<v TOTAL
II III IY V VI VII
BARBITURATES - 8 8 14 8 7 5 50
MANDRAX 1 2 8 4 4 2 2 23
NITRAZEPAM 16 3 - - - - - 19
TRICYCLIC
COMPOUNDS - 2 2 3 3 - - 10
OTHERS 3 2 6 4 4 3 3 25
TOTAL 20 17 24 25 19 12 10 127
TABLE 24.
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in oase No. 59 • Throe patient* (Cases 104, 108 and 126) from the
miscellaneous group had a flat record at the tine of initial




The age distribution of all the 127 patients is
presented in Table 25* Fifty two percent of the barbiturate
group, 60.8% of Mandrax poisoning, 50^ in the trioyclio
antidepressant group and 36^ of the aisoellaneous group
were above the age of 40.
Twelve peroent of the patients of the barbiturate
group, of the Mandrax group, 10^ of the trioyolio oompound
group and 8>£ of the miscellaneous group were above the age of
60 years. The,correlation between age and EEG grade of coma
(Table 26) for the various drug groups was found to be significant
(p - 0.05) for the Mandrax and the trioyolio group. However, the
overall oorrelation between age and EEG depth of coma was not
found to be significant (z - 1.38, p - 0.08).
IV.K.
CLINICAL ASSESSMENT OF DEPTH OF COMAi-
The olinioal depth of coma in relation to the
drug ingested by the 127 patients is shown in Table 27* Twenty
two patients (17$) were oonsoious on admission and these included
all/





DRUG 19 20/59 40/59 60/79 80 + TOTAL
BARBITURATES 2 22 20 5 1 50
MANDRAX 1 8 12 2 _ 23
NITRAZEPAM - 9 9 1 - 19
TRICYCLIC COMFOUNDS 1 4 4 1 - 10
OTHERS 6 10 7 2 - 25
TOTAL 10 53 52 11 1 127
TABLE 25
NON-PARAMETRIC CORRELATION BETWEEN AGE GROUP AND
EEG CRAPE IN VARIOUS DRUG GROUPS














ALL DRUGS 0.21 1.38 0.08
Note the overall correlation was calculated
separately and not obtained by averaging
individual correlations.
TABLE 26.
CLINICAL DEPTH OF COMA AND PRPO INGESTED
BY 127 PATIENTS.
NUMBER OF CASES
CLINICAL GRADE OF COMA
DRUG GROUP 0 1 2 5 4 TOTAL
BARBITURATES - 9 8 12 21 5°
MANDRAX 3 8 8 4 25
NITRAZEPAM 19 - - 19
' ' "** *" *" v
TRICYCLIC COMPOUNDS - 44 2 10
OTHERS 3 2 4 8 8 25
TOTAL 22 14 24 32 35 127
TABLE 27.
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all 19 patients who had taken nitrazepam and the three who had
taken fenfluramine.
Sixty seven of the 127 oaees (5 5S&) were grades 3 and
4, of whom 35 had taken barbituratee, 12 Mandrax and 6 trioyolio
antidepressants. The remaining 16 oases had taken a variety of
other drugs or drug mixtures.
An attempt was also made to oorrelate the EEO grade
of ooma with cllnioal assessment of depth of coma. EEG grade 1 was
associated with a fully conscious patient, Grade II with drowsiness,
Grades III and IT were assooiated with unooneciousnese but the
patient responded to stimulation of the sternum with the knuoklee.
In Grades V-VII the patient was deeply unoonsoious and these grades
could not be distinguished clinically.
A significant positive correlation between the
clinical assessment of depth of coma and the EEG grade of ooma
(Table 28) was found not only for all the drugs (p - 0.002) taken
together but also separately for barbiturate (p » 0.004), Mandrax
(p - 0.003), tricyolio antidepressants (p - 0.01) and miscellaneous
drugs (p » 0.004).
IV.L.
TEMPERATURE OUT ADMISSION-
The patient*s rectal temperature, as recorded on
admission to the ward, and the drug group are shown in Table 29.
Eighty five of the 127 patients (77$) had a temperature in the
range 35.6°C to 37.6°C. Forty patients (31.5$) were hypothermic
(below/
ROH-PARAMETRIC CORRELATION BETWEEN CLINICAL
GRADE AND EEG GRADE IK VARIOUS DRUG GROUPS.
DRU(f GROUP T&u Corrected p
z
BARBITURATE 0.76 2.68 0.004
MAHDRAX 0.90 2.76 0.003





ALL DRUGS * 0.85 2.87 0.002
Rote the overall correlation vaa
calculated separately and not obtained
by averaging individual correlation.
TABLE 28.
TEMPERATURE (°C) ON ADMISSION AND DRUG
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TOTAL 3 10 27 85 - 127
TABLE 29
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(belov 35.5°C) and of these 13 vara balov 34.5°C and thraa (2 from
tha barbiturata group and ona from tha miscellaneous group) balov
32.3°C. Only tvo patients (1.5/0 vara hyperthermic. Both vara from
tha barbiturata groupt ona had a temperature of 37.8°C and tha
other 39.0°C. A significant negative correlation (Table 30) betveen
tha temperature and EEC grade vas found (p - 0,01) for all tha drugs.
This implies that hypothermia vas associated vith EEG coma grades
IV-VII.
In the barbiturata group (Table 29) patients who had
taken an overdose of medium or short acting barbiturates seemed
especially to be liable to hypothermia, vith temperatures belov
35.6°Ct namely, in the pentobarbitone group, 3 of 6, in the
quinalbarbitone group, 3 of 7, and in the Tuinal group, 3 of 7.
A correlation betveen temperature and EEG grades of barbiturate
m
coma (Table 30) vas found to be significant (p - 0.01),
A correlation betveen temperature and EEG grades
vas then calculated separately for other drug groups (Table 30)
and vas found to be significant for M&ndrax (p « 0.001) and
miscellaneous (other) drug (p - 0.001) groups.
IV.M.
TOTAL PERIOD OF UKCONSCIOUSHESSi-
An estimate of the total period of coma vas made
for the unoonsclous patients. The period of unoonsolousness vas
considered to commence from the time of ingestion of the poison, as
given in the history by informants and later ascertained from the
patient.
One/
NOB-PARAMETRIC CORRELATION BETWEEN THE















Bote the overall correlation was calculated




One hundred and five patiente were unconscious on
admission to the hospital. One hundred and one regained oonsciousnessi
4 died. The distribution of ooaa duration for patients in each group
is presented in Table 31. Twenty nine of 103 patients (27.5$) were
in ooaa for less than 15 hours and 53 patients (50.5$) for 13*48 hours.
Twenty three patients (22$) were unconscious for more than 48 hours.
12 for less than 72 hours, 6 for 73-95 hours and 5 patients (2 from
the barbiturate group and 5 from the tfandrax group) for more than
95 hours. Of the 23 patients who were unconscious for more than
48 hours, 16 had taken barbiturates, 5 Mandrax and two miscellaneous
(other) drugs. The correlation between the total duration of coma
and the EEQ grade of coma for all the drug groups (Table 32) was
found to be significant (p - 0.01). Similarly a significant
correlation (p - 0.01) was observed for the barbiturate group alone.
All the patients in the tricyolio compounds group
(Table 31) were in ooaa for less than 48 hours. Only one of the 10
& patients in this group was in ooaa for more than 24 hours, while 6
were unoonsoious for less than 24 hours and 5 for less than 12 hours.
A significant (p » 0.03) correlation was found between the duration
and the BEG grade of coma (Table 52). The correlation for miscellaneous
(other) drug group (Table 32)^as also significant (p - 0.03).
IV. *.
BLOOD DRUG LEVELS 1-
Serum barbiturate levels were estimated in 49 of
50 patients with acute barbiturate poisoning (Tables 39 and 40). One
patient/
TOTAL PERIOD OF COMA (HOURS) AMD DRUG INGESTED
IS 105 CASES UNCONSCIOUS ON ADMISSION,
DRUG GROUP
NUMBER OF CASES
DURATION (HOURS) OF COMA











TOTAL 29 26 27 12 5 105
TABLE 31.
NOK-PARAMETRIC C01.RELATI0N BETWEEN DURATION
OF COMA AND EEC GRADE OF COMA IK VARIOUS
DRUO GROUPS.
DRUG GROUPS Tau Corrected p
z
BARBITURATE 0.62 2.32 0.01
MANDRAX 0.28 O.96 0.17
TRICYCLIC COMPOUNDS O.63 1.94 0.03
MISCELLANEOUS OIL OTHER 0.48 1.86 0.03
ALL DRUGS ■ 0.58 2.35 0.01
Note the overall correlation was calculated




patient who had taken barbitone had a reoord level of 67.0 mg.%,
A significant (p - 0.007) correlation was found between blood
dTrug levels of the long acting barbiturates and EEG grade (Table
36).
In the tricyclic antidepressant group estimation
of the drug in the blood was oarried out only in one patient
(Case No. 93) and she had 116 jug. percent of amitriptyline on
admission. This subsequently rose to a maximum of 147 /*{?• peroent.
In the nitrazepam group Case No. 78 had a blood nitrazepam level
of 63 and in another patient (Case No. 86) urine examination
confirmed the presence of the drug.
Blood methaqualone estimation was done in all oases
exoept 2. However* for these 2 oases the history from informants*
prescriptions issued by the family doctor, the presence of clinical
signs such as increased tone in the muscles and increased tendon
reflexes, and* on recovery* confirmation by the patient* suggested
that they had taken Handrax. Of the remaining 21 patients* on
admission nine had a blood methaqualone level of up to 2*9 mg.
percent. In eight patients it was 3.0 - 4.9 mg.5*>, two had 3*0
to 6.9 mg.$ and two had more than 7.0 mg,$>.
In four oases (Cases Nos. 54* 39* 60 and 74) the
blood methaqualone level later rose to a level higher than that
estimated on admission. It rose to a maximum of 7.6* 12.9* 3.2
and 11.7* from 4*9* 9.0* 2.2 and 4.1 mg.f& respectively. Blood




Fifty patients, 13 men and 33 women* came into this
group/
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group (Table 33). All recovered. Three (Case Nos. 6, 27 and
39) bad a oardlao arrest of less than 90 seoonds but sere
resuscitated and serial electrocardiograms shoved no evidenoe
of myocardial damage. Ten patients required assisted ventilation,
of whom four needed the respirator for less than 3 hours, five for
6-12 hours and one for 13 hours. Three patients (Case Nos. 3. 14 and
39) were treated vith forced alkaline diuresis and the remainder were
given intensive supportive therapy. Five patients (Case Nos. 6, 8, 34, 41
and 47) had also taken aloohol. The blood alcohol concentration in
patient No. 8 was 62 mg.$.
The findings from the initial EEC reoording for
patients in eaoh barbiturate preparation group are tabulated in
Table 34* These grades do not take aooount of subsequent det¬
erioration or improvement in the EEC record. Forty peroent (20 of
30) of this group vers Grades V-YII| all the 7 oases of quinal-
barbitone poisoning were in this "deep" coma range. In oontrast
v.
the majority of patients who took phenobarbitone (12 of 13) were
Grades II-IVj only one phenobarbitone patient vas Grade V.
Complete eleotrioal silence (or Isoelectric record)
lasting from three hours (Case No. 36) to 28 hours (Case No.27)
vas seen in eight oases. In five of these it vas seen in the.
Initial record, vhereaa in the remaining three it vas observed sometime
after the beginning of the initial reoording. Of the 3 patients
vho had an isoelectrio record on initial reoording, three had
taken quinalbarbitone, one butobarbitone and one barbitone.
The/
SEX DISTRIBUTION AMD BARBITURATE INGESTED
IK 50 PATIENTS.
NUMBER OP PATIENTS
BARBITURATE PREPARATION MALE FEMALE TOTAL
PHENOBARBITONE 5 6 13
BARBITONE 1 1 2
AMYLOBARBITONE 2 6 8
BUTOBARBITONE 1 3 4
Q.UINALBARBITONE 2 5 7
PENTOBARBITONE 3 3 6
CYCLOBARBITOHE 3 3
TUINAL 1 6 7
TOTAL 15 55 50
^BLE 2?f
SEP ABNORMALITY AHP BARBITURATE
INGESTED BY 50 PATIENTS.
BARBITURATE
PREPARATION
EEG GRADES OF COMA
I II III IV V VI VII TOTAL
PHENOBARBITONE 5 A 3 1 13
BAR BITONE _ _ . i 2
AMYLOBARBITONE 2 3 1 1 8
BUTOBARBITONE 3 mm i
Q.UINALBARBITONE 2 ? 3 7
PENTOBARBITONE mm m *» 3 1 2 «• 6
CYCL0BAR3IT0NE «• mm 1 1 1 _ 3
TUINAL 1 1 1 ? 1 7
TOTAL 8 8
. 14. 8 7 5 50
TABLE U
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The ages of these patients can he seen in Table 35*
Eighty percent of the patients in this group (42 out of 50) vere
20-59 years old* The correlation between age group and the EEG
grade of coma (Table 36) was not signifioant*
Clinioal assfssment of depth of coma at the time of
* *
admission to the ward is shown in Table 37• Most of the patients
(12 of 13) who had taken phenobarbitone were grades 1 and 2* where¬
as the majority of the patients taking other barbiturate preparations
were grades 3 and 4* Por example, 6 of the 7 who had taken
quinalbarbitone and 5 of the 6 who had taken pentobarbitone were
Grade 4* All the patients who had taken butobarbitone, quinal-
barbitone or pentobarbitone were grades 3 and 4* The correlation
between elinioal aseesement of depth of coma and the EEG depth of
ooma (Table 36) was significant (p - 0.002).
The frequenoy distribution of reotal temperature for
the barbiifeurafl group is shown in Table 38* Thirty four percent
(17 of 50) of patients were hypothermic (below 35*5°C) while only
.
^ -TP
trfo (2 of *50) were hyperthermic. Patients who had taken an overdose
of medium or short-acting barbiturates seemed especially to be
liable to hypothermia with temperature below 35»6°C. Six out. of the
thirteen patients who had taken either quinalbarbitone or pentobarbitone
were hypothermic whereas only 11 of the remaining 37 patients were
hypothermic. This difference however is not signifioant (X2 » 0.5f
df ■» l). The majority of phenobarbitone oases (ll of 13) had a
temperature/
AGS IN YEARS OF PATIENTS AND BARBITURATE DIGESTED
BARBITURATE NUMBER OP PATIENTS
PREPARATION AGE IN YEARS
-19 20-39 40-59 60-79 80 ♦
TOTAL
PHENOBARBITONE 1 6 6 w 13
BARBITOHE 1 1 «•» 2
AMYLOBARBITONE 1 4 3 . w 8
BUTOBARBITOHE mm 3 1 «a» 4
ftUlHALBARBITOHE mm 2 4 •» 1 7
PEHTOBARBITOHE mm 3 3 mm mm 6
CYCLOBARBITONE mm 1 2 3
TtJINAL 3 2 2 7
TOTAL 2 ?2 20 5 1 50
TABLE 35
NON-PARAMETRIC CORRELATION BECTEEK EEC GRADE OF COMA





AGE GROUP AND EEG GRADE 0.22 1.14 0.15
CLINICAL GRADE AND EEG GRADE 0.76 2.68 0.004
TEMPERATURE AND EEG GRADE -0.29 -2.35 0.01
DURATION OF COMA AND EEG GRADE 0.62 2.32 0.01
EEG GRADES AND SERUM LEVELS OF
MEDIUM AND SHORT ACTING BARBITURATE 0.17 0.97 0.17
SERUM LEVELS OF LONG-ACTING BARB¬
ITURATES AND EEG GRADES 0.74 2.54 0.001
TABLE 56
CLINICAL ASSESSMENT OF DEPTH OF COMA AND
BARBITURATE PREPARATION INGESTED BY 50 PATIENTS.
NlfMBER OF PATIENTS
BARBITURATE CL1CNICAL ORABE OF COMA
PREPARATION o \ 2 3 4 TOTAL
FHENOBARBITONE 6 6 1 13
BARBITONE 1 m l 2
AMYLOBARBITONE mp 1 1 A 8
BUTOBARBITONE mm 2 ? 4
QUIKALBARBITONE mm mm 1 6 7
PENTOBARBITONE mm mm 1 5 6
CYCL0BAR3ITQNE 1 1 1 3
TUINAL mm I mm 4 7
TOTAL _ ? 8 12 , 21 50
TABLE 37
TEMPERATURE AND BARBITURATE INGESTED BY
50 PATIENTS.




















PRE NOBAR BITONE mm 1 11 1 mm mm 13
BARBITONE mm mm 1 1 mm mm mm 2
AMYLOBARBITONE 3 5 mm mm 6
BUTOBARBITONE 1 m 1 2 mm mm mm 4
GUINALBARBITONE l 2 5 mm 1 7
PENTOBARBITONE 1 1 1 3 mm mm 6
CYCLOBARBITONE mm l 2 mm mm mm 3
TUINAL mm 2 1 4 mm mm 7
TOTAL 5 1,0 1 1 50
TABLE 58
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temperature in the range of 35.6°C to 37.8°C. A significant
oorrelation was found (Table 36) between temperature and the
EEG grade of ooma (p ■ 0.007)*
The serum barbiturate levels of fifteen patients
*ho took long-acting barbiturates (phenobarbltone or barbitone)
are shown in Table 39* Seventy three percent (ll of 13) of
oases had a blood drug level of acre than 8.0 mg.$. Sixty two
peroent (8 of 13) of phenobarbitone eases had a blood drug
level in the range of 8.0 - 14.9 ag«$. One patient in the
barbitone group had a reoord level of 67*0 ag.$. She had an
isoeleotrio EEG tracing and was treated with forced alkaline
diuresis. Blood drag levels of the long noting barbiturates
and EEG grade (Table 36) were significantly correlated (p » 0.007).
The serum concentration of medium and short-acting
:yf
barbiturates is presented in Table 40. In 17 of the 33 cases the
serum levels were 2*9 mg.$ or less. Only 3 of the 25 oases had
a serum level of more than 5.0 ag.$. In one ease (of amylobarbitone)
the level of drug in the blood was not estimated.
The period of unconsciousness following the ingestion
of barbiturates by the fifty patients is shown in Table 41. Fifty
peroent of cases (25 of 50) were in coma for 25 to 72 hours,
less than 25 hours and 12$ more than 72 hours. Only two patients
(both from the phenobarbitone group) were in ooma for more than
96 hours. The oorrelation between the total period of unconsciousness
and the EEG grade of ooma (Table 3&) was significant (p - 0.001).
PHBNQBARBITONE AHp BARBITOKB CONCENTRATION
IK BLOOD 100 m}f) IN ^TlgHTS,










TOTAL 1 3 ? 2 15
TABLE ft
MEDIUM AND SHORT ACTING BARBITURATE BEL OOP
CONCENTRATION (Bg. Mr 100 «1.) IK 55 PATIENTS.
BARBITURATE Mg. £ BLOOD LEVEL
. ' ' " ' ' •
H1EFARATI0H H1K1 -2-9 5-4.9 5-6.9 J*_ TOTAL
AKYLOBARBITOHE 1 4 2 1 6
BUTOBARBITOHE J 1 4
QUI SAL BAR BITOSE 4 1 2 - 7
PENTOBARBITONE -33- - 6
CYCLOBABBITOSE 1 1 1 3
TUINAL 5 2 7
TOTAL 1 17 12 2 3 35
TABLE AO.




PREPARATION -12 15-24 24-48 49-72 73-95 96+ TOTAL
PHENOBARBITONE 6 mm 3 2 ? 15
BARBITONE 1 _ mm 1 2
AMYLOBARBITONE 1 3 3 1 6
BUTOBARBITONE mm 1 2 mm 1 _ 4
Q.UINALBARBITONE 1 2 3 1 «•» 7
PENTOBARBITONE 1 3 1 1 6
CYCLOBARBITONE 1 1 p 3
TUINAL 2 2 1 2 7





CASE HISTORY No. 1 (ll/lOS/Cft).
A 28 year old female wae admitted to the Regional
Poisoning Treatment Centre, Royal Infirmary, Edinburgh at 11.40
hours on the 8th March 1969* after having taken a large number
of phenobarbitone tablets two hours prior to admissions*
Course in the Hospital»-
On admission to the ward she was drowsy and unable
to give any history. Physical examination did not reveal any
abnormality. Her pulse was 80 per minute and regular. Blood
pressure 400/60 mm.Hg. and rectal temperature 37,0°C. Stomach
washout was performed on admission, with some tablet material
being noticed in the return but by now she was deeply unconscious,
making no response to rubbing of the sternum with the knuckles.
Blood phenobarbitone level four hours after drug"ingestion was
9.2 mg.$. Her first electroencephalogram (EEG) reoord (Fig.21)
taken four hours after she beoame comatose, contained background
£-1 ops activity with superimposed fast activity of 9-10 ops
(Grade IV). Continuous EEG monitoring was done throughout
the period of coma and for a period afterwards.
Clinically her condition remained unchanged for
24 hours and her blood phenobarbitone level rose to 9*3 mg.#.
Her EEG tracing after eight hours of coma (Fig. 22) revealed
bursts o£ slow«-wave activity at &-1 cps aotivity on which eras
superimposed fast aotivity of 9-10 ops. Alternating with these
slow/
EBur IN ACUTE PHENOBARBITOBE FOISONING.
(Patient 11 .Female 28 yeasrs old)
Control-
Coma : 4 Hours (103/<)
ICC L TC«C).3 Sec
I Sec
Figure 21:
Grade XV BEG abnormality. Background activity of |r-l cps
with superimposed 9-10 cps activity.




After eight hours of coma EEG record showed bursts of -£-1 cps
activity, alternating with these slow waves were distinct
areas of less activity.
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slov waves were areas of less activity of 2-4 seconds duration,
thus showing a deterioration in the condition of the patient
as judged by the electrioal activity of the brain. On sternal
stimulation no clinioal response was observed, but the EEG
record (Fig, 23) showed a response, namely the areas of less
aotivity disappeared and slow wave activity increased both in
frequency and amplitude. Background aotivity was now dominantly
2 ops mixed with some 2-4 cps. This reactivity disappeared
after 100 second and the record once again contained slow
wave bursts with intervening flat areas.
Little change was noticed in the EEG record
over the next 18 hours till after 3° hours of coma. The
EEG record revealed almost continuous slow wave activity at
£-1 ops (Grade IV). The intervening flat EEG periods gradually
disappeared. Clinically the patient's condition remained the
same and no clinical response was noticeable to sternal stimulation
but the EEG record continued to show gradual improvement. After
40 hours of coma the EEG record (Fig, 24) contained dominant
aotivity at -j^-2 cps mixed with which was some activity at 2-4
cps. The superimposed fast aotivity was now absent. On stimulating
reactivity was noticed in the form of disappearance of some of the
large slow component of the record with replacement by faster
frequencies of 2-4 ops.
Forty seven hours after the ingestion of the drug
the patient first showed a olinioal response to a maximal painful
stimulus. Her blood phenobarbitone level was 9.7 mg. peroent.
After/














COMA : g H«s (After Stimulation)
ICC J_/ TC=0.3 Sec
i sEC
Figure 23t
After stimulation areas of less activity disappeared and EEG
consisted of dominant activity at ^-2 ops mixed with some
2-4 ops aotivity.
Control—
CCHA:4C H Rs. (105/s)
ICC yW-V TC.C-3 Sec
I Sec
Figure 24»
Forty hours after lapsing into coma the dominant aotivity was
£-2 ops mixed with some 2-4 ops activity. The superimposed
fast activity was now absent.
81.
After 52 hours of coma her EEG record (Fig* 23) contained ^-2 ops
slov wave activity, superimposed on which was some 6-8 ops fast
aotivityv , - *
Alternating periods of slow waves and faster
frequencies appeared spontaneously and the patient produoed such
"spontaneous shifts" without heing stimulated (Fig. 26). Eaoh
spontaneous shift was characterised by two phases. In the one
there were large slow waves at £-1 ops but with only little
superimposed fast frequency, this phase would last for 40-50
seconds and give way to 1-4 ops aotivity with little superimposed
fast activity (Fig. 27).
An EEG tracing after 76 hours of coma (Fig. 28) showed
dominant delta aotivity together with some theta (Grade III). An
EEG traoing after 84 hours of ooma (Fig. 29) showed low voltage
slow waves and increased amount of 4-6 ops aotivity (Grade III).
After 92 hours of ooma (Fig. 30) only a small number of slow waveB
at 2-4 ops were seen and the dominant activity was 5-8 ops (Grade III).
After remaining deeply unconsoious and virtually
unresponsive for four days she regained consciousness 96 hours after
drug ingestion; but was drowsy. On the 6th hospital day aha was still
drowsy, her blood phenobarbitone level was 7*9 mg.^>. She was seen
by the psychiatrist who transferred her to the North Wing of the
Royal Edinburgh Hospital for inpatient psychiatric oare.
Her blood examination for phenobarbitone concentration
was reported to be 4*2 mg.% on the 10th day after the drug ingestion,
3.4 mg. on the 11th and 2.8 mg.$ on the 12th day) 2.7 mg. on the
13th, 2*5 mg. on the 14th, and 1.5 mg. on the 17th day and 0.8 mg.$
on the 19th day after ingestion of the drug, when she asked for her
discharge/
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Figure 25»
After fifty two hours of coma alternate periods of high voltage
-^•-2 ops slow wave activity, superimposed on which was some
6-8 ops fast activity and low voltage faster frequencies of
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Figure 26:
Two phases of a spontaneous shift, low voltage faster frequencies
of 2-4 cps with marked superimposed fast activity alternates with
high voltage -§—1 cps slow wave activity with little superimposed
fast activity.
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Figure 27>
Another example of a spontaneous shift. Low voltage 1-4
cps activity with superimposed 6-8 ops activity gdLvesway to
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After seventy six hours of coma EEG record comtained high voltage
dominant activity at -g--2 cps with some low voltage 2-4 cps
activity.
EES IN ACUTE PHENOBARBITONE POISONING.
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Figure 29t
BEG record after eighty four hours showed Grade III EEG abnormality.
It contained dominant activity at 4-6 ops mixed with which was some




















After ninety two hours of coma EEG showed a predominant activity
of 5-8 ops with some slow wave activity at 2-4 cps.
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discharge. The further recovery of this patient (Patient No. 6)
is discussed in Project No. 3. " >
CASE HISTORY No. 2 (5/27/D.C.)
A 36 year old male was admitted at 13*45 hours on
the 3*4 April. 1968. having ingested 60-80 phenobarbitone tablets
(60 mg. tablets).
Course in the Hospital*-
On admission he vas unconscious but making vigorous
responses to painful stimuli. Blood pressure vas 100/60 mm.Hg. and
the pulse vas 84 per minute, regular and of good volume. Chest
examination shoved scattered crepitations but in other respects a
full physical examination was normal. His blood phenobarbitone
concentration vas 10.8 mg.$. Twelve hours after his admission his
condition deteriorated and he became deeply unconscious and made minimal
response to painful stimulation.
His first eleotroencephalographic record (Fig. 31) after
34 hours of coma revealed Grade IV EEG abnormality. Clinically his
condition remained unchanged. His blood phenobarbitone level vas
9.6 ng.fo. Thirty five hours after the drug ingestion forced alkaline
diuresis was commenced. After 40 hours of coma his EEG tracings
(Fig. 32) showed burst of slow wave activity at i-2 cps lasting for
4-6 seconds and the remainder of the epoch contained lov voltage
4.3 cps activity. "Spontaneous shifts" were also seen when slow
wave activity of several seconds duration would alternate with faster
frequencies. Fig. 33 shows a transition from lov voltage 4-5 ops





After 44 hours of ooma the patient's EEG record
(Fig.34) before stimulation shoved lov voltage 1-2 ops activity*
After stimulation lov voltage slow waves disappeared and the
reoord (Fig* 53) now consisted of a mixture of higher voltage
delta and' theta waves (Grade III). Forty eight hours after
lapsing into coma his EEG (Fig. 56) contained 1^-2 cps activity
in the upper three ohannels and 2-4 ops in the lover channels
(Grade III)* His blood phenobarbitone concentration was 8.4 mg.$.
Two hours later the patient made vigorous response to painful
stimuli. He continued to improve and was conscious after 53
hours of coma* His blood phenobarbitone level was 8.8 mg.$.
After fifty six hours, his EEG shoved a general
lov voltage 6-8 ops activity with bursts of slow wave activity
at 1-4 ops lasting for 5-4 seconds (Grade II). One hour later when
the 3»tient was left undisturbed, his EEG reoord (Fig. 5?) shoved
return of slow wave activity. This tracing contained L&-5 ops
activity. The upper two ohannels shoved more slow waves and the
lover six ohannels faster frequencies*
Sixty hours after ingestion of phenobarbitone, his
EEG traoings (Fig. 58) during sleep shoved a mixture of 1^-2 ops
waves seen in the upper three ohannels (middle of the reoord) and
2-4 ops activity more marked in the lover five ohannels. Muscle
activity was also seen. Two hours later when the patient was
drowsy (Fig. 59) his record shoved dominant 6-8 cps lov voltage
aotivity with bursts of lov voltage 1-2 ops slow waves of 8-12
seconds duration*
Like/
EEC IN ACUTE PHENPBARBTTONE POISONING,
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After stimulation, low voltage slow waves disappeared and the
record showed a mixture of higher voltage 1-2 activity and
some 3-4 cps activity.
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Figure 36:
After forty eight hours of coma record showed Grade III EEG
abnormality. Slow waves at lfc-2 cps were seen in the upper
three channels and 2-4 cps activity in the lower five channels.















When the patient was left undisturbed, he appeared asleep and
his EEG showed return of slow wave activity at 1-^-3 °P® similar
to the one seen in figure 36*
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A record five hours post coma when patient was asleep showed a
mixture of 1^—2 cps waves in the upper three ohannels and 2-4 cps
activity were marked in the lower five channels. Muscle
activity was also seen.
EEG IN ACUTE PHENOBARBITONE POISONING.














Sixty two hours aftei- ingestion of phenoharbitone (seven hours
post coma) EEG record was dominated by low voltage 6-8 cps
activity with a burst of low voltage 1-2 cps activity.











Eighteen hours post coma EEG tracings showed a mixture of low
voltage 2-3 cps activity and 4-6 cps activity.
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like other phenobarbitone overdose oases* although he
responded to vooal command at the end of 55 hours his EEG record
was abnormal for a much longer time. Seventy two hours after
ingestion of drug (16 hours post-ooma) the patient was still
drowsy and his EEG tracings (Fig. 40) showed soattered delta and
theta waves.
Upon regaining consciousness he was restless, dis¬
orientated as to time and place but gradually improved. Seventy
two hours after he took the overdose he was co-operative, but
anxious. Bis phenobarbitone level was reported to be 8.1 mg.?£.
Ten days after his admission he was fully recovered and was
discharged on the 11th day, after having been seen by the
psyohiatrist.
CASE HISTORY No. 5 (ld/29/J.M,)
A 64 year old woman was admitted to the Regional
Poisoning Treatment Centre, Royal Infirmary, Edinburgh at 09.15
hours on the 16th April, 19&8, after having ingested large
quantities of her sodium barbitone (Medinal) tablets 10-11
hours prior to admission.
Course of Illness in the Hospitali-
On admission she was deeply unoonsoious and totally
unresponsive to all stimuli. Her blood pressure was 70/40 mm.Hg.
and pulse 100 per minute. Chest examination showed expiratory
rhonchi, but was otherwise normal as was the rest of the
physioal examination. An endotracheal tube was inserted and
thereafter/
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thereafter gastrio lavage was carried out. The serum barbitone
level was 67.8 mg,fo. Her respiratory minute volume was 4 litres
and rectal temperature 35«8°C.
Continuous electroencephalograph^ (EEC) monitoring
was started soon after admission and her tracings (Fig. 41) showed
an isoelectric record without response to any stimuli (Grade VII).
Clinioally she was deeply unconsoious and totally unresponsive.
After 14 hours of coma her blood pressure was 75/55 mm.Hg., rectal
temperature 34.1°C and serum barbitone level TO mg.$. Her EEG
reoord (Fig. 42) was isoelectric even on maximum gain (20 micro
volts per cm). Seventeen hours after ingestion of the drug her
EEG record (Fig. 45) tox the first time showed two isolated bursts
of activity (Grade VI). Her olinioal condition remained unchanged
and her serum barbitone was 65 mg.$.
After 20 hours of coma her EEG (Fig. 44) showed
suppression burst activity (Grade V) which increased on stimulating
the sternum. Her reotal temperature was 53<0°C and serum barbitone
level 65 mg.$. Twenty four hours after ingestion of the drug she
was still in deep coma and did not show any clinical response to
rubbing of her sternum but her EEG record (Fig. 45) showed an
increase in electrical aotivity. Her blood barbitone level was
62 mg.$ and rectal temperature 32.1°C.
After 28 hours of ooma,clinically her oondition
remained unchanged. Her reotal temperature was 31.6°C, blood
pressure 85/60 mm.Hg. and serum barbitone level 55 mg.%. Her
EEG record (Fig. 46) contained abundant 4-5 ops activity without ♦
any intervening flat areas and over the next four hours this
activity/
EEG AFTER BARBITONE POISONING
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Figure 41:
Isoelectric EEG record approximately twelve hours after the
patient took an overdose of barbitone. Blood barbitone level
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Figure 42:
After fourteen hours of coma EEG record remained isoelectric
even on maximum amplification (20 micro-volts per cm.). Blood q




EEG IN ACUTE BARBITONE POISONING
(Patient 14. Female." 64 years old).
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Figure 45t
After seventeen hours of coma record showed Grade VI EEG
abnormality. It contained two isolated bursts of activity
marked with the arrows. Blood barbitone level was 65 mg. percent.
| TC =0.3 Sec
7 sec
Figure 44:
After twenty hours of coma her tracings showed suppression burst
activity (Grade V). Blood barbitone level was 65 mg, percent and
rectal temperature 33»0 C,
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Figure 45:
After twenty four hours of coma no clinical response was observed
on stimulation but her EEG record contained an increased amount
of cerebral electrical activity (Grade Y). Blood barbitone














Twenty eight hours after drug ingestion EEG tracings consisted of
continuous 4~5 cps activity. Blood barbitone level was 55 mg»
percent and rectal temperature 31*6 C. Clinically she was
unresponsive to all stimuli.
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activity increased both in quantity and amplitude. At the end of
. ... •*
32 hours'her EEG tracings (Pig. 47) showed 2-3 ops activity more
marked in the top three ohannels and low voltage 4-6 ops activity
in other channels.
After 33 hours of coma her rectal temperature rose
to 55*5°C and her serum barbitone level dropped to 42 mg.$ but
clinically she was still deeply unconscious and unresponsive
to all stimuli. Her EEG reoord (Fig. 48) showed 4-6 ops
activity with bursts of 2-3 ops activity. This showed further
improvement over the next five hours and a reoord after 37 hours
(Pig. 49) contained 2-5 ops in the top three channels and a
dominant low voltage 4-6 ops in the remaining reoord. Cardiac
irregularities"were also seen. Her EEG reoord after 40 hours
(Pig. 50) showed reduction in slow frequencies and contained
4-6 ops activity in the top three channels and low voltage 6-8
cps activity in the remainder of the record. Rectal temperature
was 36.4°C and serum barbitone level 39 mg.$.
After remaining unconscious for 45 hours, she for
the first time, responded clinically to painful stimulation. Four
hours later examination of blood showed a serum barbitone level of
31 mg»$ and rectal temperature of 37.2°C. After 54 hours of coma
her EEG tracings (Pig. 51) before stimulation revealed 4-6 cps
activity in the top three channels and low voltage 6-8 cps
activity in the remaining five channels. After painful stimulation
(rubbing of the sternum with the knuckles) the EEG record (Pig. 52)
showed an inorease in the voltage, 3-6 cps activity was seen in
the top three channels and high voltage 5-8 cps in the remaining
channels./
EEC IK ACUTE BARBITONE POISONING.
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Figure 47t
After thirty two hours of coma, EEG record showed 2-J cps
activity in the top three channels and low voltage 4-6 cps
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Figure 49:
Thirty five hours after lapsing into coma no clinical response
was observed but her EEG record showed 4-6 cps activity with
bursts of 2-3 cps activity. Blood barbitone level was 42 mg.
percent and rectal temperature 35 • 5 C.
EEG IN ACUTE BARBITQUE POISONING
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Figure 49s
After thirty seven hours her EEG record was dominated by 2-5 cps
activity in the top three channels and low voltage 4~6 CPS in
the remaining record. Cardiac irregularities were also seen#
•/UajV
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Forty hours after lapsing into coma her EEG tracings showed 4-6
cps activity in the top three channels and low voltage 6-8 cps
activity in the lower five channels. Blood barbitone level was
59 mg. percent and rectal temperature 56.4 C.
EEG IN ACUTE BARBITONE POISONING,
(Patient 14. Female, 64 years old).
TIMEMARKER-
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Figure 51t
After fifty four hours of coma a record before stimulation contained
4-6 cps activity in the top three channels and low voltage 6-8 cps
activity in the remaining five channels. Blood barbitone level was
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Figure 5 2:
After painful stimulation, the EEG tracings showed an increase
in voltage 3-6 cps activity in the top three channels and high
voltage 5-8 cps in the remaining five channels.
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channels. In the EEG tracing taken after 56 hours of coma (Fig. 55)
a spontaneous shift from slow to faster activity was observed. 4-7
cps activity with prominant 2-5 ops in the top three channels, gave
way to faster frequencies at 6-9 cps. Figure 54 shows another
apontaneous shift from faster frequencies to slower frequencies.
Clinically she showed vigorous response to painful stimuli. Her
rectal temperature was 57»2°C and serum barbitone level 28 mg.$.
After remaining unconscious for 59 hours she made
appropriate response to vocal command but remained very drowsy.
EEG monitoring was continued and 60 hours after ingestion of the
drug her EEG tracings (Fig. 55) showed some activity at 5-7 ops
mixed with 8-10 cps activity in the top three channels and more
generalized low voltage 6-8 cps activity with some 2-4 cps
aotivity.
Sixty eight hours after drug ingestion (nine hours
post-ooma)f she was very drowsy and on being left undisturbed,
appeared asleep. Her EEG (Fig. 56) consisted of dominant activity
at 4-8 ops mixed with which was some 5-5 cps activity. She remained
very drowsy for the next few hours. Her EEG after 75 hours (Fig.57)
showed a dominant aotivity of 7-8 cps with some 5-5 cps. Musole
artefact ^ras also visible. Her serum barbitone level waa.21.6 mg.$
and temperature 56.6°C. She continued to improve and her EEG record
after 91 hours (51 hours post-coma) was recorded while the patient
was awake (Fig. 58). It showed eye blinks. Dominant activity was
7-15 ops with occasional bursts of 2-4 ops activity. Her serum
barbitone level was 10.8 mg.°/o after 107.50 hours.
One/
EEG IN ACUTE BARBITONE POISONING.
(Patient 14. Female. 64 years old).
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Figure 551
After fifty six hours of coma EEG record contained a
spontaneous shift. Slow wave activity at 4-7 cps with
predominant 2-5 cps in the top three channels gave way
to faster frequencies at 6-9 cps.
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Figure 54*
Another example of a spontaneous shift. The dominant activity
at 6-9 cps with some 5-4 cps activity gives way to slow wave
activity at 2-4 cps. Blood barhitone level was ^b mg, percent
and rectal temperature 57.2 C,
EEG IN ACUTE BARBITONE POISONING,
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Figure 55s
Sixty hours after drug ingestion (one hour post coma) EEG
tracings showed some activity at 5-7 cps mixed with 8-10 cps
activity in the top three channels and low voltage 6-8 cps
activity with some 2-4 cps activity in the lower five channels#
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Nine hours post coma, she appeared asleep. Eer EEG tracings
contained dominant activity at 4-8 cps mixed with which was
some 5-5 cps activity.
EEG IN -ACUTE BARE ITONE POISONING















After seventy three hours (14 hours post coma) her record
showed a dominant activity of 7-8 cps with some 3-5 ops.
Muscle artefact was present. Blood barbitone level was 21,6 mg,
percent and temperature 36.6 C,
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Figure 58:
Thirty one hours post coma while the patient was awake her
EEG contained dominant activity at 7-13'cps with occasional
bursts of 2-4 cps activity. It showed eye blinks.
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One hundred and thirty hours after ingestion of the
drug the EEG reoord (Fig. 59) revealed a generalised flatness
with prominent blinks. The baokground aotivity consisted of low
voltage 7-10 ops which was blocked by eye closure. Her serum
barbitone level was 9«5 mg.$. On the 8th day of her admission her
EEG reoord (Fig. 60) showed generalised 8-10 ops activity.
On the 5th night of her admission she was reported to
have "slept very little" by the night staff. However, during the
day she was quite comfortable. The next night (jrd post-coma night)
she was reported to be "awake most of the night, seems to be very
confused at times" and during the day she developed some withdrawal
symptoms. She became confused, disorientated and paranoid for which
she received thioridazine 50 mg. six hourly orally. For her insomnia
she was prescribed 10 mg. nitrazepam cn the 7th hospital night, 5 mg.
on the 8th and 10 mg. on the 9th night. Her psychometric testing
showed no deficit and she was discharged home on the 9th hospital
day.
Her EEG reoord after one month (Fig. 61) and psychological
tests were normal. EEG and psychological tests were repeated at
intervals of three, six and nine months but they were normal.
CASE HISTORY No. 4 (59/dl/J.M.) +
A man, aged 56, was admitted to the Regional Poisoning
Treatment Centre, Royal Infirmary, Edinburgh at 08.00 hours on the
15th June, 1968, after having been found unoonsoious. He had been
last seen by his wife at 22.00 hours on 14th June. Handrax had been
prescribed/
I
EEG IN ACUTE BARBITONE POISONING
(Patient 14. Female. 64 years old).
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Figure 59:
A record 150 hours after the ingestion of drug (71 hours post
coma) revealed a generalised flatness with prominant blinks.
The background activity consisted of low voltage 7-10 cps and
was blocked by eye closure. Blood barbitone level was 9.5 mg.
percent.
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prescribed for his insomnia and was available to him. Consequently
Mandrax overdose was considered but he had no physical signs
considered diagnostic*
During the previous three years he had been orippled
owing to two attacks of myooardial infarction, a oarcinoma of the
prostate under treatment with stilboestral, a pathological fracture
of the right femur, and trigeminal neuralgia requiring tarsorraphy
after seventh nerve seotion*
Course in the Hospitali-
On admission he was deeply unconscious and totally
unresponsive to all stimuli, including rubbing of the sternum with
the knuokles and pinching of the earlobes* Sis pupils were small
and fixed. Cough, corneal and gag reflexes were absent. Plantar
reflexes were extensor and the muscles flaccid. Bowel sounds were
present. Pulse was 80 per minute, regular, poor in volume, systolio
blood pressure 60 mm.Hg. and respiration Cheyne-Stokes type. Other¬
wise there were no localizing signs. An endotracheal tube was passed
and intensive supportive therapy instituted. A blood sample tested
for drugs revealed very high methaqualcne level of 9.0 mg,$.
Continuous EEG monitoring was started and his record (Fig. 62) showed
isoelectric tracings which showed no change even on stimulation
(Grade VII). EEG recordings made with maximum gains (20 microvolts
per cm.) was still isoelectric (Fig. 63). Over the next 12 hours
his oondition deteriorated. His bowel sounds disappeared and he
developed pneumonia. His rectal temperature was 37.8°C and blood
methaqualone level 12.0 rag.?6. His EEG reoord (Fig. 64) remained
isoelectric (Grade VII),
Twenty nine hours after the ingestion of the drug
he was still deeply unoonsoious making no clinical response to
any/















Fourteen hours after drug ingestion his EEG record (on average
gain - 100 ,uv. per cm) revealed isoelectric tracings (Grade VII),
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TC- 0-3 sec.
Figure 65:
EEG recording made with maximum amplification (20 juv/cm) wa®
also isoelectric. Three waves seen in the top two channels
are artefact as they do not appear in other channels in spite
of electrodes F2, and being common to other channels#
EEG IN ACUTE MANDRAX POiaONING
Patient 59 - Male 56 years old*
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Figure 64 i
Twenty hours after lapsing into coma his EEG tracings showed no
sign of gerebral electrical activity* His rectal temperature
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Figure 65t
After forty pight hours of coma, his EEG record revealed Grade V
abnormality -(suppression burst activity). His rectal temperature
was 57C and blood methaqualone level was 9*6 mg. percent.
90.
any stimuli, but hia EES record first shoved a burst of activity
In response to stimulation of sternum with knuckles* His blood
methaqualone was 12*3 ng.fi and rose to 12*9 mgS at the end of
30 hours* After 33 hours of coma BEG record shoved spontaneous
isolated bursts of activity* Thereafter his EEG record continued
to show increased activity but he gave no clinical response to
painful stimuli. Bis methaqualone level vaa reported to be
12*9 mgat thirty hours after the drug ingestion.
* After 48 hours there was no change in his clinical
condition but his EEG record (Fig. 65) showed suppression burst
features in the EEG (Grade V) with 1-3 seconds of aotivity
alternating with 10-13 seconds of electrical silence* This
aotivity could be increased by sternal stimuli* The blood
methaqualone level was 9*8 agand the reotal temperature 37*8°C*
His olinioal condition remained unchanged for 64 hours after drug
ingestion* but his EEG (Fig* 66) now shoved continuous delta
activity without any intervening.flat areas (Grade IT). Sixty six
hours after the drug* he was responding minimally to maximum painful
stimulation* Hia temperature was 59*1°C*
After sixty nine hours of ooma there was a sudden
deterioration in the patient's condition. There was profuse sweating,
trembling of the whole body, restlessness and teohyoardia and soon
after this he once again was deeply comatose and unresponsive to
stimuli* This deterioration in his clinical state was preceded
by change in his EEG which showed the return of silent areas* One
hour later the EEG record showed suppression burst aotivity, a
record/
EEG IN ACUTE MANDRAX POISONING
Patient 59 - Male 56 years old.
Figure 66t-
After sixty hours of coma his EEG tracings contained a mixture
of low and high voltgge continuous delta activity. His rectal
temperature was 39 «1 C.
Figure 671
Seventy hours sifter lapsing into coma his EEG record showed
return of suppression burrit activity (Grade V), a record similar
to that seen after only 48 hours of coma (Figure 65). His rectal
temperature was 39.3°C and blood methaqualone 8,1 mg. percent.
91.
record similar to that seen after only 48 hours of coma (Fig. 67)*
His temperature was now 39»3°c and blood methaqualone level 8.1
mg. percent.
However his condition again improved during the next
twelve hours and he reaoted to the presence of the endotracheal
tube which therefore was removed. His temperature came down to
38,8°C from 40.3°C after 81 hours# The blood methaqualone
concentration was 6.2 mg.Jfe. His BEG also showed improvement.
An ECG taken at this time revealed left bundle branch block but
this was reported to have been present for the previous 4 months
Sti '* * '
since he had had myocardial infarction. Thereafter he continued
to make satisfactory progress and after 92.30 hours he was
responding moderately to sternal stimuli. His rectal temperature
was 38.2°C and the blood methaqualone level had dropped to 4*7 mg.$.
After remaining in coma for 106 hours he made appropriate
response to vocal oommand, but remained very frail and confused. His
methaqualone level was 2.5 mg.$ and temperature 37»5°C. On the 21st
June* (7th hospital day) he rapidly developed left ventricular
fibrillation^ died within a few hours despite aotive measures. The
post mortem showed a recent myocardial infarction which was accepted
as the cause of death. It was suggested that as Mandrax is liable
to cause disturbances of the eleotrooardiogram, and of myocardial
enzymes, it may have accelerated his death. However, very little
Mandrax was present in the blood (0.8 mg .ft), when he died.
CASE HISTORY No.5 (72/llO/E.S.)
A 49 year old female was admitted to the Regional
Poisoning/
92
Poisoning Treatment Centre on 21st March, 19&9 after having taken a
large quantity of Mandrax tablets 12 hours prior to hospitalisation*
She had been attending the psychiatric Out-Patient Clinic and had
been prescribed Mandrax by her family doctor.
■.•a-,*. •
Course in the Hospitali-
On admission she was deeply unconscious, responding
minimally to maximal stimulation* Her pulse was 84 per minute,
regular and of good volume and blood pressure 80/40 mm.Hg* The
reflexes were all intaot and normal and musole tone was normal*
Stomaoh wash-out was not oarried out in view of the time lapse
since she took the tablets* It is worthy of note that she
lacked all the diagnostic olinical signs of Mandrax poisoning,
such as increased musole tone and hyper-reflexia* Blood examination
revealed a methaqualone level of 4*1 mg. percent*
Her electroencephalograph^ tracings (Fig*68) showed
bursts of 2-4 cps activity with superimposed 4-6 ops activity. Over
the next two hours deterioration and contained suppression burst
aotivity. Clinically the patient was deeply unconsoious and did
not respond to sternal stimulation* Her bowel sounds were absent*
The respiratory minute volume was 5 litres*
After 30,hours of coma her respiratory minute
volume was 3 litres and her EEC record showed suppression burst
aotivity (Fig. 69)* Her blood methaqualone level was 8.6 mg.?6*
After thirty four hours of coma she was deeply unconscious, hypotonio
and areflexio but had faint bowel sounds* Her EEC record remained
unohanged* Her methaqualone blood level was 9*3 mg
Her/
EEC IN ACUTE MANDRAX POISONING,
Patient 72 - Female, 49 years Old.
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Figure 68;
Fourteen hours after ingestion of Mandrax her PEG
record revealed Grade V EEG abnormality. It contained
bursts of 2-4 cps activity with superimposed 4-6 cps
activity. Her blood me thaqual one was 4.1 mg. percent.
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After thirty hours of coma her EEG tracings showed
Grade V EEG abnormality (suppression burst activity). Blood
methaqualone level was 8.6 mg. percent.
93.
Her EEG tracings after 43 hours (Fig. 70) showed
improvement and contained dominant activity at 2-6 cps. Blood
methaqualone level was 11.7 mg.$, Clinically the patient*s
condition remained unchanged and her blood methaqualone level
after 47 hours was 10.2 mg.$. Her EEG continued to'F'improve
and after 56 hours (Fig. 71) it contained slow sotivity at
1-3 ops with some 2-6 cps. Superimposed on the slow waves were
6-8 cps faster frequencies. Her blood methaqualone level was
7.8 mg.$.
After 53 hours, she was still deeply unconscious,
hypotonic and areflexic. Her methaqualone 30-vel was 7.8
She was intubated and gastric lavage performedi Four hours later
her methaqualone level rose to 10.2 mg.$. Electrically she
continued to improve and EEG tracings showed 2-6 cps activity with
some superimposed 6-8 cps activity.
After 69 hours of coma she responded minimally to
sternal stimulation. Three hours later her EEG record (Fig. 72)
contained high voltage 3-6 cps activity mixed with which was some
low voltage activity at 6-9 cps. She continued to improve and the
EEG tracings after 96 hours (Fig. 73) showed an increase in voltage
and frequency. She regained consciousness after 105 hours of ooma
but 110 hours after ingestion of the drug her arms and legs were
twitching and she became restless. Her EEG reoord (Fig. 74) showed
a mixture of slow waves at 3-4 ops and faster activity at 6-10 cps.
She/
EEG IN ACUTE MANDRAX POISONING.








Forty three hours after lapsing into coma her EEG record
contained hursts of 2-6 cps activity separated by areas
of less activity. Blood methaqualone level was 11.7 mg.percent.
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Figure 7]
After fifty six hours of coma her EEG revealed slow wave
activity at 1-1 cps mixed with which was some 2-6 cps
activity. Superimposed on the slow wave activity were
6-8 cps faster frequencies,
mg. percent
Blood methaqualone level was 7.8
EEG IN ACUTE MANDRAX POISONING.
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Figure 72:
After seventy two hours of coma her EEG consisted of a
mixture of 2-3 cps slow waves and 6-0 cps faster activity.
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Figure 73«■
EEG tracings after ninety six hours of coma showed an
increased voltage and frequency namely, high voltage 3-6
cps activity mixed with which was some low voltage 6-9
cps activity. Blood methaqualone level was 4*5 nig. percent.
EEG IN ACUTE MANSRAX POISONING





















One hundred and ten hours after ingestion of the drug
her EEG record showed a mixture of slow, waves at 5-4 CPS
and 6-10 ops activity.
94.
She mad* a full clinical recovery and was seen by
the Consultant Fsychiatrist who transferred her to the North Wing
of the Royal Edinburgh Hospital for psychiatrio In-Patient care.
The further reoowery of this patient is discussed in Projeot
No* 3 (Patient No. l),
CASE HISTORY No. 6 (104/57/C.T.)
A 41 year old male was admitted to the Regional
Poisoning Treatment Centre, Edinburgh Royal Infirmary, at O4.3O
hours on 2nd December, 1968, after having taken 30 tablets
(2500 mg.) of orphenadrine hydrochloride (Disipal) and 20 tablets
(300 mg.) of promazine hydrochloride (Sparine) about three
quarters of an hour previously. He had taken a saline emetic
some 13 minutes later and had vomited copiously sinoe.
Course of Illness in the Hospital»-
On admission he was conscious with tremor of
both arms and a warm, dry skin. Pulse 120 per minute and
regular, blood pressure was not recorded. The chest was
generally clear and the abdomen normal. Tendon reflexes were
present. The pupils were dilated with some reaotion to light.
Stomach washout was commenced soon after admission
to the ward and recognisable tablets were obtained in the return.
About five minutes after the washout he became completely dis¬
orientated and apparently hallioinated. This was followed
directly by a grand mal fit which lasted for several minutes and
whioh caused deep cyanosis. He was treated with oxygen and given
paraldeyhde intramuscularly. There followed about twenty minutes
almost continuous fits after whioh he went into respiratory arrest
and becdme completely flaccid. When the endotracheal tube was/
95.
vas eventually In position it was found that oardiao arrest was
also present and oardiao massage and large amounts of bicarbonate
were required to restore a relatively normal rhythm. The estimated
duration of the cardiac arrest was about five to seven minutes.
Clinically he was deeply unconsoious and totally unresponsive to
all stimuli. His pupils were widely dilated with no reaction to
light.
His EEC record (Fig. 75) four hours after drug
ingestion was isoelectric and showedno change even after painful
stimulation of the sternum with the knuckles (Grade VII). His
rectal temperature was 37>0°C and blood pressure 8O/4O mm.Hg. He
was on a Bird's respirator. After six hours of coma his reoord
was still isoeleotrio and a reoord on higher gains (Fig. 76) showed
no sign of oerebral electrical aotivity.
After 10 hours of coma hie EEG reoord (Fig. 77)
showed oomplete electrical silence (Grade VII). Clinically he was
deeply unconsoious and totally unresponsive to stimuli including
stimulation of the sternum with the knuckles. His pulse was 124
per minute but the blood pressure was unrecordable despite
metaraminol (Aramine) followed by over two litres of plasma under
central venous monitoring control. The rectal temperature was
35*C°C. His EEG record showed no response to stimulation
(Grade VII) and to exclude any technical fault in recording,
the lead from the head box was pressed with the foot (Fig. 78)
which produced an artefact, confirming the presence of an
isoelectric record.
Sixteen/
EEG IN ORFHENAPEINE AND PROMAZINE POISONING.
Patient 104 - Male, 41 years old,
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His EEG record four hours after drug ingestion was isoelectric
(Gains 100 jttv/cm). Rectal temperature 57.0 C. Clinically
he was deeply unconscious and totally unresponsive to all
stimuli.
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Figure lot
After six hours of coma record was still isoelectric and
a record on higher gains (50 ^ttv./cmp TC * 0,5 sec.) showed
no sign of cerebral electrical activity (Grade VIl),
EEG IN ORPHENADRINE AND PROMAZINE POISONING

















After ten hours of coma this excerpt showed complete
electrical silence (Grade VII). Rectal temperature
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Pressure on the lead from head box produced an artefact,
confirming the presence of an isoelectric record.
96.
Sixteen hours after drug ingestion EEG tracings
were completely isoelectric (Grade VII) and a record (Fig. 79)
taken at highest (maximum) gains (20 yuv/cm.) contained ECG
artefact at increased sensitivity but no signs of cerebral
»■ *
electrical activity. Clinically his condition remained unchanged,
his pulse was 60 per minute and he required isoprenaline on
several oocasions for marked bradycardia. His blood pressure
was unrecordable end rectal temperature 35*8°c* After twenty
one hours of coma his EEG record (Fig. 80) was isoelectric and
showed no change on sternal stimulation.
After twenty two hours of coma his EEG tracings
(Fig, 81) were still completely isoelectric (Grade VII). The
few isolated spike like deflections are artefacts. His heart
rate was 12 per minute. Clinically he was deeply unconscious
and totally unresponsive to all stimuli. His EEG record also
remained unaffected by these stimuli. His blood pressure was
unobtainable and rectal temperature was 32.4°C. Fupils were
fixed and dilated. He died after 22 hours of coma. His
EEG record (Fig. 82) remained isoelectric all this time (Grade VII),
A post mortem was performed which confirmed the
diagnosis of cardiao arrest following poisoning with orphenadrine
hydrochloride and promazine hydrochloride.
CASE HISTORY Ho. 7 (118/VM.W.)
A female of 20 was admitted to the Edinburgh
Poisoning Treatment Centre at 13*45 hours on the 4th February,
1968/
EEG IN OgPHENADRIHE AND PROMAZINE POISONING
patient 114 - Male - 41 years old.
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Sixteen hours after drug ingestion EEG tracings were completely
isoelectric and a record taken at maximum amplification
(20 jttv./cm) contained EEG artefacts at increased sensitivity
hut EEG remains isoelectric. Rectal temperature was 33,8 C,
pulse 60 per minute and blood pressure unrecordable,
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Figure 80:
After twenty one hours of coma his EEG record was isoelectric
and showed no change on sternal stimulation.
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Twenty two hours after ingestion of drugs his EEG tracings
were still isoelectric (Grade VII). The few isolated spike
like deflections are artefacts. His heart rate was 12 per
















After twenty two hours of coma his EEG record was still
isoelectric when his heart stopped.
97.
after having taken 20-24 tablets of meprobamate (400 mg. each)
about 16-18 hours prior to admission.
Course of Illness in the Hospital1-
On admission she was deeply unconscious making
minimal response to painful stimulation. Her pulse was 100 per
minute, regular and of good volume) blood pressure 100/50 mm.Hg.
and rectal temperature 36.6°C, Reflexes were present and slightly
increased) the pupils were constricted and responded sluggishly
to light. Physical examination, otherwise, was normal.
Her EEG twenty hours after drug ingestion (Fig. 83)
showed continuous slow wave activity at £-2 cps, superimposed on
which was 12-14 ops fast activity. On sternal stimulation (Fig. 84)
the activity was increased both in frequency and amplitude. The
record contained background activity at 2-4 ops with superimposed
12-14 ops fast activity. The response to stimulation may also be
seen in figure 85. The EEG consisted of 2-4 ops activity with
superimposed 12-14 cps drug-induced fast activity.
After twenty two hours of coma her EEG reoord
(Fig. 86) revealed spontaneous shifts, where 3-6 cps faster
frequencies with superimposed 14-18 cps would alternate with
l£-3 ops slow wave activity. After 24 hours of coma the EEG
record (Fig.87) contained 4-6 cps with burst of slow wave
activity at 1-3 cps. Superimposed on these frequencies was
18-20 cps drug-induced fast activity.
Twenty/
EEG AFTER ACUTE MEPRCBAMATE POISONING
















Twenty hours after ingestion of meprobamate EEC tracings
contained continuous -2 cps slow wave activity with
superimposed 12-14 cps fast activity.


















This excerpt illustrates a. response to sternal stimulajdon, EEG
tracings showed cps slow wave (S•>■,•) activity with superimposed
fast activity. After, stimulation the record consisted of background
activity at 2-4 cps with superimposed 12-14 cps fast activity.
EEG AFTER ACUTE MEPROBAMATE POISONING
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Figure 85E
After twenty hours of coma an EEG record after sternal stimulation
showed dominant activity of 2-A ops superimposed on which was
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22 HRS. SPONTANEOUS SHIFT
Figure o<
Twenty two hours after lapsing into coma EEG record revealed
spontaneous shifts In which 3-6 cps activity would give way
to if-3~cps slow wave (SW) activity# An example is illustrated
here.
EEG AFTER ACUTE MEPROBAMATE POISONING
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After 24 hours of coma this excerpt shows fast background
frequencies of 4-6 cps and. a burst of slow wave activity
at 1-5 cps. Superimposed on all these frequencies is
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Figure 88:
Twenty six hours after lapsing into coma her EEG tracings
contained background activity at 2-6 cps with superimposed
18-20 cps drug induced fast activity. Bursts of slow wave
activity at -g-2 cps of 3~4 seconds duration were also present.
98.
Twenty six hours after lapsing into coma she made
vigorous response to painful stimulation of the sternum and her
EEG record (Fig. 88) showed dominant activity at 2-6 cps with
superimposed 18-20 cps drug-induced fast aotivity. Bursts of
slow wave* activity at £-2 cps lasting for 3-4 seconds duration
were also* seen;1 *
She continued to improve and responded to verbal
command at the end of twenty eight hours. Her EEG record (Fig.89)
contained background aotivity of 4-6 ops with some 2-3 cps activity.
Superimposed on these frequencies was drug-induced 18-20 ops fast
activity.
Thirty six hours after drug ingestion (eight hours
post-coma) the patient appeared asleep. Her EES record (Fig. 90)
showed a mixture of low voltage 4-6 cps and high voltage 2-3 ops
activity. She responded to a vocal command by opening her eyes,
when the high voltage slow waves also disappeared. The drug-
induced fast activity (Fig. 91) was present even forty eight
hours after ingestion of meprobamate.
Meprobamate concentration in blood was not
estimated but her urine oolleoted from 30.00 to 38.00 hours
after drug ingestion was reported to contain a concentration of
80 mg. per 100 ml. The battery of psychological tests was
administered 24 hours after regaining consciousness but no
evidence of organic brain damage was detected.
EEG and psyohometric tests were repeated at
intervals of one, three and nine months but no abnormality
was detected. Her EEG record (Fig.92) one month after drug
ingestion was normal.
BEG IN ACUTE MEPROBAMATE POISONING
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Figure 89:
After;28hours of coma her EEG after sternal stimulation
revealed dominant activity at 4-6 cps with some 2-3 cps
activity. Superimposed on these frequencies was drug-
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Figure 90:
Thirty six hours after drug ingestion (eight hours post coma)
when the patient was asleep her record contained mixture
of low voltage 4-6 cps and some high voltage 2-3 ops activity,
She responded to a vocal command by opening her eyes (marked
with the arrow) and the high voltage slow waves also disappeared.
EEG IN ACUTE MEPROBAMATE POISONING
Patient 118 - Female 20 years old.
Figure 91:
Forty eight hours after ingestion of meprobamate
(Twenty hours post coma) the EEG tracings still contained
drug-induced 18-20 cps fast activity.
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Figure 9,2:
Thirty thtee days after drug ingestion her EEG record showed
9-10 cps activity which was blocked by eyes opening.
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CASE HISTORY No. 6 (82/99/E.J.)
A female of 19 was admitted to the Regional Poisoning
Treatment Centre, Edinburgh at 09,00 hours on 26th February 1969,
after having taken 40 tablets (200 mg.) of nitrazepam about nine
hours prior to admission.
Course of Illness in the Hospitali-
On admission she was conscious and physical examination
was normal. Her EEG record (Fig. 93) showed Grada I EEG abnormality
as it revealed 18 cps activity* Her EEG 16 hours after drug
ingestion (Fig. 94) showed 18 ops activity. On the same day she
was seen by the Consultant Psychiatrist and transferred to the
North Wing of the Royal Edinburgh Hospital for psychiatrio in¬
patient care, t^urther studies with this patient are described
in Project No. 3 (Patient No. 4«)
CASE HISTORY No.9 (ll7/l0l/N.R.)
A 36 year old female was admitted to the Regional
Poisoning Treatment Centre, Edinburgh at 07.3° hours on the 1st
Maroh, 1969 after having taken 40 tablets (200 mg. each) of
methyprylon (Noludar) approximately eight hours prior to
admission.
Fast History1 She has two previous admissions to the hospital
with similar overdoses. On her first admission in 1966, she had
taken methyprylon (400 mg.) and became conscious four hours after
admission. On first and seoond post-coma nights she was reported
to be "restless" and "very poor night, only dozed off and on" and
was/
-.'EG IN ACUTE NITRAZEPAM POISONING
Patient 82 - Female 19 years old.
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Twelve hours after ingestion of 200 nig. nitrazepam EEG
record revealed Grade. I EEG abnormality• It contained
16-18 ops activity.
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Figure 94i
This excerpt sixteen hourd after drug ingestion shows
18 cps activity.
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was prescribed sodium amylobarbitone 200 mg. as night
sedation.
On her seoond admission in April, 1967 she had taken 20 tablets
of Mandrax and her methaqualone level in blood on admission was
4.2 mg. peroent. During reoovery she was reported to be "terribly
obstreporous" and required 50 mg. of chlorpromazine intramuscularly.
Course of the Present Illness»-
On admission she was deeply unconscious and made no
response to stimulation of the sternum with the knuckles. Erythematous
areas were noted over contact areas around knees, feet, thighs and
the right ear. Pulse was 102 per minute, regular and good volumej
blood pressure 80/60 mm. of Hg. Tendon reflexes were present but
plantarrasponses were not elicited. Her pupils were dilated and
reacted sluggishly to light but fundi were normal. Chest clinically
olear but respiration was shallow and respiratory minute volume
was litres. Heotal temperature was 36.0°C.
No stomach washout was performed but intensive
supportive therapy instituted. Her initial EEC record, ten hours after
drug ingestion, showed Grade VI abnormality. It contained three
isolated bursts of activity separated from each other by areas of
electrical silence. Clinically she was in deep coma and unresponsive
to stimulation. Her methyprylon level In the blood was 8.2 mg.
o
percent and rectal temperature 35*8 C»
After twelve hours of coma her EEG record showed
Grade V abnormality! 5-10 cps activity of several seconds duration
would alternate with electrical silence. Clinically she was deeply
unconscious/
101.
unconscious and made no response to stimulation. Her blood
methyprylon level was 5,6 mg. percent, rectal temperature
36,9°C and respiratory minute volume 5 litres.
Fifteen hours after drug ingestion her BEG record
oontained 1-4 ops activity with occasional brief isoelectric
intervals (Grade IV) but clinically her oondition remained
unchanged. After 19 hours of coma her EEG showed continuous
activity at 1-4 cps. Her drug levels was 3.5 nig. percent and
reotal temperature 37»5°C. Clinically she made a minimum
response to maximum stimulation.
After twenty four hours of ooma her EEG showed
Grade III abnormality. Her methyprylon level was reported
to be 3.0 mg. percent and rectal temperature 36.4°C. Clinically
she responded maximally to a minimal painful stimulation. She
continued to improve and 28 hours after drug ingestion she
responded appropriately to verbal commands.
Thirty six hours after drug ingestion her ESG
showed Grade II abnormality. Her blood methyprylon concen¬
tration was 2.2 mg. percent and reotal temperature 36.5°C.
Clinically she was drowsy. Four hours later she was seen
by the consultant psychiatrist and transferred to the North
Wing (Female Ward) of Royal Edinburgh Hospital for psychiatrio
in-patient care. A blood examination 96 hours after drug
ingestion (68 hours post-coma) still showed presenoe of drug
in a ooncentration of 1.6 mg. percent. A further account
of this patient's recovery over the subsequent weeks is
presented in project 3 (Patient No. 3»)
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CASE HISTORY No. 10 (24/22/3F)
A 32 year old male was admitted to the Regional Poisoning
Treatment Centre at 01.40 hours on the 18th March, 1968, after
having taken about 100 sleeping tablets (quinalbarbltone) belonging
to his wife, three hours prior to admission to the hospital. In
1969 he had been admitted to this oentre after an overdose of a
hypnotic.
Course of Illness In the Hospitali-
On admission he was deeply unconscious and made no
response to any stimuli. His tendon reflexes were absent. Bis
pulse was 92 per minute, regulart blood pressure 70/45 mm.Eg.
and rectal temperature 55*5°C>. Bo focal neurological signs were
found. Respiration was depressed with a rate of 5-8 per minute
with respiratory minute volume of 3 litres. Arterial blood gas
analysis showed oxygen desaturation (4796) and barbiturate levels
in the blood 1.9 mg.$ as quinalbarbitone. An endotracheal tubs
was inserted and thereafter gastric aspiration and lavage
carried out, successfully removing a proportion of the poison.
Analysis of gastrio aspirate was reported to oontain quinalbarbitone
and 165 mg. of the drug was recovered.
Continuous EEC monitoring was started soon after admission
and his initial record showed complete eleotrioal silence (Grade VII).
After eight hours of coma his EEG traoings showed isolated bursts of
activity (Grade VI) in response to stimulation of the sternum by
rubbing with the knuckles. His rectal temperature was now 35*0°C
and blood barbiturate level 1.7 mg,^.
Bine/
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Vine hours after drug Ingestion his blood oxygen
saturation was 81$. Clinically he remained unchanged. After 12 hours
of coma his EEG tracings contained spontaneous isolated bursts of
3-7 ops activity which would increase both in frequency and amplitude
■<»*!
on stimulating the sternum of the patient.
After 14 hours of oomay the patient's REG record deteriorated
and the isolated bursts of activity seen before disappeared. His
rectal temperature was 36»1°C, respiratory minute volume 7*4 litres,
arterial blood oxygen saturation 81$ and barbiturate level 2.2 mg.$.
Clinically the patient's condition showed no change.
Eighteen hours after drug ingestion the spontaneous
activity returned in his EEG reoord (Grade VI) and thereafter
continued to improve. Twenty hours after lapsing into coma his
EEG reoord showed suppression burst activity (Grade V). Clinically
the patient was deeply unoonsoious and unresponsive to all stimuli.
His temperature rose to 37«8°C. Three hours later he made the
first olinioal response to stimulation. EEG reoord consisted of
continuous slow waves (Grade IV). His temperature was 3&.8°C and
blood barbiturate level 1.7 mg.$. After 34 hours of coma EEG
tracings showed Grade IV changes. His blood barbiturate level
was 1.3 mg.$ and reotal temperature 38»3°C. Clinically he made
minimal response to a maximal painful stimulation. Eight hours later
his endotracheal tube was removed.
Forty five hours after drug ingestion he responded
vigorously to painful stimulation! his EEG revealed Grade III
abnormality. His temperature was 37.8°C and blood barbiturate
level 0.8 mg.$. After sixty three hours of coma, the patient
responded/
104.
responded appropriately to vooal command• His barbiturate level
was 0.4 mg.?6 and body temperature was 37»2°C. Forty eight hours
after regaining oonsoiousness a battery of psyohologioal tests
was administered, but no evidence of any organic brain damage
was found. BEG and psychometrio tests repeated after one, three
and nine months were normal.
CASE HISTORY No. 11 (25/40/B,B.)
A 26 year old female took 60-70 capsules (100 mg. each)
of seoonal (Sodium quinalbarbitone) at about 03.00 hours on the
14th June, 1968, and was admitted to the Regional Poisoning
Treatment Centre, Edinburgh Royal Infirmary at 16.40 hours on
the same day.
Course of Illness in the Hospital»-
On admission she was deeply unconscious with no
response to any stimuli. The pulse was 130 per minute regular, but
poor in volume and blood pressure was 90/60 mm.Hg. Tendon reflexes
were absent and muscle tone flaooid. Cough, corneal and gag
reflexes were absent and so were the bowel sounds. No focal
neurological signs were found. There was bronchial breathing
at the right lung base with some crepitations. Examination
otherwise was normal. An endotracheal tube was inserted but
gastric lavage and aspiration wars not carried out in view of the
time that had elapsed since the tablets were taken. Arterial
blood gas analysis showed oxygen desaturation and a chest X-ray
showed consolidation in the right lung. Her rectal temperature
was 39*4°C and blood barbiturate level 0.7 mg.$ as quinalbarbitone*
Continuous EEG monitoring started two hours after her
admission to the ward. The record showed oomplete electrical
silence/
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(Grade VII) and remained ieoelectrie even on Maximum: gains cat v;,;i
(20 juv/om). Clinically she was deeply unconscious and totally
unresponsive to all stimuli including rubbing of the sternum
vith the knuckles. After 22.50 hours of coma her EEG showed
isolated bursts of aotivity (Grade VI). Her reotal temperature
was 39.5°C and blood barbiturate concentration 1.0 mg.$ as
quinalbarbitone.
After 26 hours of ooma EEG tracings showed suppression-
burst aotivity (Grade V), Her blood barbiturate level was 1.0 mg.$
and temperature 39»7°C. Clinically she was deeply unconscious and
made no response to sternal stimulation. Her barbiturate level
after 33 hours was 0.8 mg.$ and temperature 30*3°0. Thirty six
hours after drug ingestion a clinical response was observed to
sternal stimulation.
After 52 hours of coma her EEG tracings showed Grade III
abnormality. Her barbiturate concentration was 0.6 mg.$. Clinically
she responded vigorously to painful stimulation* Thereafter she
continued to improve slowly and after remaining in ooma for 54 hours
she regained consciousness. Her barbiturate level was still 0.7 mg.$
which in fact was the same as on admission. Her EEG showed Grade II
EEG abnormality. Sixty two hours after drug ingestion her blood
barbiturate ooncentration was less than 0.5 mg.$ and temperature
37.0°C.
On her 5th hospital night (two post-coma nights) she
complained of insomnia, for whioh she was prescribed dichloral-
phenazone 1300 mg. as night sedation, which was discontinued
on 13th July when nitrazepam 10 mg. was prescribed.
Bight days after drug ingestion (5 post-coma days) she
was/
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administered a battery of psychologioal tests but no evidenoe
of any brain damage vas found* EEG and psychologioal tests
were repeated at intervals of one. three and nine months but
no abnormality was found.
CASE HISTORY No* 12 (27/52/WR)
A 48 year old female took 90 of her own quinalbarbitone
(Seconal) tablets at about 09*00 hours on the 18th October. 1968
and was found unconscious at 12*50 hours* She was apnoeic and
cyanosed. The Family Doctor instituted external oardiao massage
and artificial respiration and she was admitted to the Regional
Poisoning Treatment Centre. Edinburgh*
Course of Illness in the Hospitali-
On admission to the hospital she was deeply unconscious
and made no response to any stimuli. Her pulse was 80 per
minute and regular, blood pressure 85/40 mm.Hg. Her breathing
was depressed though present* An endotracheal tube was inserted
and assisted respiration instituted. Tendon reflexes, cough,
corneal and gag reflexes were all absent and so were the bowel
sounds* Her pupils were fixed, dilated and did not react to
light. Her reotal temperature was 55*8°C. During stomaoh
washout she had a oardiao arrest but was resuscitated* Her ECG
showed sinus bradyoardia with a rate of 48 per minute. She
remained hypotensive and was put on a respirator*
Her eleotroenoephalogram soon after admission showed
oomplete eleotrioal silence (Grade VII). Clinically she was still
deeply unconscious and totally unresponsive to all stimuli. The
barbiturate concentration in the blood was 5*8 mg.^ as quinal¬
barbitone/
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barbitone. After 15 hours of ooma, her EEG tracings were still
isoeleotrio (Grade VII) and showed no change to stimulation of
the sternum with the knuckles* Her rectal temperature was
54.1°C and she was on the respirator* After 28 hours of ooma
her EKG record *as still Isoelectric. Her temperature rose to
37*2°C but. clinically she showed no improvement. Three hours
later her EEG reoord showed two isolated bursts of activity on
maximal stimulation* Her blood barbiturate level was 4*5 mg.^.
Thirty four houro after drug ingestion, the EEG
tracings showed spontaneous isolated bursts of activity at
j-j- ■ or*
3-7 ops occurring every 15-20 seconds (Grade VI). After
36 hours of coma her record showed suppression-burst activity
(Grade 7)* Clinically she was deeply unconsoious and made no
response to sternal stimulation* Her temperature was 37*8°C*
After thirty eight hours of coma the patient's cough and
swallowing reflexes returned but she made no clinical response to
sternal stimulation although an increase both in frequenoy and
amplitude of eleotrioal activity was seen* Four hours later her
reoord showed continuous activity (Grade IV).
Forty nine hours after drug ingestion, the patient
was able to resume spontaneous breathing and was taken off
the ventilator* Her minute volume was 4*5 litres and temperature
36*3°C. Clinically she now responded minimally to a maximal
painful stimulation. After 56 hours of coma the patient's
EEG reoord showed Grade III abnormality. Her temperature was
38*0°C, Five hours later the patient was extubated* Her EEG
record/
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record continued to improve and after 64 hours it revealed
Grade III changes. Her temperature was 38.5°C. Thereafter
the patient oontinued to improve satisfactorily and finally
responded appropriately to vooal commands after 71 hours of
oomai her reotal temperature was 37.5°c»
Eighty three hours after drug ingestion, although
the patient was fully consoious, she was drowsy, confused
and expressed paranoid ideas. Over the next 20 hours, she
became less drowsy but her delusions became paramount in
her mind. She herself denied taking *ny tablets and was
convinced that she was not in the Royal Infirmary and that
someone else had done this thing to her.
Ninety eight hours after drug ingestion (27 hours
post-ooma) she was declared medioally fit and was seen by
the consultant psychiatrist who elicited delusions} as
she said, "I have been watched. They know everything about
me. This is not the R.I.E." The following day (3th hospital
day) she was transferred to a psychiatric in-patient unit
at the Royal Edinburgh Hospital.
CASE HISTORY No. IS (*>/WL.O.)
A 34 year old female took large quantity of butobarbitone
(Soneryl) at about 03.00 hours on 1st June, 1968. She was
admitted to the Regional Poisoning Treatment Centre, Royal
Infirmary, Edinburgh at 09.00 hours on the same day. In the
ambulanoe en route to the hospital she had apparently had
a oardiac arrest and when she came to the ward she was gravely
ill. She had been attending the psychiatric out-patient clinio
for a depressive illness./
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Course of Illness In the Hospital*-
On admission she was deeply unconscious and unresponsive
to all stimuli. Her pulse was 92 per minute, regular and good
volume. Blood pressure, despite her deep ooma, was markedly
raised at 220/140 mm.Hg. Tendon reflexes were absent and musole
tone flaccid. Cough, corneal and gag reflexes were absent,
as were bowel sounds. Light reflexes were also absent. An
endotracheal tube was inserted and thereafter she required
assisted ventilation with a ventilator, as blood gas analysis
had shown marked hypoxia. Her reotal temperature was 32.2°C
and blood butobarbitone concentration 7»1 mg.^. ri. "■fcrti 1 ore ,
Continuous EEC monitoring was started soon after
admission and this revealed a complete electrical silence
(Grade VII). Twelve hours after drug ingestion, her rectal
temperature was J1,0°C and blood barbiturate level 7 »0mg,"/o.
Fourteen hours after drug ingestion, forced alkaline diuresis
was oommenoed. One hour later her EEG record was still
isoelectric even on maximum amplification (20 yuv/cm), Her
reotal temperature was 30.6°C. After 18 hours EEG tracings
showed an isolated burst of activity (Grade VI) on sternal
stimulation.
After 24 hours of ooma her EEG revealed spontaneous
isolated bursts of aotivity (Grade VI). Her temperature was
53*6°C and blood butobarbitone level 6.6 mg.$. Clinically she
was deeply unconscious and made no response to any stimuli
but resumed spontaneous breathing and was taken off respirator.
Thirty eight hours after drug ingestion her EEG record
showed Grade V changes. EEG aotivity would inorease both in
frequency and amplitude when the patient was stimulated by
rubbing/
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rubbing the sternum with the knuckles. Her rectal
temperature was J6.4°C and butobarbitone level 6.2 mg.$.
After 45 hours of coma her butobarbitone level was 5.9 mg.^
and temperature 57.8°C. Her ECG reoorded at this time
revealed a sinus tachycardia and right bundle branch block.
After 52 hours of coma her EEG showed Grade IV
abnormality Four hours later the patient was extubated. Sixty
hours after drug ingestion she made a clinical response to
painful stimulation. Her reotal temrerature was 38.2°C and
blood butobarbitone level 4-0 mg.$. Eighteen hours Inter the
butobarbitone level dropped to 2.5 and olinioally she
responded moderately to painful stimuli. Arterial blood
oxygen saturation was 60$. The EEG record continued to show
improvement but was still Grade IV Eighty hours after drug
ingestion the EEG reoord showed Grade III abnormalities and three
hours later the patient's response to painful stimulation beoame
vigorous. Her temperature was 37.8°C and blood butobarbitone
level 1.8 mg.$.
After 89 hours of coma she responded appropriately
to a verbal command, but remained drowsy and oonfused. Her
temperature was 37.0°C and butobarbitone 1.5 mg.$. On the 5th
post-coma day she was still very confused and paranoid and on the 19th
hospital day (15 days post-coma) she was transferred to the
Royal Edinburgh Hospital for psyohiatrio in-patient care.
CASE HISTORY No. 14 (8/93/MO)
A 25 year old female was admitted to the Regional
Poisoning Treatment Centre at 16.50 hours on the 3rd February
1968/
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1968, after having taken an unknown quantity of amitriptyline
tablets approximately twelve hours prior to admission.
Course of Illness in the Hospitalt-
On admission she was deeply unconscious, responding
minimally to stimulation of the sternum with the knuckles. Her
pulse was 120 per minute, regular and of good volume and the blood
pressure was 120/90 mm.Hg. Tendon reflexes were present and
increased and plantar reflexes extensor. Muscle tone was
increased and the patient exhibited intermittent episodes
of general bilateral twitching with hypertonicity. Cough and
gag reflexes were present but the corneal reflex was absent. The
pupils were dilated, eoual and reacted poorly to light. Bowel
sounds were present but rare. Gastric lavage was done and
intensive supportive therapy instituted.
Her EEG record after admission showed Grade IV
abnormality and contained continuous 1-3 ep» activity which
would increase both in frequency and amplitude following
sternal stimulation. Her reotal temperature was 55.8°C. After
13 hours of coma her EEG was of Grade III abnormality, and
olinioally she made moderate responses to painful stimulation.
Her rectal temperature was 36.4°C. Seventeen hours after drug*
ingestion her ECG record showed non-speoifio changes, with
sinus taohyoardla of 120 per minute, and a PR interval of 0.14
seconds.
Nineteen hours after drug ingestion hor EEG record
showed Grade II abnormality, it contained dominant activity at
5-8 cps mixed with which was some 6-1? ops aotivity. Clinically
the/
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patient made appropriate response to verbal commands. Her rectal
temperature was 37.2°C and examination of the urine showed it to
contain a fair amount of amitriptyline.
After 28 hours (nine hours post-coma) she had
hallucinations whioh disappeared on the 3rd day and she was
discharged home on the 4th hospital day.
CASE HISTORY No. 15 (108/59/0.0.)
A 31 year old male waa admitted to the Heg-onal
Poisoning Treatment Centre on 13th December, 1968, at 13.45 hours,
after having been found by the police staggering about the
street, aoting strangely. Initially he was taken to the People's
Palace where he had a major fit and was then brought to the
hospital.
Past History»- He had been partially investigated for
fits in April 1967, but had not kept an
EEG outpatient appointment. He had been
maintained on 30 mg. phenobarbitone daily.
Course of Illness in the Hospitalt-
On admission he was deeply unconscious and unresponsive
to any Btimuli. He was cyanosed and required intubation and was put
on a respirator. His pulse was 100 per minute, regular and blood
pressure 130/90 mm.Hg. Muscle tone was markedly reduoed in all
limbs with residual knee Jerks and no obtainable plantar responses.
Chest examination revealed many coarse crepitations in both lung
fields. No bowel sounds were heard and soon after admission his
pupils became dilated and fixed. His rectal temperature was
3?.2°C. Gastric aspiration and lavage were performed and tablets
and alcohol were observed to be in the return.
Continuous EEG monitoring was commenoed two hours after
admission and his EEG record was isoelectric. It did not show any/
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any ohange to stimuli (Grade VIl) including stimulation of the
sternum with the knuckles. Clinically he was in deep coma and
made no response to any stimuli. His systolic blood pressure
was 90 mm.Hg. and temperature 31.9°C.
Eight hours after admission his EEC tradings shoved
complete electrical silence which remained unohanged on maximum
gains (20 jav/an) as veil as after stimulation of the sternum
with the knuckles (Grade VII). Clinically his condition
deteriorated. His pulse fell to 4B per minute. His temperature
and blood pressure folloved a gradual downward trend despite an
Initial injection of metaraminol followed by intravenous plasma
under central stenous monitoring and heavy wrapping in blankets.
These measures appeared to have no effeot. Examination of his
blood for the deteotion and estimation of drugs revealed barbiturates
at 1.1 mg. percent.
After 12 hours of ooma his EEG record shoved complete
electrical silence and no ohange was seen on maximum gains (Grade 711).
Clinically his condition remained unohanged. His reotal temperature
was 30.4°C and blood pressure 70 mm.Hg. systolic. He was noted to
have bilateral papl11oedema but no localising CNS signs. The
neurosurgeons were called to see him but considered that there
was nothing they could offer.
After 24 hours his EEG tracings showed no sign of
oerebral eleotrioal activity and no change was seen after
stimulation (Grade VII). A record taken at maximum gains (20 juv/om)
showed an isoelectric record. Clinically he was deeply unoonscious
and totally unresponsive to all stimuli. His pupils were dilated
and/
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and fixed and did not react to light. His pulse was ?2
per minute, blood pressure 55 an.Hg. systolic and reotal
temperature ?9.8°C. He was on respirator. Ho significant
poison was discovered in blooi or urine (only therapeutio
levels of barbiturate).
His oondition continued to deteriorate and
he died on the 14th December. 1968. A provisional diagnosis
of intracerebral haemorrhage was made. A post mortem was
performed and histological examination of the brain sections
showed probable astrocytoma of frontal lobe.
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CASE HISTORY Ho. 16 (llO/60/JL)
A 40 year old female wae admitted to the Regional
Poisoning Treatment Centre, Edinburgh on the 26th December, 1968
at 19.50 hours after having taken 20 tablets of Dioonal* and 10
tablets of Uandrax.
Course of Present Illness in the Hospital1-
On admission she was deeply unconsoious and totally
unresponsive to all stimuli. Her pulse was 60 per minute, regular
and of poor volume 1 blood pressure 60 mm.Hg. systolioi respiration
was shallow and inadeouate and she was oyanosed. All tendon reflexes
were absent and plantar reflexes oould not be elicited. Muscle
tone was markedly reduced. Cough, oomeal and gag reflexes were
absent but bowel sounds were audible. The pupils were fixed,
dilated and erual. Her reotal temperature wae 55.0°C. She was
intubated and hand ventilation served to correct the anoxia, and
the pupils beoame pinpoint in size.
Gastrio aspiration and lavage were performed with a
small nuantity of pink material in the return. Her respiratory
minute volume was 2.5 litres. She was given nalorphine 20 mg.
intravenously after which spontaneous respiration returned in
5-7 minutes and her respiratory minute volume was 4.5 litres
but no change was seen in the level of ooma. Thirty minutes later
nalorphine 5 intravenously was repeated,
* Diconal is a oombinat on of dipipanone 10 mg.
and cyclizine.
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Continuous EEG monitoring was commenced two hours
after admission and her record showed Grade VI abnormality. It
contained near silenoe but with two bursts of isolated and low
voltage 3-7 ops wares oocurring singly in each epoch. Clinically
she was in deep coma and totally unresponsive to all stimuli.
Her blood pressure was 80/60 mm.Hg. and rectal temperature 55.2°C.
Blood examination for drug levels was reported to oontain metha-
qualone 1.3 nig. percent. Eight hours after drug ingestion her
EEG record showed suppression burst aotivity (Grade V). Her
respiration rate was 16 per minute, respiratory minute volume
3.5 litrest temperature 35.5°C and blood pressure 85 mm.Hg.
systolio. Nalorphine 5 ®g. was repeated. Two hours later her
"EG record showed Grade IV abnormality.
After 12 hours of ooma her EEG record deteriorated
and showed Grade V abnormality. Clinically the patient was deeply
unconscious and made no response to painful stimulation of the
c
sternum. Her respiration rate was 10 per minute, temperature 35.5 C
and blood pressure 100/60 mm.Hg. One hour later her respiration
rate was 7 per minute. Fourteen hours after drug ingestion her
EEG record contained suppression burst activity. Her respiration
rate was 10 per minute,respiratory minute volume of 3.5 litres,
blood pressure 100/60 mm.Hg. and rectal temperature ^6.6°C.
After 16 hours of ooma the patient was given
nalorphine and her respiration rate rose from 9 per minute to
18 per minute and her respiratory minute volume became 5.5 litres.
Her reotal temperature was 37.8°C. A rapid infusion of nalorphine
30 mg. in 500 ml. of saline over 30 minutes improved her respiratory
minute/
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minute volume to 8 litres, with a respiration rate of 24
per minute. Clinioally her pupils were larger and she
responded moderately to painful stimulation. Her EEG record
revealed Grade IV abnormality. Nalorphine 30 mg. was repeated
after 17 hours of coma. Her blood pressure was 100/60 mm.Hg.,
rectal temperature was 37.8°C, respiration 20 per minute and
respiratory minute volume 6 litres.
Eighteen hours after drug ingestion her EEG record
contained dominant activity at 1-2 cps (Grade IV). Clinically
she made vigorous response to painful stimulation. Examination
of the urine revealed methaqualone (10 mg. peroent), diphenhydramine
and dipipanone hydrochloride together with some proteins and sugar.
After 24 hours of ooma the EEG reoord showed Grade III abnormality.
Clinically the patient was unconsoious but responded vigorously
to painful stimulation. Her respiration rate was 22 per minute $
respiratory minute volume 6 litres and rectal temperature 38«3°C.
She continued to improve and 41 hours after drug ingestion she was
extubated. Her blood pressure was 130/80 mm.Hg,, respiration
10 per minute and temperature 38.3°C.
Forty five hours after lapsing into coma her EEG
record contained dominant activity at 2-4 ops. mixed with which
was some 3-6 cps activity. Clinioally she made appropriate
responses to vooal oommands but remained very drowsy and confused
for the next 48 hours.
On her 5th hospital night (2 days post-coma) she was
reported* "dazed all night, did not sleep well"i on the 7th
nighti "unco-operative". On her 9th hospital day she was seen by
the/
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the consultant psychiatrist and was transferred to Royal
Edinburgh Hospital on the Jrd January, 1969 (7 days post-ooma) for
psychiatric in-patient care.
After recovery from coma it was noted that her short
term memory span had decreased to about 10 seoonds, suggesting
some brain damage, therefore a repeat EEG and full psyohometrio
testing were carried out at the Royal Edinburgh Hospital.
Her psychometric testing revealed that she scored
at the defective level on verbal intelligence tests and showed
some aphasia. Her immediate memory was normal and had improved
in her ability to learn or register new material but her memory
for personal end current information and orientation was poor.
CASE HISTORY No. 17 (126).
An IB year old girl had taken unknown quantities of
ferrous sulphate and paraoetamol tablets on 15th May, 1968. The
following day she was unwell and vonited, but by ?4 hours after
drug ingestion she felt better. Thirty six hours after drug
Ingestion she became unconscious and was admitted to the Regional
Poisoning Treatment Centre, Edinburgh,
Course in the Hospitalt-
On admission to the ward she was pale and unoonsoious
but responded vigorously to painful stimulation of her sternum
with the knuckles. Her pulse was 140 per minute and pupils
normal. Her blood gluoose level was reported to be extremely low
and blood iron concentration was 90 microgrammes peroent. the
was/
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was treated with desferrioxamine mesylate.
Two hours after admission (3° hours after drug
ingestion) she had haemateiiesls and three litres of blood was
aspirated through the stoaaoh tube However, she improved over
the next three hours and was fully conscious five hours after
admission but was agitated and complained of backache* Six
hours after admission (45 hours after drug ingestion) her
blood pressure again fell and the ouestion of gastrio surgery
to control haemateresis was considered but as her prothrombin
time was increased to 5 times that of control, it could not
be carried out. Seven houri after admission she had a cardiao
arrest, but was resuscitated. Her blood pressure continued to
fall despite all measures and she had a second cardiac arrest
and once again was resuaoitated. Clinically she was deeply
unooneoious and totally unresponsive to any stimuli. She was
on assisted ventilation.
Her EGG reoord eight hours after admission was
completely isoelectric (Grade VII) and shoved no sign of
cerebral eleotrioal activity, even after painful stimulation.
Clinically her oondition remained unchanged. Her blood pressure
was unobtainable and temperature not reoorded.
Nine hours after admission (46 hours after drug
ingestion) she had a third cardiao arrest and external oardiao
massage was started. Her EEG reoord was completely isoelectric
and shoved no sign of activity even when recording was done on
maximum gains (20 pv/era) and after stimulation. Clinioally she
was deeply comatose and totally unresponsive to all stimuli. She
had marked hyoptension and was on a respirator. External oardiao
massage/
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massage was continued and the opinion of a consultant
oardlologiet sought.
In view of her ollnloal condition, Including
marked hypotension, severe haematemesis, three oardiao
arrests, assisted ventilation, failure of return of
spontaneous cardiao rhythm and a completely isoelectric
EEG reoord, she was pronounced dead in consultation with
the Consultant Physician, Consultant Cardiologist and Dr.
Ian Oswald. She was a donor for the first lung transplant
operation parried out by the Edinburgh aurgloal team (Matthew
et al.. 1968).
CASE HISTORY No. 18 (l2Vl!9/CM)/
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CASE HISTORY NO. 18 (l23/ll9/CM),
A sixteen year old girl was admitted to the Regional
Poisoning Treatment Centre, Royal Infirmary of Edinburgh at 02.30
hours, three and a half hours after the ingestion of 40 tablets
(800 mg.) of fenfluramine. She was agitated, anxious, uncooperative,
flushed, sweating and slightly obese. Blood pressure was 120/80 mm.
Hg., pulse 134 per minute, regular in time and foroe, temperature
37.2°C and respirations 22 per minute. She was fully conscious
with dilated pupils, unreactive to light? there was a rotary nystagmus,
and the deep tendon reflexes were brisk and symmetrical. A pronounced
feature was a continuous tremor of the lower jaw with chattering
of the teeth. Stomach washout was performed with return of tablet
material.
Continuous EEC monitoring was started three hours
after admission and her EEC record revealed Grade I EEG. At 09.00
hours she was hyperventilating and the widely dilated pupils
reacted sluggishly to light. Arterial blood-gas showed a respiratory
alkalosis - serum pH 7.55, standard bioarbonate 23 meq. per litre,
and PCOg 21 mm.Hg, Blood-glucose was 59 mg./lOO ml.
A foroed acid diuresis was started at 13.00 hours.
She was given a total of three litres of fluid including 70 meq. of
ammonium ion intravenously during four hours. At the end of this
time she was ventilating normally, was less agitated, and the
tremor of the lower jaw was absent. The arterial blood-gas now
showed/
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a pH of 7.32, standard bicarbonate 16.6 meq., per litre, and
PC02 28.5 mm.Hg.
The further recovery of this patient is discussed
in projeot No, 5 (Patient No. 11).
CASE HISTOBY No. 19 (l24/l20/YM).
A sixteen year old girl was admitted at 22.00 hours,
having ingested JO tablets (600 mg.) of fenfluramine two and a half
hours earlier. She complained of a burning sensation in her
epigastrium, of feeling hot all over, and of some blurring of
vision.
She was fully oonscious and cooperative but flushed
and warm. Her blood pressure was I30/9O mm.Hg., pulse 130 per
minute, regular in time and foroe, respiratory rate JO per minute
o
and temperature 39.0 C. The pupils were widely dilated and failed
to react to light. A rotary nystagmus, and a weakness of the left
lateral rectus muscle were present* There was a continuous tremor
of the lower jaw with chattering of teeth. Generalised hypereflexia
and ankle olonus were present. The blood-gases after stomach washout
revealed a pH of 7»35» a PCO,, of 43 mm.Hg, and a standard bicarbonate
of 22 meq. per litre.
Continuous EEG monitoring was started two hours after
admission. Her reoord revealed Grade I EEG changes and contained
continuous muscle artefact in all dhannels, superimposed on the
EEG trace8.
Next morning at 09.00 hours her vision had cleared but
her other symptoms were unchanged. The pupils were still dilated
and/
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and unresponsive to light and the rotary nystagmus remained.
There was no weakness of the left lateral rectus and limb
reflexes were normal. The next day she was symptom free, the
pupils were dilated but reaoting to light. Further studies
with this patient are described in project No. 3 (Patient No.12).
CASE HISTORY No. 20 (l25/l2l/M).
This sixteen year old girl was admitted at 22.00
hours having ingested 20 tablets (400 mg.) of fenfluramine two
and a half hours prior to admission, in company with another
patient (Case No. 124). She complained of a "ball of fire" in
her epigastrium and of feeling hot all over.
She was conscious, cooperative, flushed and warm.
Her pulse was 108 per minute, regular in time and foroe, blood
pressure I3O/7O mra.Hg., temperature 37.6°C and respiratory rate
26 per minute. The pupils were widely dilated and unresponsive to
light and there was a significant rotary nystagmus. The deep
tendon reflexes were brisk and symmetrical. Stomach washout was
performed with a good return.
Continuous EEG monitoring was started three hours
after admission and her record revealed Grade I EEG changes.
Next morning at 09.00 hours she complained of feeling tired,
said her legs felt like jelly and that she had a burning feeling
all over. Her pupils were dilated and slightly responsive to
light. There was no nystagmus. Serum-fenfluramine 14 hours after





As outlined in the introduction previous investigations
of drug induced coma (7ulff, 1950) Mantz et al.. 1965)
Wallace and Allen, 1968) have described the slowing and general
flattening of the electroencephalogram in acute drug intoxication
but these reports dealt with only small series of comas compared
with the present study and did not employ continuous EEG monitoring.
The results of the present investigation offer strong confirmation
of the few previous case reports ("Warter et al.. 1963) Bird and
Plum, 1968) that flat EEG records in cases of drug intoxication
are quite compatible with eventual recovery. The use of term
"flat" record in previous reports (Mellerio, 1964) Wallace
and Allen, 1968) is difficult to interpret owing to the use
of only short periods of EEG sampling (Mantz et al.. 1965).
The continuous EEG monitoring technique employed in this study
confirmed the presence of very prlonged periods of isoelectric
recor-d in the oases reported here. In the investigations mentioned
above, the recording sensitivity used *as only that customary
in routine clinical recordings and it was this that was used in
determining electrocerebral silence. The use of stimulation
and increased amplification in the present study made it possible
to show that the EEG records were completely isoelectric.
EEG monitoring proved at times superior to clinical
observation and of great help in assessing a change in the
condition of those patients (Case Histories No. 1 and 4)who
were/
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deeply comatose and unresponsive to all stimuli.
The EEG grades V-VII were associated with deep coma and
could not be distinguished clinically whereas the EEG
provided evidence of beginning improvement from, for
example. Grade VII to Grade V. In this respect the present
investigation confirms the findings of Sament and Huott (1969).
An improvement in the electrical activity always preceeded
the olinical signs of improvement. For many hours a patient
may not show any notable change in the clinical condition,
whereas EEG adtivity will continue to show steady improvement
(Haider et al.. 1968). This is also illustrated by case
histories 1, 3, 5» 10, 11, 12 and 13)* Another area in which
EEG monitoring proved to be useful, ms in the assessment of the
effectiveness of some active regime adopted (case histories
No.3 and 13)« Other investigators (Brazier et al,.1945<
Swank and Foley, 1948| Bickford, 1950i Courtin et al.. 1950j
Kiersey et *al.. 1951| Saoent and Huott, 1969). have shown
that the EEG is the best single measure of the depth of
barbiturate narcosis and that it is superior, in this respect,
to clinical or biochemical testing. These studies were performed
experimentally on animals and also during thiopentone anaesthesia
in man. The present study allows the same conclusions for acute
drug intoxication in man.
Nitrazepam proved remarkable in that it produced least
change of consciousness, and only minor EEG abnormalities were
seen even with large dverdose (40 tablets, 200 mg. - case history
No. 6)/
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Whereas a similar quantity of other hypnotics (40 tabs,
of methyprylon - case history No.9f 40 tablets of Mandrax -
case history No. 5) resulted in deep coma and severe EEG
abnormalities.
Non-parametric tests were able to establish significant
correlations between the EEG grades of coma and the age,
olinical assessment of depth of coma, body temperature,
duration of unconsciousness, and blood drug levels. As far
as is known no previous investigation of these inter-relationships
has been reported. If the EEG is to be used to monitor coma
it is plain that body temperature especially, must always be
taken into account.
The value of the EEG for monitoring coma is abundantly
clear but its routine clinical use must be admitted to have
limitations because it throws heavy demands on skilled labour
and involves oomplex and bulky equipment producing miles and
miles of recorded paper. It must be thought too expensive and
intricate for use in routine monitoring. However the present
study suggests that a simple and less expensive devioe for
continuous monitoring such as the cerebral function monitor
described fry Maynard et al.. (1969), could be a valuable aid to
the clinician in making decisions about the treatment of comatose




V, A, TITLEi- Follow up study of late brain rtooysry
of patients after thoy have made a
ollnloal recovery from acuto drug poisoning.
CV.B, Introductions-
Persona taking very large amounts of
barbiturates are liable to convulsions, delirium, insomnia,
and other symptoms if their drugs are suddenly withdrawn.
These features ooour especially in the first week but oan
continue for two weeks (Wulff, 1959f Fraser et >1.. 19 54).
Barbiturates suppress REM sleep, not merely
reducing its duration and delaying its onset, but reducing
also its Intensity, as judged by a significant reduction in
the profusion of accompanying rapid eye movements (Oswald et al,,
1965t Baekland, 1967). The profusion of rapid eye movements
is correlated with the degree of "activity" of the accompanying
dream (Dement and Wolpert, 1958» Berger and Oswald, 1962).
Withdrawal of amylobarbitone sodium following its
regular administration for eighteen consecutive nights led to
rebound abnormalities (Oswald and Priest, 1965). Despite the
short period of exposure to the drug, the abnormalities did
not completely subside till the sixth week after withdrawal. The
same authors reported similar findings in a parallel study of
the non-barbiturate hypnotic, nitrasepam. In each oase with¬
drawal of the drug was accompanied by unpleasant subjeotlve
effeots/
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effects, in nightmares. Le Gassicke et al.. (1965) reported
vivid nightmares provoked by withdrawal of tranyloyproaine
from an addict. Withdrawal of all these drugs waa reported
to have caused a very early onset and an early-night exoess
of REM sleep. Kales and Jaoobson (1967) have observed
similar nightmare induction by withdrawal of pentobarbitone
and also withdrawal of methyprylon. Freemon et al.. (1965)
reported that meprobamate in clinical doses suppresses REM
sleep and a rebound effect on withdrawal of the drug has also
been described (Oswald et al.. 19681 Evans and Lewis, 1968).
Kales et al., (1968) reported sleep patterns of
a sodium pentobarbitone addict before and after drug withdrawal.
While on the drug, the percentage of REM sleep was low (10$)
and stage 4 sleep was absent. As the drug was withdrawn,
percentage stage REM increased to levels of 30-40$ and the
patient reported a number of dreams, several being nightmares.
Four months after discharge, he was reported to have a normal
percentage of stage REM and 4.
It is known now that the hypnotic drugs depress
REM (dreaming) sleep, and that, after several nights, some
toleranoe develops with a return towards normal REM sleep values
despite continuation of the drugs (Oswald and Priest, 1965I
Kales et al.. 1968» Evans et al.. 1968). When the drug is
stopped the characteristic "rebound" increase in REM sleep is
observed. At this time eye movements are very active and the
subjects frequently report frightening dreams.
Other drugs known th cause abnormalities in sleep
patterns/
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patterns are amphetamines (Rechtsohaffen and Maron, 1964).
■ethylphenidate (Baekeland, 1966) and diethylpropion (Oswald et
^ ■
al.. 1969). Then patients addicted to dexamphetamine, dexsmphetamine-
barbiturate mixtures, or phenmetrazine, continued to take their
aocustomed drugs, the proportion of whole-night REM sleep was
normal. When the drug was withdrawn abnormalities appeared.
When the drug was restored, these abnormalities of brain funotion
disappeared, and reappeared when the drug was withdrawn onoe again.
The abnormalities inoluded excess whole-night REM sleep, with
a particular excess in the early part of the night, and abnormally
early onset of REM sleep (Oswald and Thaoore, 1963). Up to two
months elapsed before these abnormalities resolved. Anti-obesity
drugs such as diethylpropion and fenfluramine were compared for
their effect on sleep (Oswald et al.. 1968). Diethylpropion
caused three principal abnormalities of sleep» freouent awakenings,
suppression and delay to REM sleep, and frequent shifts into and
increased time in stage 1. Fenfluramine caused neither of the
first two abnormalities, but did oauae freouent shifts into ttage
1 sleep and increase of time spent in it.
All these studies are concerned with the sleep patterns
of either normal healthy volunteers who were given relatively
small doses of drug or patients who had been taking the maximum
prescribed therapeutio dose of hypnotics over a long period, and
the present literature laoks any systematic study of sleep
patterns of patients after aoute drug poisoning. However, some
clinical observations on the sleep of patients of barbiturate
intoxication have been made. Prolonged post-ooma insomnia is not
rare. Wulff (1950) noted persistent wakefulness after drug/
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overdose coma In a study of 85 oasas of barbiturate withdrawal
syndrom®. In 21 oasas decreased or absent sleep, amounting to
four hours or l®ss in 36 of th® 140 nights was r®port®d. Th®
third, fourth and fifth nights were th® most sleeploss in two
8T thirds of th® cases.
Bird «t al.. (1968) reported pronounced post-ooma
insomnia in six of seven oases of drug poisoning but only
one patient's post-ooma EEC sleep was recorded which revealed an
increase in slow wave sleep without an inorease in REM sleep. The
same authors also studied sleep patterns of three oats before and
If
after sodium pentobarbitone-induoed coma, no post-ooma insomnia
was observed, and the oats had increased slow wave sleep, but
no decrease In REM sleep. REM sleep time was reported to be
less than control levels in the immediate post-coma period, then
gradually increased to, but did not exceed, pre-coma levele*
Some authors (Bird and Plum, 1968) reported recovery of a patient
from barbiturate overdose coma who did not sleep at all for two
and one-half days post-coma and had no significant periods cf
sleep until the eleventh hospital day. However no EEG sleep
recording was done in this oase.
Some of the patients studied in Project No. 2 during
their follow-up mentioned poor sleep and nightmares in the weeks
after coma. Therefore a follow-up study of sleep reoovery of
some of these patients after they had made a clinical recovery
from aoute drug poisoning was undertaken.
-V.C, METHODS AND MATERIAL1-
Seleoted/
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Selected patient* vara drawn from a thousand
poisoned patients admitted in 1969 to the Regional Poisoning
Treatment Centre, Royal Infirmary of Edinburgh under the oare of
Br. H.J. Matthew. They were later transferred to a psychiatric
ward of the Royal Edinburgh Hospital where the patient's individual
needs oaused variability in the extent of the studies.
The patient prepared for sleep each night and had
small silver diso electrodes attached above and below eaoh outer
canthus, to the scalp, and over the submental muscles. Fine wires
from these electrodes, gathered together at the scalp, made
possible reoording of electroencephalogram (EEC), eye
movements and muaole tension (EMG) at a paper speed of 15 mm/second.
The patient then slept in a small room within the ward, the EEG
machine being in an adjaoent room.
Approximately a third of a mile of reoording paper
(64 miles in all) was obtained each night and this was scored
page by page according to standard criteria (Rechtschaffen and
Kales, 1968). Among soores obtained werei total time asleep,
the number and duration of awakenings and the number of shifts
to and duration of the various stages of sleep, namely stage 1
(drowsiness), 2, 5 *nd 4 (largest slow EEG waves) of orthodox
(NREM) sleep, and paradoxioal (REM or rapid eye movement) sleep.
Partioular reference is made below to the peroentage of sleep
spent as REM sleep. In addition, since a variety of previous
studies (Oswald and Priest, 1965i Oswald et_al., 1968) have




informative period, reference ie made to a measure of
spontaneous restlessness In this time, namely the total
number of shifts from any other stage of sleep tp stage 1
(drowsiness) or wakefulness between first falling asleep
(onset of first sleep spindles of stage 2) and the accumulation
of a total of ? hours of sleep, and also to the duration of
REM sleep in this two hours. The latter duration does not
normally exoeed 55 minutes In young people, in whom also the
delay between the first sleep onset and first REM sleep normally
exceeds 43 minutes (Oswald, 1968). In addition I took particular
note of the presence and eventual disappearance of EEG fast
activity of the type often oalled "barbiturate fast" which,
however, also is caused by various other drugs, and to this
end recordings were made without the use of high frequency filters.
134.
PATIENT It (72/llO/ES)
A woman of 47 was admitted to the Regional Poironing
Treatment Centre on 21at March, 1969, after having taken an
overdose of M&ndrax (about 40 tablets). She had been taking
one or tvo "Mandrax" (methaqualone 250 mg. with diphenhydramine
25 mg.) nightly for three months. On admission to the ward she
was deeply unconscious and unresponsive exoept to maximal
stimulation. Continuous EEC monitoring was started soon after
admission to the ward and continued throughout her period of
unconsciousness and for some time after. Her clinical oourse in
the hospital and EEC changes have already been described in
Project 2 (see case history No. 5). She regained consciousness
after 105 hours and was seen by Dr. Ian Oswald, the consultant
psychiatrist, who transferred her to the North Wing of the
Royal Edinburgh Hospital for psyohiatrio in-patient care, where
her all-night sleep studies were done. No physioal treatments
were employed during the period of study outlined below*
In the subsequent two days she developed a mild
delirium with visual hallioinationa and disorientation which
did not wholly clear till the 11th day. No drugs were given.
Her all-night sleep was recorded on the 5th post-overdose night,
but on this, and the next three nights, it was extremely broken
and irregular, consisting on nights 5. 6 and 7 only periods of
stage 1 and of REM sleep, each briefly intruding directly from
wakefulness and often for only a few seconds at a time. On the
5th night recording lasted for eight hours and five minutes, but
she slept for only 12 minutes. Her reoord (Fig. 95) consisted of
periods/
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On the fifth post-overdose night she had five minutes of
stage 2 sleep but she began her night with REM sleep. These
four excerpts are continuous. The top excerpt indicates that
the patient is awake, with eye blinks and increased muscle
tone (MS), The second excerpt contains rapid eye movements
and low voltage 3~4 cps EEG waves. These features suggest
REM sleep yet muscle tone remains increased. The third excerpt
shows rapid eye movements of the appearance usual in REM sleep
and decreased muscle tone with low voltage EEG slow waves. This
picture continues into the fourth excerpt, in the middle of which
waking eye blinks re-appear and muscle tone is increased, no
rolling eye movements of stage 1 sleep are visible.
MS = Muscle tone.
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periods of wakefulness with eye blinks, stage 1 with alpha
rhythm and REM sleep with rapid eye movements and low voltage
EEG. Musole tone was quite variable but mB:vfir.;lsbBEin,t / 'Hhd
therefore, at times, a distinction between REMS of REM sleep
and blinks or REM of wakefulness beoame difficult. Moreover
as the REMS mixed with blinks occupied 20-50^ of an epoch
the scoring of the epoch was almost impossible. She began
her night's sleep with what was interpreted as REM sleep but
there were no stages 2, 3 or 4. In the morning she was
oonfused and disorientated. Her blood siethaqualone level was
3.3 mg.fi.
On the 6th post-overdose night she slept for 69
minutes. Her first sleep was REM sleep and her EEG record
(Fig. 96) still oontained a mixture of periods of low voltage
slow wave EEG with REMS like those of REM sleep, on the one
hand, and obvious wakefulness on the other. Shere were no
stages 2, 3 or 4. She was fearful of being left alone, and
wanted the light left burning. She took the central heating
pipes for some sort of device to kill her after I had left
the room. In the middle of night she shouted for help and asked
for taloum powder which she started sprinkling on the blankets
saying that she wanted to die smelling nice. In the early
hours of the morning she was seeing thingp orawling toward her
and these ohanged colour.
On the 7th night she slept for 139 minutes but there
was no stage 2, 3 or 4. She again began her night's sleep
with REM sleep (Fig. 97) and shifted between stage 1, RBM'*■-*" *
sleep/
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Figure : 96
The 6th night after the overdose. These two continuous
excerpts illustrate the transition from wakefulness to what
is probably REM sleep and again to wakefulness. The upper
excerpt shows wakefulness with eye blinks and increased muscle
tone passing directly into a period of rapid eye movements
and decreased muscle tone. Seven to eight seconds later
eye blinks re-appear and muscle tone is increased. The second
excerpt shows obvious wakefulness with eye blinks and increased
muscle tone passing into a period in which low voltage slow
EEG waves accompanying rapid eye movements of the appearance
seen in REM sleep, but muscle tone remains unchanged. Five
seconds later eye blinks are prominent, muscle tone shows no
change and the patient must be judged awake. MS * muscle tone.
SLEEP AFTER MANDRAX OVERDOSE.
PATIENT 1



















On 7th post-overdose night her sleep consisted of periods
of stage 1 and of REM sleep. These excerpts illustrate the
transition from wakefulness, with EEG alpha rhythm, though
drowsiness with rolling eye movements and loss of alpha
rhythm directly into REM sleep with low voltage 3-4 cps
EEG waves and rapid eye movements. All the four excerpts
are continuous with one another. The third and fourth
excerpt show a transition from REM sleep to wakefulness
with the return of alpha rhythm, eye blinks and increased
muscle potentials.
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sleep, and wakefulness. Most of her reoord consisted of a
mixture of REM5 and blinks in the same epoohs but some of the
REM periods were typioal. She was hallucinated, and saw smoke
around the light bulb, and complained of terrible smells in the
room. She firmly believed that she was going to be blown up.
The following night (8th night) for the first time
her reoord (Fig. 98) oontained some pomr spindles (Stage 2),
She slept for 2 hours and 5 minutes, She continued to be
hallucinated, disorientated and confused. On this 8th night she
had 5 minutes of stage 2 sleep, 53 minutes on the 9th night, and
160 minutes on the 11th, when she slept for just over 5 hours in
all. On the 14th night she had 386 minutes 6f sleep and remained
at just over this duration nightly thereafter.
Fig. No. 99 illustrates the broken nature of her sleep.
Her intra-sleep restlessness is shown by the increased number of
shifts to stage 1 sleep from any other stage of sleep, or to
wakefulness. They numbered 39 on the 7th night. With gradual
recovery throughout the period of study they dropped to 12 on the
37th night.
The reoovery course of her REM sleep is indicated in
Fig. 100. On the first four nights her sleep consisted mainly
of REM sleep, stage 1 or wakefulness with no stages 2, 3 or 4.
On these nights, as already pointed out, scoring of her reoord
according to the standard criteria was almost impossible but an
attempt was made, as best could be. The percentage of REM sleep
for these nights is, however, shown merely by dots on Fig.100,
whioh shows high REM sleep percentages on early nights with
recovery to normal levels after five weeks. Other abnormalities




On 8th post-overdose night the patient passes from Stage 2
with a poor spindle and decreased muscle tone directly
on to REM sleep with rapid eye movements, and irregular
5-9 cps EEG waves posteriorly, yet without normal abolition
of muscle tone. The three excerpts are continuous. The
bottom excerpt shows a series of eye blinks as the patient
wakes up. Note muscle tone has greatly increased.









Restless sleep in the weeks after "Mandrax" poisoning.
The number of spontaneous shifts from sleep to wakefulness
or to stage 1 sleep before attaining a total of 2 hours
of sleep is shown. Restlessness declines towards normal
in the month of study. On nights 5, 6 and 10, she slept a total
only 12, 69 and 89 mins, and for these nights the absolute
number of shifts in the time asleep is shown, so underestimating
the degree of restlessness.
SLEEP AFTER MANDRAX OVERDOSE»
PATIENT 1
REM IN FIRST TWO
HOURS OF SLEEP XX XXX
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The percentage of sleep spent as paradoxical (REM) sleep following
"Mandrax" poisoning returns to normal a month after overdose, but
the excess of early paradoxical sleep and its early onset, indicated
by the atars across the top of the figure, indicates that full
recovery of this brain function has not occurred in the period
during which study was possible.
In the study as a whole the percentage of oaradoxical sleep is based
on total sleep from sleep onset with first stage 2 EEG sleep spindles.
Since on nights 5, 6, 7 and 8 paradoxical sleep appeared in broken
episodes without preceding stage 2 sleep, the percentages for those
nights are based simply on total sleep, which was mainly paradoxical (REM)
sleep with little stage 1. Mean for young women is from Williams et al..
(1966).
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in her aleep included early onset of REM sleep and its excess
in the early part of night. These abnormalities were still
f •
present on the 37th night after drug ingestion when she was
discharged. Therefore she presumably had not fully recovered
to normal by the time of discharge.
Her NREM sleep was also abnormal. Stage 3 sleep
was absent until the 16th night (2 per cent) and stage 4 sleep
absent until the 31>t night. Combined stages 3 and 4 (Fig.lOl)
rose gradually towards normal in the last three weeks.
Blood methaqualone levels rOse to a maximum on the
third day (Fig. 102). The curve suggests blood levels would
have been negligible by the 7th day but a continuing presenoe
of drug in the brain was revealed by drug-induoed EE6 fast
activity in stage 1 and REM sleep still marked on the 10th
day and disappearing on the 16th day.
PATIENT 2i
A 69 year old woman who took about 40 "Mandrax"
and who was then unconsoious for 2 days had her sleep recorded
on the 6th night when, in a total of only 194 minutes of Bleep
she had 34.5$ HEM sleep, and woke 18 times before accumulating
two hours of sleep. However, she was chiefly of interest on
aocount of the fact that during the night some EEC abnormalities
typical of epilepiy were observed in her sleep record. Spikes
(Fig. 103) and isolated spike and wave bursts were seen during
stages of NREM sleep. She had three prolonged spike-and-wave
EEC paroxysms of the type seen in epileptio patients (Fig. 104)
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Figure: 101
The EEG slow-wave stages of sleep known as stages 3 and 4
were absent after the poisoning till the sixteenth night
after which they recovered normal levels in the subsequent
three weeks.
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Blood methaquslone estimations for Patient.
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Figure 105:-
Sixth post-overdose night. Top excerpt shows sleep spindles and
spikes, the lower excerpt reveals spike-and-wave activity.
STAGE JU SLEEP
Figure 104t-
Sixth post-overdose night. Top excerpt illustrates generalised
spike-and-wave EEG paroxysm typical of epilepsy and is distinctly
different from the slow wave activity of NREM sleep (lower
excerpt) of the same patient. S <+■ W « spike and wave.
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different from the slow waves of NREM sleep. She had no
ollnloal seizures and two weeks later a sleep EEC showed
no further paroxysmal features and nor did a waking recording
on the 9th day.
PATIENT 3» (117/lOl/N.R.)
A 36 year old woman was admitted to the Regional
Poisoning Treatment Centre, Edinburgh at 1st March, 19&9* She
had taken 200 mg. tablets of methyprylon hypnotio nightly, but
no alcohol, for several months. She was unoonsoious and totally
unresponsive to stimuli.. Continuous EE6 monitoring was started
two hours after her admission to the ward. Her EEG tracings
showed only brief low voltage slow waves in bursts on an other¬
wise flat background (Grade VI). She regained consciousness after
28 hours of ooma and it was learned that she had taken approximately
40 tablets (8000 mg.) of methyprylon about eight hours prior to
admission. The olinioal course of her illness and EEG changes
observed during the period of acute drug poisoning are described
in Project No. 2 (see oase histories - No. 9).
Forty hours after drug ingestion she was seen by the
consultant psychiatrist *nd transferred to the Royal Edinburgh
Hospital for psychiatric in-patient oare, under Dr. Ian Oswald,
where her all-ni(£:t sleep recording was done.
She did not sleep at all on either of the next two
nights (her EEG was recorded throughout). She became delirious,
seeing snakes, gravestones, trees and flowers in the ward,
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Restless sleep in the weeks after methyprylon overdose. The number
of spontaneous shifts from sleep to wakefulness or stage 1 sleep
(drowsiness) to readh a cummulative total of 2 hours of sleep is shown.
The rate is very high in the first three weeks and declines towards
normal levels over the course of the two months.
SLEEP AFTER METHYPRYLON OVERDOSE.
(PATIENT 3)
DELAY TO FIRST
REM < 45 MINUTES
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The percentage of sleep spent as paradoxical (REM) sleep rises
to high levels with an irregular decline over the two months.
Excess of paradoxical sleep in the first two hours is shown
by a star as 'late as the 52nd night. Drug-induced EEG activity
disappeared on the 19th night, when HEM sleep percent was also
highest. The horizontal line is the mean value for young women
(Williams et al.. 1966).
SLEEP AFTER METHYPRYLON OVERDOSE
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During REM sleep the eye movements were larger and more profuse
about the time of peak REM sleep percentage than when the REM
sleep percentage had later returned to normal. Illustration
examples are shown from RIM periods of patient 3 on (a)
6th. post-overdose night and (b) the 31st nigiht#
BLOOD METHYPRYLON LEVELS AFTER METHYPRYLON






















. Figure, t 108
Blood methyprylon levels after methyprylon overdose*
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No attempt was made to record her EEG on the third night but the
night nurse reported that the patient had remained awake all
night. On the next night she slept for a total of $16 minutes.
The sleep, especially in the early night, was punctuated by
repeated spontaneous arousals (Fig. 105) indicates that her
intra-sleep restlessness was greatest 11 nights after the
overdose (with $2 shifts from sleep to stage 1 or wakefulness).
She gradually recovered and her sleep patterns returned toward
normal over a period of two months.
Her delirium cleared after the first night of sleep
and sleep duration increased to 448 minutes by night 8, remaining
rou^ily constant thereafter. The peroentage of REM sleep
(Fig. 106) was elevated above normal by the 6th reoovery night,
reaching a maximum of 44*5^' on the 19th night. The peroentage
deolined in irregular fashion towards normal values over several
weeks but as late as the 53rd night there was an abnormally
large amount of REM sleep (40 mine.) in the first two hours of
sleep. During REM sleep the eye movements (Fig. 107) were
larger and more profuse about the time of peak REM sleep
peroentage than when the REM sleep percentage had later
returned to nowaal. Her combined stages 3 plus 4, was 5.4. 7.9.
9.8, 10.6, 14.6, 15.3. 16.6, 18.5, and 20,8 peroent on nights
5, 7. 14, 19, 21. 24. 26, 28 and 3° respectively.
Drug-induced EEG fast activity, seen in Stage 1 and
REM sleep, and drug-accentuated EEG sleep spindles in stage 2,
were judged much reduced on the 17th night and absent on the
19th. Blood methyprylon (Fig. 108) in the first six days was




A nurse of 19 was admitted to the Regional Poisoning
Treatment Centre, Edinburgh, at 09.00 hours after having taken
about 40 tablets (200 rag.) of nitrazepam eight and a half hours
previously. She had been taking two tablets nightly for some
months. She was oonsoious and able to give a history in a quiet,
slightly drunken manner.
Continuous EEC monitoring was started soon after
admission to the ward. The olinioal course of her illness and
EEG changes seen during acute drug poisoning are described in
Project No. 2 (see oase histories-No. 6). She remained oonscious
throughout the day and was transferred to Royal Edinburgh Hospital
for psychiatric in-patient oare where sleep studies were carried
out.
Her sleep, on the first night was of 462 minutes
duration. Drug-induced EEG fast aotivity at about 18 cps was
very prominent in stage 1 and REU sleep and on this first night
an enhancement of stage 2 sleep spindles was observed. (Fig.109).
The second night she slept only 173 minutes, 336 minutes on the
third night, and thereafter her total sleep duration varied
irregularly between 239 and 495 minutes. EEG drug-induoed fast
aotivity disappeared after 9 nights. She was discharged,
having received no drugs, after 6 weeks and seen thereafter at
the out-patient clinio, from which she was defaulted.
She was re-admitted six weeks later having taken
25 tablets, (125 mg.) of nitrazepam, together with 100 mg. of
perphenazine. She was oonsoious and discharged home the next
day from the Poisoning Treatment Centre. At home she "felt
I wanted to move my legs all the time" and oould not sleep.
Two/
SLEEP AFTER NITRAZEPAM OVERDOSE.








Showing drug-induced accentuation of EEG sleep spindles. The
two representative excerpts from the records of patient 4»
both illustrate Stage 2 sleep.
The spindles are accentuated three nights after her overdose
whereas they appear normal on the 13th night.
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Two days after the overdose her family doctor gave her 16 mg*
of perphenazine and 400 mg. of pentobarbitone sodium and after
another two days 5 mg. of nitrazepam and 25 mg. thioridazine.
She was readmitted to the Royal Edinburgh Hospital
as a psychiatric ln-patient on the next day when she received
no further drugs. Drug-induoed EEG fast activity was again
prominent till the ninth post-overdose night. On the first
night in hospital (the sixth post-overdose) she slept 254
minutes and sleep duration thereafter showed no special trends
and varied between 275 and 467 minutes*
In Fig. 110 it may be seen that after eaoh
admission intra-sleep restlessness rose to a maximum around
the 10th post-overdose night and deolined slowly towards
normal throughout the following month. REM sleep appears from
Fig.Ill to be suppressed by the drug* to reaoh a maximum
around the 10th post-overdose night* and to decline in the
subsequent weeks* During REM sleep the eye movements (Fig.112))
were more profuse and larger about the time of peak REM sleep
percentage than when REM sleep percentage had later returned
towards normal* Stages 5 and 4 were never absent and rose
regularly from 8$ on the first night of her admission to around
25-50$ of sleep before discharge.
PATIENT 5i S.D.
A 65 year old housewife* who had had meningitis
thirty years earlier, after taking a half tablet (2.5 mg.)
of nitrazepam nightly fvr several weeks took about 40 tablets
or 200 mg. of the same drug. She was admitted unoonscious but
responding/
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Figurej 110
An index of intra-sleep restlessness following overdose of
nitrazepam. It may be specially noted that in each case
restlessness is maximal about 10 days post-overdose and declines
towards normal over each six weeks. Two months after the last
value shown for the readmission study, and without any further
drugs, the number of shifts in the first two hours of sleep on
two successive nights was only 0 and 2 respectively.
SLEEP AFTER NITRAZEPAM OVERDOSE.









































Paradoxical (BEM) slegpis LSjappwsaBed "by the nitrazepam overdose.
After each overdose the curves rise to very high levels around
the tenth post-overdose day and decline thereafter. Drug-induced
EEG fast activity had persisted nine days. As late as the
thirty-sixth night after the second overdose one of the limits
of normality indicated at the top of the figure, was surpassed by
paradoxical (REM)sleep beginning only 39®in. from sleep onset,
SLEEP AFTER NITRAZEPAM OVERDOSE.
Patient 4 - Female, 19 years old.
Fi& 112
Variation in intensity of rapid eye movements.
Upper traces show continuous high amplitude eye movement potentials
on the 10th night after the overdose.
Lower traces show short hursts of low amplitude eye movement
potentials 35 nights after the overdose.
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8. •
responding to painful stimuli. She regained consciousness on
the second day and was transferred to North Wing of the Royal
Edinburgh Hospital for psychiatric in-patient care.
Her sleep was first recorded on the third night.
Drug-induced EEG fast aotivity disappeared on the 11th night.
Her early night intra-sleep restlessness is indioated by
Fig. 113. It Increased to a peak on the 8th night and declined
in the subsequent month. The percentage of sleep spent as REU
sleep rose from nil on the third night to a peak of 42.4$ on the
eighth night, with eventual stabilisation around 18$ after a
further three weeks (Fig. 114).
She had no stages 3+4 sleep.on the third night,
11$ the next night and this peroentage rose irregularly to
values over 30$ by the third week. Her total sleep duration
on night 3 was 517 minutes and this duration fell steadily
on successive nights till the twelfth night, when she slept
only 203 minutes and then rose to a more normal figure in the
subsequent week (Fig. 113). She reoeived no drugs or other
treatment during the period of study.
Clinical examination suggested mild organic brain
impairment and this was oonfirmed by psychological testing on
which, 24 days after overdose, she showed speoifio impairment in
the ability to learn new material and greater impairment in
retention, particularly of visual items, though general
intelligence (Wechsler Full Scale, I, Q ■ 120) was not reduced.
It was assumed that it was owing to meningitis and not overdose.
PATIENT 6/
SLEEP AFTER NITRAZEPAM OVERDOSE.
'
PATIENT 5
Intra-sleep restlessness in the early night rises to high levels
from the eighth to fifteenth nights and declines gradually
in the succeeding three weeks. Nitrazepam-induced EEG fast
activity disappeared on the eleventh night in this patient.
REM sleep was suppressed after the nitrazepam overdose,
rose to the very high level of 42..2$ on the eighth night,
appeared to fall below her normal after three weeks and
thereafter rose slightly to a low-normal figure.
SLEEP AFTER NITRAZEPAM OVERDOSE.
PATIENT 5
Figure:- 115
Total nocturnal sleep duration was very high at first
tlirtl steadily to under three and a hal? hours on thelrug"adnif« r a"r Ef fast a0tiVity indicated the
the end of the study? t0 ^ hours by
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PATIENT 6s (11/105/Cft)
A 28 year old female who had not been taking any
drugs took 80 tablets (8000 mg.) of phenobarbitone and was
admitted to the Regional Poisoning Treatment Centre, Royal
Infirmary, Edinburgh on the 8th March, 1969* On admission she
was drowsy but after the stoaaoh washout she was deeply comatose
and totally unresponsive to all stimuli. Continuous EBG
monitoring was started soon after admission. Her initial
EEG record revealed Grade IV changes. The clinical oourse of
her illness and EEG changes seen during aoute phenobarbitone
poisoning are deaoribed in detail in Project 2.(see case histories -
No. 1).
She regained consciousness after 96 hours of coma and
was transferred to the Royal Edinburgh Hospital for psychiatric
in-patient care where further studies were continued.
After one week she was ambulant, and, to the clinical
observer, fully conscious. Her blood phenobarbitone level (Fig.116)
at the time of admission to the Poisoning Treatment Centre was
9.2 mg.$. Itlwam 9.7iug$ After 96 hours at the time when she became
conscious. The level had fallen to 0.8 mg.$ on the 19th day after
drug ingestion, on which day she asked for her discharge.
Her all-night sleep was recorded from the 6th post-
overdose night onwards. Her sleep was disturbed as indicated by
increased intra-sleep restlessness (Fig. 117). The number of
shifts to stage 1 and wakefulness in the first two hours of sleep
rose gradually from 16 on the 6th night to 37 on the 18th night.
At the same time her blood phenobarbitone level fell steadily from





















Blood phenobarbitone estimation actually revealed a higher
level when, after 96.hours, she regained consciousness
than had been present on admission. Note that after 10 days
with a fully ambulant patient very high blood levels persisi
and that three weeks would apparently have been needed to
clear the drug from the blood.
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Total nightly sleep duration, whioh was 509 minutes
on the first recorded night, also declined gradually and was
J87 minutes on the night "before discharge. The sleep EEGs showed
an excess of drug-induced fast activity which was present till
the sixteenth night. Combined stages 3 and 4 of NREM sleep
increased irregularly during the time of study and were 15,9#
feS * *- -5f
10.8, 18.8, 19.0 and 23.9$ on nights 6, 10, 15, 16 and 18
respectively.
REM sleep duration in the whole night (Pig. 118) was
reduced (7.79«) end contained only few, small eye movements on
the 6th post-overdose night but there was gradual accentuation
and the whole-night percentage of REM sleep rose to 36.59^ on
the 18th night. Other abnormalities like early onset of the
first REM period in the night and increased amount of REM sleep
occurring within the 1st 2 hours of sleep were also seen as
whole-night REM sleep percentage increased and were present on
the 18th post-overdose night, the day before her discharge.
PATIENT 7:- (20/114/EW)
A 21 year old female, who was not regularly taking
*
hypnotics was admitted to the Regional Poisoning Treatment
Centre, Royal Infirmary, Edinburgh on 8th June, 1969, after
having "feken about 15 tablets (3000 mg.) of sodium amylobarbitone.
On admission she was only drowsy and could be aroused
to verbal responses. Her blood pressure was 110/65 mm.Hg. and pulse
76 per minute, regular and good volume. Phyeioal examination was
normal in all respects. Stomach washout was productive and she
was/




















When compared, with Figji6it may be seen that as the blood
level of phenobarbitone fell, so the intra-sleep restlessness





































REM sleep was suppressed by the drug but a rebound occurs
and it appears that the curve would have had a maximum at around
three weeks post-overdose#
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was fully conscious 24 hours after admission. She was seen by the
consultant psychiatrist and transferred to the North tfing of
the Royal Edinburgh Hospital for psychietrio in-patient care
where further studies were carried out.
Her sleep was recorded on the fourth night and the early
night intra-sleep restlessness increased to a peak of 2C shifts
in the first two hours of sleep on the 6th night and then fell
to 4 shifts by discharge on the 17th day. Likewise her all-
night percentage of REM sleep (Pig. 119) rose to a peak of 30.4$
on the 6th night and quickly fell away on later nights.
Four days after drug ingestion her blood barbiturate
level was less than 0.3 mg.$ and it was zero the following day.
EEC barbiturate-induced fast activity was visible only on
the fourth night. The combined stages 3 + 4 of NREM sleep
gradually rose from 27$ on the 4th night to 42.2$ on the
16th night after drug ingestion.
PATIENT 3 (40/78/BH)
A 29 year old man was admitted to the Poisoning
Treatment Centre, Royal Infirmary, Edinburgh on 21st February,
1969# after being found unconscious that evening. It was discovered
later that he had taken 25-30 tablets (2500-3000 mg.) of sodium
butobarbitone.
On admission he was deeply unconscious. Blood pressure
105/65 ram.Kg} pulse 76, regular, fundi normal. His pupils were
somewhat constricted, reacting to light) cough and gag
reflexes present. Knee and ankle jerks symmetrically
increased/
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Effect of a small overdose of sodium amylobarbitone in a woman
not previously receiving them. There appears to be a small
and brief REM sleep rebound with a peak of 30,4ej° on the
sixth night with a quick fall to her presumed normal of around
20^o in the whole night. No definite early-night paradoxical (REM)
sleep abnormalities occurred. Her intra-sleep restlessness
was also maximal on the sixth night.
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increased with reduction in biceps and trioeps jerks and flexor
plantar responses.
Gastric aspiration and lavage were performed with no
return of indentifiable tablet material. Continuous EEC monitoring
was started two hours after his admission to the ward and the
initial EEC record revealed Grade IV EEC changes. His rectal
temperature was 35.5°C and serum barbiturate level 3.0 mg.$.
He gradually improved and regained consciousness after 36 hours
of coma and later on he was very obstreperous and violent for
a short time. He was seen by the consultant psychiatrist on
25th February and transferred to the Royal Edinburgh Hospital
for psychiatrio in-patient care.
His all-hight sleep was reoorded on the 4th post-
overdose night. He slept for 182 minutes and no EEG barbiturate
fast activity was seen. REM sleep began abnormally early, namely
only 13 minutes from sleep onset, and occupied an exoess of the
first two hours of sleep, namely 32 minutes with a whole night
sleep percentage of 29$. His aggressive behaviour did not
permit further study.
PATIENT 9l (36/lOa/MM)
A 41 year old housewife, after an argument with her
husband for the fifth time took an overdose of drugs. On this
occasion it was of 30 tablets (3000 mg.) of sodium pentobarbitone.
She was admitted to the Poisoning Treatment Centre deeply
unconscious and on the 3rd day, after recovery of consciousness,
transferred to psychiatric care.
Her/
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Her sleep was recorded on the 3rd* 4th and 6th night*
during which there were successive Increases In intra-sleep
restlessness (19* 22 and 24 shifts In the first 2 hours) in
stages 3+4 sleep (6.9, 9.2, and 15.6$) and in REM sleep (Pig.l20)
from 19.3$ to 37.8$ in the whole night with early onset of REM
sleep and early night exoess. EEG barbiturate fast activity
disappeared on the sixth night on which night she had barely
four and a half hours total sleep. She took her own discharge
on the seventh day.
PATIEHT 10.(PB).
A 20-year old nurse, who had taken an overdose
of ferrous sulphate a year earlier, took 150 tablets, or 50
grams of aspirin. Two hours later she was admitted to the
Regional Poisoning Treatment Centre, Royal Infirmary, Edinburgh
on 3rd June, 1969. On admission she was consoious. Gastrio
aspiration and lavage was performed and some tablets were
obtained In the return. In view of her high blood salioylate
level (70 rag. percent) foroed alkaline diuresis was commenced,
after which her salioylate level dropped to 40 mg.$. After
clinical recovery from aoute drug poisoning she was transferred
to psychiatrio care.
Sleep was recorded on the fourth post-overdose night.
Intra-sleep restlessness was low, rising from 7 shifts in the
first two hours on the fourth night to 10 on the sixth and
falling to 6 on the ninth and tenth nights. REM sleep showed
some signs of possible rebound increase with early onset, after
42 and 39 minutes on the sixth and seventh nights but as Fig.121
shows/
 
REM SLEEP AFTER SALICYLATE OVERDOSE.
PATIENT10.














t 10 IDAYS AFTER DRUG
150 TAB. k. . I .. Discharged
Op ASPIRIN Menstruation Home
^S"o 6n) Started
Figure s 121
In contrast to the hypnotics, acetyl salicylic acid, in
massive overdose, has only slight effects possibly suppressing REM
paradoxical sleep at first with minimal signs of rebound on the
sixth and seventh nights. The immediate pre-menstrual period
can be associated with a small increase, in REM sleep,.
and, in view of the smallness of the effects noted, the time
of menstruation onset is consequently indicated.
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shows, there was little remarkable. Stages 3+4 sleep
showed no trends or features of note and totalled 20-30%
each night. Blood salicylate had fallen below 5 mg.% by
the sixth day.
PATIENT 11 (119/123) CM)
A sixteen year old girl took 40 tablets (800 mg.) of
fenfluramine and was admitted to the Reg onal Poisoning Treatment
Centre, Royal Infirmary, Edinburgh on 15th July, 1969 at 02.30
hours. Continuous EEG monitoring was started three hours after
admission to the ward. Her EEG record revealed Grade I EEG
changes. The clinical course in the hospital described
under Project No. 2. (See case histories - No.18).
She did not appear to sleep on the first night.
Her whole-night sleep was recorded by electroencephalography
on nights 3» 4, 5, 6, 8, 9, 11, 12, 14, 15 and 19 dfter overdose.
It was frankly abnormal on night 3» when 11 minutes of REM sleep
occurred at initial sleep onset, instead of after about an hour
as is normally the case (Oswald, 1968). Her all-night percentage
of REM sleep was also highest on that night. There appeared tojbe
aocentuation of EEG sleep spindles on the same night. The percentages
of sleep as REM sleep (Pig. 122) on the various nights were 29.8,
24.1, 22.8, 27.1, 22.9, 20.2, 24.2, 25.8, 26.7, 23.1 and 20.8
respeotively - all within normal limits. There were two other
features which also suggested abnormality of rebound type,
namely, a short delay of 45 minutes (night 4) from sleep onset
to first REM sleep and excess REM sleep within the first two
hours of sleep, namely, 31 minutes (Night 5).
PATIENT 18/
REM SLEEP AFTER FENFLURAMINE OVERDOSE





























Fenfluramine, in massive overdose, has only slight effects,
possibly suppressing REM sleep at first (Patient 120) with
minimal signs of rebound on the second (patient 119) and sixth
(patient 120) nights. In patient 119 an early onset of REM
sleep (night 4) and excess REM sleep within the 1st two hours
of sleep (night 5) was also noted. The first two values on the
graph for patient 120 are inspired guesses based upon the 95
minute and 34O minute of sleep recorded on these nights.
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PATIENT 12. (l20/l24/M )
A 16 year old girl was admitted to the Regional
Poisoning Treatment Centre, Edinburgh at 22,00 hours on the
23rd July, 1969 after having taken 3° tablets (600 mg.) of
fenfluramine two and a half hours prior to admission. On admission
she was conscious. Continuous EEG monitoring was started soon after
admission to the ward. The clinical course of her illness is
described in Project No. 2 (see case histories - No. 19).
She fell asleep at 02.30 hours, four and a half
hours after admission, and her EEG was continuously recorded
for the first 95 minutes of sleep. The record was abnormal
in that continuous musole artefact was present in all channels,
superimposed on the EEG sleep traces. In addition Stages 3 and
4 EEG sleep appearanoes, which would normally be seen in the
first hour of sleep, were not present, the record consisting
only of stage 2 sleep with brief periods of stage 1. No REM
sleep was seen.
On her second night the first 3 hours. 40 minutes of
sleep was recorded. Stage 3 »as present early in the night. The
excess of continuous musole artefact was still deteotable but
muoh reduced. REM sleep did not appear till after 4 hours 20
minutes and lasted only two minutes. There appeared to be some
enhancement of the EEG sleep spindle activity.
Her sleep was also recorded for the whole night on
nights 3» 4, 6, 7 and 11. The REM sleep (Pig. 122) percentages
were all normal, namely, 26.8, 27.6, 28.0, 26.3, 20.8 respectively.
REM sleep began early, after 46 minutes on night 4 and occupied
31 minutes in the first two hours of sleep on night 6.
150.
DISCUSSION
A syndrome which may include restlessness,
insomnia, delirium and oonvulsions occurs after withdrawal of
almost all hypnotioa, if they have been taken in sufficient
dose and for long enough (Wulff, 1959* Hudson and Walker, 1962|
James, 1963| Fraser et al.. 1954). Recent work has shown that
REM sleep is grossly increased in the delirium of aloohol and
barbiturate withdrawal (Gross et al.. 1966} Greenberg and
Pearlman, 1967* Evans and Lewis, 1968* Lewis, 1969). Therefore
it seems likely that all hypnotics have these effects on human
sleep in some measure.
In this study restlessness, insomnia, delirium
■*#
and also EEG epileptic-type abnormalities were observed in
patients in whom a high degree of tolerance and dependence had
presumably been acquired in the presence of massive concentrations
of drug. Patient 6\(phenobarbitone case) had taken no previous
drugs but after four days had acquired such tolerances to
continuing high concentrations of phenobarbitone that she regained
consciousness.
The phenomena described oannot be deemed non¬
specific responses to hospital admission. Restlessness at night,
for example was not maximal in these patients at initial study
but maximal about the time the drug ceased to act. Patient 6
got more and more restless, slept less and less, and got more
and more REM sleep as the three weeks to full excretion of
phenobarbitone/
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proceeded. Patients 4 and 5 (nitrazepam overdose) also well
illustrate the same phenomena, which in their oases, reached
a peak at about the tenth post-overdose day.
The relation between the duration of drug aotion
and the observed phenomena also means that they oould not be
interpreted as sequalae to the emotional crisis that led to the
taking of an overdose. In addition aspirin overdose (Patient 7)
serves as a oontrol. Aspirin is a drug which stimulates respiration
but has only Slight effects on meohanisms of consciousness and it
• * '-wag*
had only slight effects on the variables measured. Overdose of
fenfluramine in two young women (Patients 11 and 12) had equally
slight effects (Riley et al.. 1969)* adding further evidence that
neither the original psychological state nor the fact of hospital
'•
. ' ' 1 ■ . v • . • .
( 'i'i . •-
admission could be held responsible. I believe the important
variables are the nature of the drug, the duration of exposure
to it and the dosage. It should be added that many of the post-
overdose effects are seen not only after hypnotics but after
overdose of suoh drugs as imipramine (Lewis and Oswald, 1969)•
debrisoquine (Oswald, I. and Dunleavy, D., unpublished),
phenelzine (Akindele et al.. 1970) and, by inference, amphetamine
(Oswald and Thacore, 1963). Similar phenomena have been observed
too in the weeks after experimental administration of drugs to
normal volunteers, for example, nitrazepam and sodium amylobarbitone
(Oswald and Priest, 1965) and heroin (Lewis et al.. 1970). These
volunteers had neither been driven to take overdoses nor admitted
for treatment.
Certain lessons may be drawn, ^hen psyohiatric
assessment is made in the day or twb after recovery of conscious¬
ness a patient may still be very much under the influence of an/
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anxiety-reducing drug. If it is deoided that the patient
should go straight hone, as do 80$ at Edinburgh, it nay be
several days later that withdrawal insomnia, nightmares (often
an accompaniment of raised REM sleep), confusion, or even
delirium, become manifest. A desire to resume hypnotics,
oontrary to medical wishes, oan be understood.
Regular intake of hypnotic drugs can result,
after their withdrawal, in restlessness, insomnia, nightmares
and abnormally increased REM sleep for several weeks (Oswald
and Priest, 1965). The phenomena were extreme in the present
study and prior-to-overdose medication cannot be held solely
responsible for e.g. Patient 6. In the study of Oswald and
Priest (1963), as in this study, a close relation between delay
to drug-elimination (indicated by persisting EEG fast aotivity)
and the delay to peak REM sleep rebound after drug withdrawal
was present. This delay seems to be a general guide to
persisting drug action on the brain (Oswald, 1969) and a better
one than blood levels, which can be no guide after trioyolio
drug overdose (Lewis and Oswald, 1969).
The safety of nitrazepam, Matthew et al«. (l9<>9)
means it is to be preferred to its contemporary rivals, but it
is not rapidly eliminated to judge by EEO fast activity (Oswald and
Priest, 1965), and one must not expect normal motor co-ordination,
a customary degree of emotional stability or £ood judgement, just
because a patient has remained conscious after overdose of
nitrazepam. The slowness of phenobarbitone elimination revealed
in/
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this study serves once more to underline the unsuitability
of phenobarbitone as a hypnotlo.
An impressive feature of the results is the
length of time, of up to tvo months, seen in the various
recovery-period ourves. It has been argued that such slow
recoveries of brain function are dependent upon the slowness
ft** - 4ft
of neuronal protein synthesis (Oswald, 1969)* After severe
overdose the patient may be unconscious two days, ill for a
few more, and appear superficially normal after a week, One
is reminded of a kick on the shins, where temporary incapacity
may be followed by only a day or two of limping, yet the bruise
takes a couple of months to disappear. In the brain, repair
after chemical injury can likewise take many weeks.
Evidence accumulates that while sleep may be
a general restorative, the phase known as REM sleep, with its
very high brain blood flow, may be specifically concerned with
brain repair, whereas stages 3 and 4 (EES slow wave) sleep are
especially concerned with general bodily repair (Oswald, 1969)#
It is noteworthy that, in patient 1, Stage 4 sleep took a month
after overdose to re-appear. On the other hand, at a time when
stages 3 and 4 sleep were absent, REM sleep'seemed to have high
priority and was increased above normal. This could hardly
be a non-specific result of sleep interruption since the latter
alone will decrease REM sleep. The observations thus support
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